Publications

  1. Atieh J, Sack J, Thomas R, Rahma OE, Camilleri M, Grover S. Correction to: Gastroparesis Following Immune Checkpoint Inhibitor Therapy: A Case Series. Dig Dis Sci. 2021 Aug; 66 (8):2843-2844
    View PubMed
  2. Kuo B, Scimia C, Dukes G, Zhang W, Gupta S, Chen C, Chuang E, Camilleri M. Randomised clinical trial: safety, pharmacokinetics and pharmacodynamics of trazpiroben (TAK-906), a dopamine D2 /D3 receptor antagonist, in patients with gastroparesis. Aliment Pharmacol Ther. 2021 Aug; 54 (3):267-280 Epub 2021 June 20
    View PubMed
  3. Camilleri M. A Review of Irritable Bowel Syndrome-Reply. JAMA 2021 Jul 13; 326 (2):189-190
    View PubMed
  4. Camilleri M. What is the leaky gut? Clinical considerations in humans. Curr Opin Clin Nutr Metab Care. 2021 Jun 16 Epub 2021 June 16
    View PubMed
  5. Atieh J, Sack J, Thomas R, Rahma OE, Camilleri M, Grover S. Gastroparesis Following Immune Checkpoint Inhibitor Therapy: A Case Series. Dig Dis Sci. 2021 Jun; 66 (6):1974-1980 Epub 2020 Aug 07
    View PubMed
  6. Beinvogl BC, Manini ML, Camilleri M, Donato LJ, Harmsen WS, Absah I, Burch E, Schechter NL, Nurko S. Markers of Bile Acid Metabolism in Pediatric Diarrhea Predominant Irritable Bowel Syndrome and Healthy Controls. J Pediatr Gastroenterol Nutr. 2021 Jun 1; 72 (6):859-865
    View PubMed
  7. Camilleri M, Dilmaghani S, Vosoughi K, Zheng T. A North American perspective on the ESNM consensus statement on gastroparesis. Neurogastroenterol Motil. 2021 May 17; e14174 [Epub ahead of print]
    View PubMed
  8. Camilleri M. New Drugs on the Horizon for Functional and Motility Gastrointestinal Disorders. Gastroenterology. 2021 May 11 [Epub ahead of print]
    View PubMed
  9. Tack J, Camilleri M, Hale M, Morlion B, Nalamachu S, Webster L, Wild J. Establishing Minimal Clinically Important Differences in Quality of Life Measures in Opioid-Induced Constipation. Clin Gastroenterol Hepatol. 2021 May 6 Epub 2021 May 06
    View PubMed
  10. Chedid V, Brandler J, Arndt K, Vijayvargiya P, Wang XJ, Burton D, Harmsen WS, Siegelman J, Chen C, Chen Y, Almansa C, Dukes G, Camilleri M. Randomised study: effects of the 5-HT4 receptor agonist felcisetrag vs placebo on gut transit in patients with gastroparesis. Aliment Pharmacol Ther. 2021 May; 53 (9):1010-1020 Epub 2021 Mar 12
    View PubMed
  11. Wang XJ, Burton DD, Breen-Lyles M, Camilleri M. Gastric accommodation influences proximal gastric and total gastric emptying in concurrent measurements conducted in healthy volunteers. Am J Physiol Gastrointest Liver Physiol. 2021 May 1; 320 (5):G759-G767 Epub 2021 Mar 10
    View PubMed
  12. Vijayvargiya P, Gonzalez Izundegui D, Calderon G, Tawfic S, Batbold S, Saifuddin H, Duggan P, Melo V, Thomas T, Heeney M, Beyde A, Miller J Jr, Valles K, Oyemade K, Brant JF, Atieh J, Donato LJ, Camilleri M. Increased Fecal Bile Acid Excretion in a Significant Subset of Patients with Other Inflammatory Diarrheal Diseases. Dig Dis Sci. 2021 Apr 22 [Epub ahead of print]
    View PubMed
  13. Camilleri M. Towards a new era with safer micro-opiate receptor analgesia. Gut. 2021 Apr 19 [Epub ahead of print]
    View PubMed
  14. Khoshbin K, Khanna L, Maselli D, Atieh J, Breen-Lyles M, Arndt K, Rhoten D, Dyer RB, Singh RJ, Nayar S, Bjerkness S, Harmsen WS, Busciglio I, Camilleri M. Development and Validation of Test for "Leaky Gut" Small Intestinal and Colonic Permeability Using Sugars in Healthy Adults. Gastroenterology. 2021 Apr 16 [Epub ahead of print]
    View PubMed
  15. Wang XJ, Carlson P, Chedid V, Maselli DB, Taylor AL, McKinzie S, Camilleri M. Differential mRNA Expression in Ileal Mucosal Biopsies of Patients With Diarrhea- or Constipation-Predominant Irritable Bowel Syndrome. Clin Transl Gastroenterol. 2021 Apr 12; 12 (4):e00329
    View PubMed
  16. Dilmaghani S, Camilleri M. Epidemiology of gastroparesis: important answers and still more questions. Gut. 2021 Apr; 70 (4):631-632 Epub 2020 July 21
    View PubMed
  17. Wang XJ, Babameto M, Babovic-Vuksanovic D, Bowen JM, Camilleri M. Audit of Gastrointestinal Manifestations in Patients with Loeys-Dietz Syndrome and Vascular Ehlers-Danlos Syndrome. Dig Dis Sci. 2021 Apr; 66 (4):1142-1152 Epub 2020 Apr 18
    View PubMed
  18. Acosta A, Camilleri M, Abu Dayyeh B, Calderon G, Gonzalez D, McRae A, Rossini W, Singh S, Burton D, Clark MM. Selection of Antiobesity Medications Based on Phenotypes Enhances Weight Loss: A Pragmatic Trial in an Obesity Clinic. Obesity (Silver Spring). 2021 Apr; 29 (4):662-671
    View PubMed
  19. Camilleri M. Relationship of motor mechanisms to gastroparesis symptoms: toward individualized treatment. Am J Physiol Gastrointest Liver Physiol. 2021 Apr 1; 320 (4):G558-G563 Epub 2021 Feb 10
    View PubMed
  20. Cifuentes L, Camilleri M, Acosta A. Gastric Sensory and Motor Functions and Energy Intake in Health and Obesity-Therapeutic Implications. Nutrients. 2021 Apr 1; 13 (4) Epub 2021 Apr 01
    View PubMed
  21. Zheng T, Camilleri M. Selecting optimal patients with gastroparesis for G-POEM procedure. Gut. 2021 Mar 30 [Epub ahead of print]
    View PubMed
  22. Calderon G, Patel C, Camilleri M, James-Stevenson T, Bohm M, Siwiec R, Rogers N, Wo J, Lockett C, Gupta A, Xu H, Shin A. Associations of Habitual Dietary Intake With Fecal Short-Chain Fatty Acids and Bowel Functions in Irritable Bowel Syndrome. J Clin Gastroenterol. 2021 Mar 12 [Epub ahead of print]
    View PubMed
  23. Camilleri M. Ten Reasons to Think About Bile Acids in Managing Inflammatory Bowel Disease. J Crohns Colitis. 2021 Mar 5; 15 (3):511-515
    View PubMed
  24. Camilleri M. Diagnosis and Treatment of Irritable Bowel Syndrome: A Review. JAMA. 2021 Mar 2; 325 (9):865-877
    View PubMed
  25. Wang XJ, Gong P, Zhou C, Huang C, Lok UW, Tang S, Taylor A, Eckert D, Chen S, Camilleri M. Liraglutide reduces attenuation coefficient as a measure of hepatic steatosis during 16 weeks' treatment in nondiabetic obese patients: A pilot trial. JGH Open. 2021 Feb; 5 (2):193-198 Epub 2020 Dec 30
    View PubMed
  26. Camilleri M. Human Intestinal Barrier: Effects of Stressors, Diet, Prebiotics, and Probiotics. Clin Transl Gastroenterol. 2021 Jan 25; 12 (1):e00308
    View PubMed
  27. Maselli DB, Camilleri M. Effects of GLP-1 and Its Analogs on Gastric Physiology in Diabetes Mellitus and Obesity. Adv Exp Med Biol. 2021; 1307:171-192
    View PubMed
  28. Khanna L, Camilleri M. Review article: Elobixibat: a novel treatment for chronic constipation. Aliment Pharmacol Ther. 2021 Jan; 53 (2):234-242 Epub 2020 Dec 09
    View PubMed
  29. Barnes NM, Ahern GP, Becamel C, Bockaert J, Camilleri M, Chaumont-Dubel S, Claeysen S, Cunningham KA, Fone KC, Gershon M, Di Giovanni G, Goodfellow NM, Halberstadt AL, Hartley RM, Hassaine G, Herrick-Davis K, Hovius R, Lacivita E, Lambe EK, Leopoldo M, Levy FO, Lummis SCR, Marin P, Maroteaux L, McCreary AC, Nelson DL, Neumaier JF, Newman-Tancredi A, Nury H, Roberts A, Roth BL, Roumier A, Sanger GJ, Teitler M, Sharp T, Villalon CM, Vogel H, Watts SW, Hoyer D. International Union of Basic and Clinical Pharmacology. CX. Classification of Receptors for 5-hydroxytryptamine; Pharmacology and Function. Pharmacol Rev. 2021 Jan; 73 (1):310-520
    View PubMed
  30. Maselli DB, Park SY, Camilleri M. Gastric Motor Functions in Patients with Mood Disorders and Functional Gastroduodenal Symptoms. Psychosom Med. 2020 Dec 4 Epub 2020 Dec 04
    View PubMed
  31. Wang XJ, Chedid V, Vijayvargiya P, Camilleri M. Clinical Features and Associations of Descending Perineum Syndrome in 300 Adults with Constipation in Gastroenterology Referral Practice. Dig Dis Sci. 2020 Dec; 65 (12):3688-3695 Epub 2020 July 14
    View PubMed
  32. Pajot G, Camilleri M, Calderon G, Davis J, Eckert D, Burton D, Acosta A. Association between gastrointestinal phenotypes and weight gain in younger adults: a prospective 4-year cohort study. Int J Obes (Lond). 2020 Dec; 44 (12):2472-2478 Epub 2020 May 15
    View PubMed
  33. Vijayvargiya P, Camilleri M, Carlson P, Nair A, Nord SL, Ryks M, Rhoten D, Burton D, Busciglio I, Lueke A, Harmsen WS, Donato LJ. Effects of Colesevelam on Bowel Symptoms, Biomarkers, and Colonic Mucosal Gene Expression in Patients With Bile Acid Diarrhea in a Randomized Trial. Clin Gastroenterol Hepatol. 2020 Dec; 18 (13):2962-2970.e6 Epub 2020 Feb 21
    View PubMed
  34. Bi D, Choi C, League J, Camilleri M, Prichard DO. Food Residue During Esophagogastroduodenoscopy Is Commonly Encountered and Is Not Pathognomonic of Delayed Gastric Emptying. Dig Dis Sci. 2020 Nov 25 [Epub ahead of print]
    View PubMed
  35. Ford AC, Sperber AD, Corsetti M, Camilleri M. Irritable bowel syndrome. Lancet. 2020 Nov 21; 396 (10263):1675-1688 Epub 2020 Oct 10
    View PubMed
  36. Shin A, Ballou S, Camilleri M, Xu H, Lembo A. Information- and Health-care Seeking Behaviors in Patients With Irritable Bowel Syndrome. Clin Gastroenterol Hepatol. 2020 Nov; 18 (12):2840-2842 Epub 2019 Sept 20
    View PubMed
  37. Vijayvargiya P, Camilleri M, Taylor A, Busciglio I, Loftus EV Jr, Donato LJ. Combined Fasting Serum C4 and Primary Bile Acids From a Single Stool Sample to Diagnose Bile Acid Diarrhea. Gastroenterology. 2020 Nov; 159 (5):1952-1954.e2 Epub 2020 July 06
    View PubMed
  38. Travagli RA, Browning KN, Camilleri M. Parkinson disease and the gut: new insights into pathogenesis and clinical relevance. Nat Rev Gastroenterol Hepatol. 2020 Nov; 17 (11):673-685 Epub 2020 July 31
    View PubMed
  39. Davis J, Camilleri M, Eckert D, Burton D, Joyner M, Acosta A. Physical activity is associated with accelerated gastric emptying and increased ghrelin in obesity. Neurogastroenterol Motil. 2020 Nov; 32 (11):e13879 Epub 2020 May 11
    View PubMed
  40. Khoshbin K, Camilleri M. Effects of dietary components on intestinal permeability in health and disease. Am J Physiol Gastrointest Liver Physiol. 2020 Nov 1; 319 (5):G589-G608 Epub 2020 Sept 09
    View PubMed
  41. Kittah E, Camilleri M, Jensen MD, Vella A. A Pilot Study Examining the Effects of GLP-1 Receptor Blockade Using Exendin-(9,39) on Gastric Emptying and Caloric Intake in Subjects With and Without Bariatric Surgery. Metab Syndr Relat Disord. 2020 Nov; 18 (9):406-412 Epub 2020 Aug 20
    View PubMed
  42. Camilleri M. Irritable Bowel Syndrome: Straightening the road from the Rome criteria. Neurogastroenterol Motil. 2020 Nov; 32 (11):e13957 Epub 2020 Aug 17
    View PubMed
  43. Brandler J, Camilleri M. Pretest and Post-test Probabilities of Diagnoses of Rectal Evacuation Disorders Based on Symptoms, Rectal Exam, and Basic Tests: a Systematic Review. Clin Gastroenterol Hepatol. 2020 Oct; 18 (11):2479-2490 Epub 2019 Dec 04
    View PubMed
  44. Camilleri M, Vijayvargiya P. The Role of Bile Acids in Chronic Diarrhea. Am J Gastroenterol. 2020 Oct; 115 (10):1596-1603
    View PubMed
  45. Marek T, Mahan MA, Amrami KK, Blackburn PR, Caffes PL, Carter JM, Camilleri M, Spinner RJ. Expanding the phenotypic spectrum of lipomatosis of the sciatic nerve: Early-onset colonic diverticular disease. Neurogastroenterol Motil. 2020 Oct; 32 (10):e13917 Epub 2020 June 21
    View PubMed
  46. Camilleri M, Chedid V. Actionable biomarkers: the key to resolving disorders of gastrointestinal function. Gut. 2020 Oct; 69 (10):1730-1737 Epub 2020 Apr 08
    View PubMed
  47. Mars RAT, Yang Y, Ward T, Houtti M, Priya S, Lekatz HR, Tang X, Sun Z, Kalari KR, Korem T, Bhattarai Y, Zheng T, Bar N, Frost G, Johnson AJ, van Treuren W, Han S, Ordog T, Grover M, Sonnenburg J, D'Amato M, Camilleri M, Elinav E, Segal E, Blekhman R, Farrugia G, Swann JR, Knights D, Kashyap PC. Longitudinal Multi-omics Reveals Subset-Specific Mechanisms Underlying Irritable Bowel Syndrome. Cell. 2020 Sep 17; 182 (6):1460-1473.e17 Epub 2020 Sept 10
    View PubMed
  48. Camilleri M, Nord SL, Burton D, Oduyebo I, Zhang Y, Chen J, Im K, Bhad P, Badman MK, Sanders DS, Walters JRF. Randomised clinical trial: significant biochemical and colonic transit effects of the farnesoid X receptor agonist tropifexor in patients with primary bile acid diarrhoea. Aliment Pharmacol Ther. 2020 Sep; 52 (5):808-820 Epub 2020 July 23
    View PubMed
  49. Camilleri M, Brandler J. Refractory Constipation: How to Evaluate and Treat. Gastroenterol Clin North Am. 2020 Sep; 49 (3):623-642 Epub 2020 June 14
    View PubMed
  50. Misawa N, Higurashi T, Takatsu T, Iwaki M, Kobayashi T, Yoshihara T, Ashikari K, Kessoku T, Fuyuki A, Matsuura T, Ohkubo H, Usuda H, Wada K, Naritaka N, Takei H, Nittono H, Matsumoto M, Honda A, Nakajima A, Camilleri M. The benefit of elobixibat in chronic constipation is associated with faecal deoxycholic acid but not effects of altered microbiota. Aliment Pharmacol Ther. 2020 Sep; 52 (5):821-828 Epub 2020 July 20
    View PubMed
  51. Khoshbin K, Busciglio I, Burton D, Breen-Lyles MK, Camilleri M. Expanding criteria for slow colonic transit in patients being evaluated for chronic constipation by scintigraphy. Neurogastroenterol Motil. 2020 Sep; 32 (9):e13878 Epub 2020 May 12
    View PubMed
  52. Atieh J, Chedid V, Khoshbin K, Kane S, Camilleri M. Development of a Score to Predict Positive Colonic Histology in Chronic Diarrhea Assessed in Open-access Colonoscopy. J Clin Gastroenterol. 2020 Aug 21 [Epub ahead of print]
    View PubMed
  53. Vijayvargiya P, Chedid V, Wang XJ, Atieh J, Maselli D, Burton DD, Clark MM, Acosta A, Camilleri M. Associations of gastric volumes, ingestive behavior, calorie and volume intake, and fullness in obesity. Am J Physiol Gastrointest Liver Physiol. 2020 Aug 1; 319 (2):G238-G244 Epub 2020 July 06
    View PubMed
  54. Wang XJ, Camilleri M. A smart toilet for personalized health monitoring. Nat Rev Gastroenterol Hepatol 2020 Aug; 17 (8):453-454
    View PubMed
  55. Manini ML, Barazi A, Khemani D, Abd-Rabu R, Absah I, Fischer PR, Mara K, Stephens M, Camilleri M. Gastrointestinal motility evaluation in children with orthostatic intolerance: Mayo Clinic experience. Neurogastroenterol Motil. 2020 Aug; 32 (8):e13863 Epub 2020 June 01
    View PubMed
  56. Maselli DB, Camilleri M. Pharmacology, Clinical Effects, and Therapeutic Potential of Cannabinoids for Gastrointestinal and Liver Diseases. Clin Gastroenterol Hepatol. 2020 Jul 13 Epub 2020 July 13
    View PubMed
  57. Vijayvargiya P, Gonzalez Izundegui D, Calderon G, Tawfic S, Batbold S, Camilleri M. Fecal Bile Acid Testing in Assessing Patients With Chronic Unexplained Diarrhea: Implications for Healthcare Utilization. Am J Gastroenterol. 2020 Jul; 115 (7):1094-1102
    View PubMed
  58. Vijayvargiya P, Camilleri M, Vijayvargiya P, Erwin P, Murad MH. Systematic review with meta-analysis: efficacy and safety of treatments for opioid-induced constipation. Aliment Pharmacol Ther. 2020 Jul; 52 (1):37-53 Epub 2020 May 27
    View PubMed
  59. Mirza SA, Wentworth AB, Harvey JA, Bridges AG, Camilleri MJ, El-Azhary RA, McEvoy MT, Sartori Valinotti JC, Wetter DA, Davis MDP. Serum triamcinolone levels during intensive, inpatient wet-dressing therapy. Clin Exp Dermatol. 2020 Jul; 45 (5):549-554 Epub 2020 May 14
    View PubMed
  60. Holtmann G, Quigley EM, Shah A, Camilleri M, Tan VP, Gwee KA, Sugano K, Sollano JD, Fock KM, Ghoshal UC, Chen M, Dignass A, Cohen H. "It ain't over ... till it's over!" Risk-mitigation strategies for patients with gastrointestinal diseases in the aftermath of the COVID-19 pandemic. J Gastroenterol Hepatol. 2020 Jul; 35 (7):1117-1123 Epub 2020 June 29
    View PubMed
  61. Liu A, Chedid V, Wang XJ, Vijayvargiya P, Camilleri M. Clinical presentation and characteristics of pelvic floor myofascial pain in patients presenting with constipation. Neurogastroenterol Motil. 2020 Jul; 32 (7):e13845 Epub 2020 Apr 13
    View PubMed
  62. Camilleri M. Sex as a biological variable in irritable bowel syndrome. Neurogastroenterol Motil. 2020 Jul; 32 (7):e13802 Epub 2020 Jan 13
    View PubMed
  63. Camilleri M, Lembo A, McCallum R, Tourkodimitris S, Kemps L, Miller MB, Bertelsen K, Iacob A. Overall safety of relamorelin in adults with diabetic gastroparesis: Analysis of phase 2a and 2b trial data. Aliment Pharmacol Ther. 2020 Jun; 51 (11):1139-1148 Epub 2020 Apr 17
    View PubMed
  64. Vijayvargiya P, Gonzalez Izundegui D, Calderon G, Tawfic S, Batbold S, Camilleri M. Fecal Bile Acid Testing in Assessing Patients With Chronic Unexplained Diarrhea: Implications for Healthcare Utilization. Am J Gastroenterol. 2020 May 22 [Epub ahead of print]
    View PubMed
  65. Kadouh H, Chedid V, Halawi H, Burton DD, Clark MM, Khemani D, Vella A, Acosta A, Camilleri M. GLP-1 Analog Modulates Appetite, Taste Preference, Gut Hormones, and Regional Body Fat Stores in Adults with Obesity. J Clin Endocrinol Metab. 2020 May 1; 105 (5)
    View PubMed
  66. Calderon G, McRae A, Rievaj J, Davis J, Zandvakili I, Linker-Nord S, Burton D, Roberts G, Reimann F, Gedulin B, Vella A, LaRusso NF, Camilleri M, Gribble FM, Acosta A. Ileo-colonic delivery of conjugated bile acids improves glucose homeostasis via colonic GLP-1-producing enteroendocrine cells in human obesity and diabetes. EBioMedicine. 2020 May; 55:102759 Epub 2020 Apr 25
    View PubMed
  67. Brandler J, Miller LJ, Wang XJ, Burton D, Busciglio I, Arndt K, Harmsen WS, Camilleri M. Secretin effects on gastric functions, hormones and symptoms in functional dyspepsia and health: randomized crossover trial. Am J Physiol Gastrointest Liver Physiol. 2020 Apr 1; 318 (4):G635-G645 Epub 2020 Feb 10
    View PubMed
  68. Rangan V, Ballou S, Shin A, Camilleri M, Lembo A, Beth Israel Deaconess Medical Center GI Motility Working Group. Use of Treatments for Irritable Bowel Syndrome and Patient Satisfaction Based on the IBS in America Survey. Gastroenterology. 2020 Feb; 158 (3):786-788.e1 Epub 2019 Nov 09
    View PubMed
  69. Desai A, Low PA, Camilleri M, Singer W, Burton D, Chakraborty S, Bharucha AE. Utility of the plasma pancreatic polypeptide response to modified sham feeding in diabetic gastroenteropathy and non-ulcer dyspepsia. Neurogastroenterol Motil. 2020 Feb; 32 (2):e13744 Epub 2019 Oct 22
    View PubMed
  70. Sadowski DC, Camilleri M, Chey WD, Leontiadis GI, Marshall JK, Shaffer EA, Tse F, Walters JRF. Canadian Association of Gastroenterology Clinical Practice Guideline on the Management of Bile Acid Diarrhea. J Can Assoc Gastroenterol. 2020 Feb; 3 (1):e10-e27 Epub 2019 Dec 06
    View PubMed
  71. Black CJ, Yuan Y, Selinger CP, Camilleri M, Quigley EMM, Moayyedi P, Ford AC. Efficacy of soluble fibre, antispasmodic drugs, and gut-brain neuromodulators in irritable bowel syndrome: a systematic review and network meta-analysis. Lancet Gastroenterol Hepatol. 2020 Feb; 5 (2):117-131 Epub 2019 Dec 16
    View PubMed
  72. Sadowski DC, Camilleri M, Chey WD, Leontiadis GI, Marshall JK, Shaffer EA, Tse F, Walters JRF. Canadian Association of Gastroenterology Clinical Practice Guideline on the Management of Bile Acid Diarrhea. Clin Gastroenterol Hepatol. 2020 Jan; 18 (1):24-41.e1 Epub 2019 Sept 14
    View PubMed
  73. Camilleri M, Sandler RS, Peery AF. Etiopathogenetic Mechanisms in Diverticular Disease of the Colon. Cell Mol Gastroenterol Hepatol. 2020; 9 (1):15-32 Epub 2019 July 25
    View PubMed
  74. Black CJ, Burr NE, Camilleri M, Earnest DL, Quigley EM, Moayyedi P, Houghton LA, Ford AC. Efficacy of pharmacological therapies in patients with IBS with diarrhoea or mixed stool pattern: systematic review and network meta-analysis. Gut. 2020 Jan; 69 (1):74-82 Epub 2019 Apr 17
    View PubMed
  75. Vargas EJ, Bazerbachi F, Calderon G, Prokop LJ, Gomez V, Murad MH, Acosta A, Camilleri M, Abu Dayyeh BK. Changes in Time of Gastric Emptying After Surgical and Endoscopic Bariatrics and Weight Loss: A Systematic Review and Meta-Analysis. Clin Gastroenterol Hepatol. 2020 Jan; 18 (1):57-68.e5 Epub 2019 Apr 04
    View PubMed
  76. Vriesman MH, Koppen IJN, Camilleri M, Di Lorenzo C, Benninga MA. Management of functional constipation in children and adults. Nat Rev Gastroenterol Hepatol. 2020 Jan; 17 (1):21-39 Epub 2019 Nov 05
    View PubMed
  77. Anderson B, Carlson P, Laurenti M, Vella A, Camilleri M, Desai A, Feuerhak K, Bharucha AE. Association between allelic variants in the glucagon-like peptide 1 and cholecystokinin receptor genes with gastric emptying and glucose tolerance. Neurogastroenterol Motil. 2020 Jan; 32 (1):e13724 Epub 2019 Nov 05
    View PubMed
  78. Brandler JB, Sweetser S, Khoshbin K, Babameto M, Prokop LJ, Camilleri M. Colonic Manifestations and Complications Are Relatively Under-Reported in Systemic Sclerosis: A Systematic Review. Am J Gastroenterol. 2019 Dec; 114 (12):1847-1856
    View PubMed
  79. Ballou S, McMahon C, Lee HN, Katon J, Shin A, Rangan V, Singh P, Nee J, Camilleri M, Lembo A, Iturrino J. Effects of Irritable Bowel Syndrome on Daily Activities Vary Among Subtypes Based on Results From the IBS in America Survey. Clin Gastroenterol Hepatol. 2019 Nov; 17 (12):2471-2478.e3 Epub 2019 Aug 13
    View PubMed
  80. Manini ML, Camilleri M. How does one choose the appropriate pharmacotherapy for pediatric patients with functional dyspepsia? Expert Opin Pharmacother 2019 Nov; 20 (16):1921-1924 Epub 2019 Aug 06
    View PubMed
  81. Camilleri M. What's in the pipeline for lower functional gastrointestinal disorders in the next 5 years? Am J Physiol Gastrointest Liver Physiol. 2019 Nov 1; 317 (5):G640-G650 Epub 2019 Aug 28
    View PubMed
  82. Luthra P, Camilleri M, Burr NE, Quigley EMM, Black CJ, Ford AC. Efficacy of drugs in chronic idiopathic constipation: a systematic review and network meta-analysis. Lancet Gastroenterol Hepatol. 2019 Nov; 4 (11):831-844 Epub 2019 Aug 29
    View PubMed
  83. Wang XJ, Camilleri M. Hirschsprung disease: Insights on genes, penetrance, and prenatal diagnosis. Neurogastroenterol Motil. 2019 Nov; 31 (11):e13732
    View PubMed
  84. Smushkin G, Sathananthan A, Man CD, Camilleri M, Cobelli C, Rizza RA, Vella A. Letter to the Editor: "Defects in GLP-1 Response to an Oral Challenge Do Not Play a Significant Role in the Pathogenesis of Prediabetes". J Clin Endocrinol Metab 2019 Nov 1; 104 (11):5106-5107
    View PubMed
  85. Vijayvargiya P, Gonsalves W, Burton D, Hogan WJ, Miceli T, Rossini W, Taylor A, Lueke A, Donato L, Camilleri M. Increased fecal primary bile acids in multiple myeloma with engraftment syndrome diarrhea after stem cell transplant. Bone Marrow Transplant. 2019 Nov; 54 (11):1898-1907 Epub 2019 May 31
    View PubMed
  86. Camilleri M, Staiano A. Insights on Obesity in Children and Adults: Individualizing Management. Trends Endocrinol Metab. 2019 Oct; 30 (10):724-734 Epub 2019 Aug 06
    View PubMed
  87. Brenner DM, Hu Y, Datto C, Creanga D, Camilleri M. Response to Luthra et al. Am J Gastroenterol 2019 Oct; 114 (10):1695
    View PubMed
  88. Chakraborty S, Desai A, Halland M, Burton D, Camilleri M, Zinsmeister AR, Bharucha AE. Relationship between symptoms during a gastric emptying study and intestinal chemosensitivity with daily symptoms. Neurogastroenterol Motil. 2019 Oct; 31 (10):e13686 Epub 2019 July 21
    View PubMed
  89. Wang XJ, Camilleri M. Chronic Megacolon Presenting in Adolescents or Adults: Clinical Manifestations, Diagnosis, and Genetic Associations. Dig Dis Sci. 2019 Oct; 64 (10):2750-2756 Epub 2019 Apr 05
    View PubMed
  90. Wang XJ, Camilleri M, Vanner S, Tuck C. Review article: biological mechanisms for symptom causation by individual FODMAP subgroups - the case for a more personalised approach to dietary restriction. Aliment Pharmacol Ther. 2019 Sep; 50 (5):517-529 Epub 2019 July 15
    View PubMed
  91. Camilleri M. Leaky gut: mechanisms, measurement and clinical implications in humans. Gut. 2019 Aug; 68 (8):1516-1526 Epub 2019 May 10
    View PubMed
  92. Vijayvargiya P, Camilleri M. Use of prucalopride in adults with chronic idiopathic constipation. Expert Rev Clin Pharmacol. 2019 Jul; 12 (7):579-589 Epub 2019 May 23
    View PubMed
  93. Camilleri M, Vakil N. Microbiome: In Search of Mechanistic Information and Relevance. Am J Gastroenterol. 2019 Jul; 114 (7):1014-1016
    View PubMed
  94. Camilleri M, Lyle BJ, Madsen KL, Sonnenburg J, Verbeke K, Wu GD. Role for diet in normal gut barrier function: developing guidance within the framework of food-labeling regulations. Am J Physiol Gastrointest Liver Physiol. 2019 Jul 1; 317 (1):G17-G39 Epub 2019 May 24
    View PubMed
  95. Chedid V, Camilleri M. Assessing the efficacy of peripherally acting mu-opioid receptor antagonists (PAMORAs) in the treatment of opioid-induced constipation. Gut 2019 Jun; 68 (6):1133-1134 Epub 2018 June 08
    View PubMed
  96. Chakraborty S, Halland M, Burton D, Desai A, Neja B, Low P, Singer W, Camilleri M, Zinsmeister AR, Bharucha AE. GI Dysfunctions in Diabetic Gastroenteropathy, Their Relationships With Symptoms, and Effects of a GLP-1 Antagonist. J Clin Endocrinol Metab. 2019 Jun 1; 104 (6):1967-1977
    View PubMed
  97. Brenner DM, Hu Y, Datto C, Creanga D, Camilleri M. A Randomized, Multicenter, Prospective, Crossover, Open-Label Study of Factors Associated With Patient Preferences for Naloxegol or PEG 3350 for Opioid-Induced Constipation. Am J Gastroenterol. 2019 Jun; 114 (6):954-963
    View PubMed
  98. Chedid V, Halawi H, Brandler J, Burton D, Camilleri M. Gastric accommodation measurements by single photon emission computed tomography and two-dimensional scintigraphy in diabetic patients with upper gastrointestinal symptoms. Neurogastroenterol Motil. 2019 Jun; 31 (6):e13581 Epub 2019 Mar 13
    View PubMed
  99. Vijayvargiya P, Jameie-Oskooei S, Camilleri M, Chedid V, Erwin PJ, Murad MH. Association between delayed gastric emptying and upper gastrointestinal symptoms: a systematic review and meta-analysis. Gut. 2019 May; 68 (5):804-813 Epub 2018 June 02
    View PubMed
  100. Saffouri GB, Shields-Cutler RR, Chen J, Yang Y, Lekatz HR, Hale VL, Cho JM, Battaglioli EJ, Bhattarai Y, Thompson KJ, Kalari KK, Behera G, Berry JC, Peters SA, Patel R, Schuetz AN, Faith JJ, Camilleri M, Sonnenburg JL, Farrugia G, Swann JR, Grover M, Knights D, Kashyap PC. Small intestinal microbial dysbiosis underlies symptoms associated with functional gastrointestinal disorders. Nat Commun. 2019 May 1; 10 (1):2012 Epub 2019 May 01
    View PubMed
  101. Nakajima A, Taniguchi S, Kurosu S, Gillberg PG, Mattsson JP, Camilleri M. Efficacy, long-term safety, and impact on quality of life of elobixibat in more severe constipation: Post hoc analyses of two phase 3 trials in Japan. Neurogastroenterol Motil. 2019 May; 31 (5):e13571 Epub 2019 Feb 21
    View PubMed
  102. Vijayvargiya P, Camilleri M, Chedid V, Mandawat A, Erwin PJ, Murad MH. Effects of Promotility Agents on Gastric Emptying and Symptoms: A Systematic Review and Meta-analysis. Gastroenterology. 2019 May; 156 (6):1650-1660 Epub 2019 Jan 31
    View PubMed
  103. Vijayvargiya P, Camilleri M, Chedid V, Carlson P, Busciglio I, Burton D, Donato LJ. Analysis of Fecal Primary Bile Acids Detects Increased Stool Weight and Colonic Transit in Patients With Chronic Functional Diarrhea. Clin Gastroenterol Hepatol. 2019 Apr; 17 (5):922-929.e2 Epub 2018 June 12
    View PubMed
  104. Alexander JA, Ravi K, Geno DM, Tholen CJ, Higginbotham TC, Wildhorn S, Camilleri M, Vaezi MF, Katzka DA. Comparison of mucosal impedance measurements throughout the esophagus and mucosal eosinophil counts in endoscopic biopsy specimens in eosinophilic esophagitis. Gastrointest Endosc. 2019 Apr; 89 (4):693-700.e1 Epub 2018 Aug 24
    View PubMed
  105. Camilleri M, Wieben E, Eckert D, Carlson P, Hurley O'Dwyer R, Gibbons D, Acosta A, Klee EW. Familial chronic megacolon presenting in childhood or adulthood: Seeking the presumed gene association. Neurogastroenterol Motil. 2019 Apr; 31 (4):e13550 Epub 2019 Jan 20
    View PubMed
  106. Camilleri M, Carlson P, Chedid V, Vijayvargiya P, Burton D, Busciglio I. Aquaporin Expression in Colonic Mucosal Biopsies From Irritable Bowel Syndrome With Diarrhea. Clin Transl Gastroenterol. 2019 Apr; 10 (4):e00019
    View PubMed
  107. Revicki DA, Speck RM, Lavoie S, Puelles J, Kuo B, Camilleri M, Almansa C, Parkman HP. The American neurogastroenterology and motility society gastroparesis cardinal symptom index-daily diary (ANMS GCSI-DD): Psychometric evaluation in patients with idiopathic or diabetic gastroparesis. Neurogastroenterol Motil. 2019 Apr; 31 (4):e13553 Epub 2019 Feb 07
    View PubMed
  108. Wang XJ, Camilleri M. Personalized medicine in functional gastrointestinal disorders: Understanding pathogenesis to increase diagnostic and treatment efficacy. World J Gastroenterol. 2019 Mar 14; 25 (10):1185-1196
    View PubMed
  109. Camilleri M. Implications of Pharmacogenomics to the Management of IBS. Clin Gastroenterol Hepatol. 2019 Mar; 17 (4):584-594 Epub 2018 Apr 27
    View PubMed
  110. Vijayvargiya P, Camilleri M, Burton D, Busciglio I, Lueke A, Donato LJ. Bile and fat excretion are biomarkers of clinically significant diarrhoea and constipation in irritable bowel syndrome. Aliment Pharmacol Ther. 2019 Mar; 49 (6):744-758 Epub 2019 Feb 10
    View PubMed
  111. Camilleri M. Gastrointestinal hormones and regulation of gastric emptying. Curr Opin Endocrinol Diabetes Obes. 2019 Feb; 26 (1):3-10
    View PubMed
  112. Lacy BE, Crowell MD, Camilleri M. The Challenges of Gastroparesis: Changing Study Design to Improve Clinical Care. Am J Gastroenterol. 2019 Jan; 114 (1):1-3
    View PubMed
  113. Szarka LA, Camilleri M. Evaluation of Patients with Suspected Gastroparesis. Gastrointest Endosc Clin N Am. 2019 Jan; 29 (1):39-54 Epub 2018 Sept 11
    View PubMed
  114. Chedid V, Brandler J, Vijayvargiya P, Park SY, Szarka LA, Camilleri M. Characterization of Upper Gastrointestinal Symptoms, Gastric Motor Functions, and Associations in Patients with Diabetes at a Referral Center. Am J Gastroenterol. 2019 Jan; 114 (1):143-154
    View PubMed
  115. Chedid V, Vijayvargiya P, Halawi H, Park SY, Camilleri M. Audit of the diagnosis of rectal evacuation disorders in chronic constipation. Neurogastroenterol Motil. 2019 Jan; 31 (1):e13510 Epub 2018 Nov 13
    View PubMed
  116. Revicki DA, Lavoie S, Speck RM, Puelles J, Kuo B, Camilleri M, Almansa C, Parkman HP. The content validity of the ANMS GCSI-DD in patients with idiopathic or diabetic gastroparesis. J Patient Rep Outcomes. 2018 Dec 13; 2 (1):61
    View PubMed
  117. Camilleri M. Anal Achalasia: The Rat Tail Gas Sign. Clin Gastroenterol Hepatol. 2018 Dec; 16 (12):e124 Epub 2018 June 15
    View PubMed
  118. Tack J, Camilleri M. New developments in the treatment of gastroparesis and functional dyspepsia. Curr Opin Pharmacol. 2018 Dec; 43:111-117 Epub 2018 Sept 21
    View PubMed
  119. Camilleri M. Management Options for Irritable Bowel Syndrome. Mayo Clin Proc. 2018 Dec; 93 (12):1858-1872
    View PubMed
  120. Camilleri M, Chedid V, Ford AC, Haruma K, Horowitz M, Jones KL, Low PA, Park SY, Parkman HP, Stanghellini V. Gastroparesis. Nat Rev Dis Primers. 2018 Nov 1; 4 (1):41 Epub 2018 Nov 01
    View PubMed
  121. Camilleri M, Acosta A. Combination Therapies for Obesity. Metab Syndr Relat Disord. 2018 Oct; 16 (8):390-394 Epub 2018 July 11
    View PubMed
  122. Desai A, O'Connor M, Neja B, Delaney K, Camilleri M, Zinsmeister AR, Bharucha AE. Reproducibility of gastric emptying assessed with scintigraphy in patients with upper GI symptoms. Neurogastroenterol Motil. 2018 Oct; 30 (10):e13365 Epub 2018 May 02
    View PubMed
  123. Chedid V, Vijayvargiya P, Camilleri M. Elobixibat for the treatment of constipation. Expert Rev Gastroenterol Hepatol. 2018 Oct; 12 (10):951-960 Epub 2018 Sept 20
    View PubMed
  124. Garcia-Etxebarria K, Zheng T, Bonfiglio F, Bujanda L, Dlugosz A, Lindberg G, Schmidt PT, Karling P, Ohlsson B, Simren M, Walter S, Nardone G, Cuomo R, Usai-Satta P, Galeazzi F, Neri M, Portincasa P, Bellini M, Barbara G, Jonkers D, Eswaran S, Chey WD, Kashyap P, Chang L, Mayer EA, Wouters MM, Boeckxstaens G, Camilleri M, Franke A, D'Amato M. Increased Prevalence of Rare Sucrase-isomaltase Pathogenic Variants in Irritable Bowel Syndrome Patients. Clin Gastroenterol Hepatol. 2018 Oct; 16 (10):1673-1676 Epub 2018 Feb 21
    View PubMed
  125. Camilleri M. Cannabinoids and gastrointestinal motility: Pharmacology, clinical effects, and potential therapeutics in humans. Neurogastroenterol Motil. 2018 Sep; 30 (9):e13370 Epub 2018 May 10
    View PubMed
  126. Fox MR, Kahrilas PJ, Roman S, Gyawali CP, Scott SM, Rao SS, Keller J, Camilleri M, International Working Group for Disorders of Gastrointestinal Motility and Function. Clinical measurement of gastrointestinal motility and function: who, when and which test? Nat Rev Gastroenterol Hepatol. 2018 Sep; 15 (9):568-579
    View PubMed
  127. Tack J, Corsetti M, Camilleri M, Quigley EM, Simren M, Suzuki H, Talley NJ, Tornblom H, Van Oudenhove L. Plausibility criteria for putative pathophysiological mechanisms in functional gastrointestinal disorders: a consensus of experts. Gut. 2018 Aug; 67 (8):1425-1433 Epub 2017 Aug 16
    View PubMed
  128. Nakajima A, Seki M, Taniguchi S, Ohta A, Gillberg PG, Mattsson JP, Camilleri M. Safety and efficacy of elobixibat for chronic constipation: results from a randomised, double-blind, placebo-controlled, phase 3 trial and an open-label, single-arm, phase 3 trial. Lancet Gastroenterol Hepatol. 2018 Aug; 3 (8):537-547 Epub 2018 May 25
    View PubMed
  129. Waldman SA, Camilleri M. Guanylate cyclase-C as a therapeutic target in gastrointestinal disorders. Gut. 2018 Aug; 67 (8):1543-1552 Epub 2018 Mar 21
    View PubMed
  130. Bonfiglio F, Zheng T, Garcia-Etxebarria K, Hadizadeh F, Bujanda L, Bresso F, Agreus L, Andreasson A, Dlugosz A, Lindberg G, Schmidt PT, Karling P, Ohlsson B, Simren M, Walter S, Nardone G, Cuomo R, Usai-Satta P, Galeazzi F, Neri M, Portincasa P, Bellini M, Barbara G, Latiano A, Hubenthal M, Thijs V, Netea MG, Jonkers D, Chang L, Mayer EA, Wouters MM, Boeckxstaens G, Camilleri M, Franke A, Zhernakova A, D'Amato M. Female-Specific Association Between Variants on Chromosome 9 and Self-Reported Diagnosis of Irritable Bowel Syndrome. Gastroenterology. 2018 Jul; 155 (1):168-179 Epub 2018 Apr 05
    View PubMed
  131. Chedid V, Vijayvargiya P, Carlson P, Van Malderen K, Acosta A, Acosta A, Zinsmeister A, Camilleri M. Allelic variant in the glucagon-like peptide 1 receptor gene associated with greater effect of liraglutide and exenatide on gastric emptying: A pilot pharmacogenetics study. Neurogastroenterol Motil. 2018 Jul; 30 (7):e13313 Epub 2018 Feb 28
    View PubMed
  132. Edogawa S, Peters SA, Jenkins GD, Gurunathan SV, Sundt WJ, Johnson S, Lennon RJ, Dyer RB, Camilleri M, Kashyap PC, Farrugia G, Chen J, Singh RJ, Grover M. Sex differences in NSAID-induced perturbation of human intestinal barrier function and microbiota. FASEB J. 2018 Jun 13; fj201800560R Epub 2018 June 13
    View PubMed
  133. Aburub A, Fischer M, Camilleri M, Semler JR, Fadda HM. Comparison of pH and motility of the small intestine of healthy subjects and patients with symptomatic constipation using the wireless motility capsule. Int J Pharm. 2018 Jun 10; 544 (1):158-164 Epub 2018 Apr 17
    View PubMed
  134. Giudicessi JR, Ackerman MJ, Camilleri M. Cardiovascular safety of prokinetic agents: A focus on drug-induced arrhythmias. Neurogastroenterol Motil. 2018 Jun; 30 (6):e13302 Epub 2018 Feb 14
    View PubMed
  135. Camilleri M. Toward an effective peripheral visceral analgesic: responding to the national opioid crisis. Am J Physiol Gastrointest Liver Physiol. 2018 Jun 1; 314 (6):G637-G646 Epub 2018 Feb 22
    View PubMed
  136. van Malderen K, Vijayvargiya P, Camilleri M, Larson DW, Cima R. Malignancy and Meckel's diverticulum: A systematic literature review and 14-year experience at a tertiary referral center. United European Gastroenterol J. 2018 Jun; 6 (5):739-747 Epub 2018 Jan 16
    View PubMed
  137. Lacy BE, Parkman HP, Camilleri M. Chronic nausea and vomiting: evaluation and treatment. Am J Gastroenterol. 2018 May; 113 (5):647-659 Epub 2018 Mar 15
    View PubMed
  138. Oduyebo I, Camilleri M, Nelson AD, Khemani D, Nord SL, Busciglio I, Burton D, Rhoten D, Ryks M, Carlson P, Donato L, Lueke A, Kim K, Rossi SJ, Zinsmeister AR. Effects of NGM282, an FGF19 variant, on colonic transit and bowel function in functional constipation: a randomized phase 2 trial. Am J Gastroenterol. 2018 May; 113 (5):725-734 Epub 2018 May 02
    View PubMed
  139. Keller J, Bassotti G, Clarke J, Dinning P, Fox M, Grover M, Hellstrom PM, Ke M, Layer P, Malagelada C, Parkman HP, Scott SM, Tack J, Simren M, Tornblom H, Camilleri M, International Working Group for Disorders of Gastrointestinal Motility and Function. Expert consensus document: Advances in the diagnosis and classification of gastric and intestinal motility disorders. Nat Rev Gastroenterol Hepatol. 2018 May; 15 (5):291-308 Epub 2018 Apr 06
    View PubMed
  140. van Malderen K, Halawi H, Camilleri M. Insights on efficacious doses of PAMORAs for patients on chronic opioid therapy or opioid-naive patients. Neurogastroenterol Motil. 2018 May; 30 (5):e13250 Epub 2017 Nov 09
    View PubMed
  141. Halawi H, Vijayvargiya P, Busciglio I, Oduyebo I, Khemani D, Ryks M, Rhoten D, Burton D, Szarka LA, Acosta A, Acosta A, Camilleri M. Effects of naloxegol on whole gut transit in opioid-naive healthy subjects receiving codeine: A randomized, controlled trial. Neurogastroenterol Motil. 2018 May; 30 (5):e13298 Epub 2018 Feb 06
    View PubMed
  142. Vijayvargiya P, Busciglio I, Burton D, Donato L, Lueke A, Camilleri M. Bile Acid Deficiency in a Subgroup of Patients With Irritable Bowel Syndrome With Constipation Based on Biomarkers in Serum and Fecal Samples. Clin Gastroenterol Hepatol. 2018 Apr; 16 (4):522-527 Epub 2017 June 27
    View PubMed
  143. Khera R, Pandey A, Chandar AK, Murad MH, Prokop LJ, Neeland IJ, Berry JD, Camilleri M, Singh S. Effects of Weight-Loss Medications on Cardiometabolic Risk Profiles: A Systematic Review and Network Meta-analysis. Gastroenterology. 2018 Apr; 154 (5):1309-1319.e7 Epub 2018 Jan 03
    View PubMed
  144. Manini ML, Camilleri M, Grothe R, Di Lorenzo C. Application of Pyridostigmine in Pediatric Gastrointestinal Motility Disorders: A Case Series. Paediatr Drugs. 2018 Apr; 20 (2):173-180
    View PubMed
  145. Vijayvargiya P, Camilleri M. Update on Bile Acid Malabsorption: Finally Ready for Prime Time? Curr Gastroenterol Rep. 2018 Mar 26; 20 (3):10
    View PubMed
  146. Vijayvargiya P, Camilleri M, Cima RR. COL1A1 Mutations Presenting as Descending Perineum Syndrome in a Young Patient With Hypermobility Syndrome. Mayo Clin Proc. 2018 Mar; 93 (3):386-391
    View PubMed
  147. Herrick LM, Camilleri M, Schleck CD, Zinsmeister AR, Saito YA, Talley NJ. Effects of Amitriptyline and Escitalopram on Sleep and Mood in Patients With Functional Dyspepsia. Clin Gastroenterol Hepatol. 2018 Mar; 16 (3):401-406.e2 Epub 2017 Dec 01
    View PubMed
  148. Henstrom M, Diekmann L, Bonfiglio F, Hadizadeh F, Kuech EM, von Kockritz-Blickwede M, Thingholm LB, Zheng T, Assadi G, Dierks C, Heine M, Philipp U, Distl O, Money ME, Belheouane M, Heinsen FA, Rafter J, Nardone G, Cuomo R, Usai-Satta P, Galeazzi F, Neri M, Walter S, Simren M, Karling P, Ohlsson B, Schmidt PT, Lindberg G, Dlugosz A, Agreus L, Andreasson A, Mayer E, Baines JF, Engstrand L, Portincasa P, Bellini M, Stanghellini V, Barbara G, Chang L, Camilleri M, Franke A, Naim HY, D'Amato M. Functional variants in the sucrase-isomaltase gene associate with increased risk of irritable bowel syndrome. Gut. 2018 Feb; 67 (2):263-270 Epub 2016 Nov 21
    View PubMed
  149. Lacy BE, Saito YA, Camilleri M, Bouras E, DiBaise JK, Herrick LM, Szarka LA, Tilkes K, Zinsmeister AR, Talley NJ. Effects of Antidepressants on Gastric Function in Patients with Functional Dyspepsia. Am J Gastroenterol. 2018 Feb; 113 (2):216-224 Epub 2017 Dec 19
    View PubMed
  150. Donato LJ, Lueke A, Kenyon SM, Meeusen JW, Camilleri M. Description of analytical method and clinical utility of measuring serum 7-alpha-hydroxy-4-cholesten-3-one (7aC4) by mass spectrometry. Clin Biochem. 2018 Feb; 52:106-111 Epub 2017 Oct 16
    View PubMed
  151. van Malderen K, Camilleri M. Large Meckel's Diverticulum and Dilated Adjacent Small Intestine Presenting With Intestinal Obstruction. Clin Gastroenterol Hepatol. 2018 Jan; 16 (1):A33 Epub 2017 Sept 09
    View PubMed
  152. Saito YA, Camilleri M. Editorial: patient assessment of constipation-symptoms (PAC-SYM) questionnaire has a minimal important difference. Aliment Pharmacol Ther 2018 Jan; 47 (1):138-139
    View PubMed
  153. Camilleri M, Ford AC, Mawe GM, Dinning PG, Rao SS, Chey WD, Simren M, Lembo A, Young-Fadok TM, Chang L. Chronic constipation. Nat Rev Dis Primers. 2017 Dec 14; 3:17095
    View PubMed
  154. Halawi H, Khemani D, Eckert D, O'Neill J, Kadouh H, Grothe K, Clark MM, Burton DD, Vella A, Acosta A, Zinsmeister AR, Camilleri M. Effects of liraglutide on weight, satiation, and gastric functions in obesity: a randomised, placebo-controlled pilot trial. Lancet Gastroenterol Hepatol. 2017 Dec; 2 (12):890-899 Epub 2017 Sept 27
    View PubMed
  155. Camilleri M, Wilcox CM, El-Serag HB, Kanwal F. Anniversary Tribute From the Editors of Clinical Gastroenterology and Hepatology. Clin Gastroenterol Hepatol. 2017 Dec; 15 (12):1823-1827 Epub 2017 Sept 12
    View PubMed
  156. Paterson W, Camilleri M, Simren M, Boeckxstaens G, Vanner SJ. Breath Testing Consensus Guidelines for SIBO: RES IPSA LOCQUITOR. Am J Gastroenterol 2017 Dec; 112 (12):1888-1889
    View PubMed
  157. Malhi H, Camilleri M. Modulating bile acid pathways and TGR5 receptors for treating liver and GI diseases. Curr Opin Pharmacol. 2017 Dec; 37:80-86 Epub 2017 Nov 05
    View PubMed
  158. Bazerbachi F, Haffar S, Szarka LA, Wang Z, Prokop LJ, Murad MH, Camilleri M. Secretory diarrhea and hypokalemia associated with colonic pseudo-obstruction: A case study and systematic analysis of the literature. Neurogastroenterol Motil. 2017 Nov; 29 (11) Epub 2017 June 05
    View PubMed
  159. Park SY, Camilleri M, Packer D, Monahan K. Upper gastrointestinal complications following ablation therapy for atrial fibrillation. Neurogastroenterol Motil. 2017 Nov; 29 (11) Epub 2017 May 19
    View PubMed
  160. Vella A, Camilleri M. The Gastrointestinal Tract as an Integrator of Mechanical and Hormonal Response to Nutrient Ingestion. Diabetes. 2017 Nov; 66 (11):2729-2737
    View PubMed
  161. Jacob D, Busciglio I, Burton D, Halawi H, Oduyebo I, Rhoten D, Ryks M, Harmsen WS, Camilleri M. Effects of NK1 receptors on gastric motor functions and satiation in healthy humans: results from a controlled trial with the NK1 antagonist aprepitant. Am J Physiol Gastrointest Liver Physiol. 2017 Nov 1; 313 (5):G505-G510 Epub 2017 Aug 16
    View PubMed
  162. Park SY, Acosta A, Camilleri M, Burton D, Harmsen WS, Fox J, Szarka LA. Gastric Motor Dysfunction in Patients With Functional Gastroduodenal Symptoms. Am J Gastroenterol. 2017 Nov; 112 (11):1689-1699 Epub 2017 Sept 12
    View PubMed
  163. Camilleri M, McCallum RW, Tack J, Spence SC, Gottesdiener K, Fiedorek FT. Efficacy and Safety of Relamorelin in Diabetics With Symptoms of Gastroparesis: A Randomized, Placebo-Controlled Study. Gastroenterology. 2017 Nov; 153 (5):1240-1250.e2 Epub 2017 July 29
    View PubMed
  164. Halawi H, Camilleri M, Acosta A, Vazquez-Roque M, Oduyebo I, Burton D, Busciglio I, Zinsmeister AR. Relationship of gastric emptying or accommodation with satiation, satiety, and postprandial symptoms in health. Am J Physiol Gastrointest Liver Physiol. 2017 Nov 1; 313 (5):G442-G447 Epub 2017 Aug 03
    View PubMed
  165. Camilleri M, Ford AC. Pharmacotherapy for Irritable Bowel Syndrome. J Clin Med. 2017 Oct 27; 6 (11)
    View PubMed
  166. Chedid V, Camilleri M. Relamorelin for the treatment of gastrointestinal motility disorders. Expert Opin Investig Drugs. 2017 Oct; 26 (10):1189-1197 Epub 2017 Aug 31
    View PubMed
  167. Nelson AD, Camilleri M, Chirapongsathorn S, Vijayvargiya P, Valentin N, Shin A, Erwin PJ, Wang Z, Murad MH. Comparison of efficacy of pharmacological treatments for chronic idiopathic constipation: a systematic review and network meta-analysis. Gut. 2017 Sep; 66 (9):1611-1622 Epub 2016 June 10
    View PubMed
  168. Camilleri M, Lembo A, Katzka DA. Opioids in Gastroenterology: Treating Adverse Effects and Creating Therapeutic Benefits. Clin Gastroenterol Hepatol. 2017 Sep; 15 (9):1338-1349 Epub 2017 May 19
    View PubMed
  169. Vijayvargiya P, Camilleri M, Carlson P, Lueke A, O'Neill J, Burton D, Busciglio I, Donato L. Performance characteristics of serum C4 and FGF19 measurements to exclude the diagnosis of bile acid diarrhoea in IBS-diarrhoea and functional diarrhoea. Aliment Pharmacol Ther. 2017 Sep; 46 (6):581-588 Epub 2017 July 10
    View PubMed
  170. Camilleri M. Medical Therapies in the Pipeline for Irritable Bowel Syndrome. Gastroenterol Hepatol (N Y). 2017 Sep; 13 (9):550-552
    View PubMed
  171. Pasricha PJ, Camilleri M, Hasler WL, Parkman HP. White Paper AGA: Gastroparesis: Clinical and Regulatory Insights for Clinical Trials. Clin Gastroenterol Hepatol. 2017 Aug; 15 (8):1184-1190 Epub 2017 Apr 12
    View PubMed
  172. Park SY, Khemani D, Acosta A, Eckert D, Camilleri M. Rectal gas volume: Defining cut-offs for screening for evacuation disorders in patients with constipation. Neurogastroenterol Motil. 2017 Jul; 29 (7) Epub 2017 Mar 06
    View PubMed
  173. Nelson AD, Camilleri M, Acosta A, Boldingh A, Busciglio I, Burton D, Ryks M, Zinsmeister AR. A single-center, prospective, double-blind, sham-controlled, randomized study of the effect of a vibrating capsule on colonic transit in patients with chronic constipation. Neurogastroenterol Motil. 2017 Jul; 29 (7) Epub 2017 Feb 08
    View PubMed
  174. Halawi H, Camilleri M. Pharmacogenetics and the treatment of functional gastrointestinal disorders. Pharmacogenomics. 2017 Jul; 18 (11):1085-1094 Epub 2017 July 07
    View PubMed
  175. Camilleri M. A Selection of Best AGA Abstracts of DDW 2017. Gastroenterology. 2017 Jun 2; e1-e5 Epub 2017 June 02
    View PubMed
  176. Peters SA, Edogawa S, Sundt WJ, Dyer RB, Dalenberg DA, Mazzone A, Singh RJ, Moses N, Smyrk TC, Weber C, Linden DR, MacNaughton WK, Turner JR, Camilleri M, Katzka DA, Farrugia G, Grover M. Constipation-Predominant Irritable Bowel Syndrome Females Have Normal Colonic Barrier and Secretory Function. Am J Gastroenterol. 2017 Jun; 112 (6):913-923 Epub 2017 Mar 21
    View PubMed
  177. Saito YA, Locke GR, Almazar AE, Bouras EP, Howden CW, Lacy BE, DiBaise JK, Prather CM, Abraham BP, El-Serag HB, Moayyedi P, Herrick LM, Szarka LA, Camilleri M, Hamilton FA, Schleck CD, Tilkes KE, Zinsmeister AR, Talley NJ. Polymorphisms of 5-HTT LPR and GNbeta3 825C>T and Response to Antidepressant Treatment in Functional Dyspepsia: A Study from The Functional Dyspepsia Treatment Trial. Am J Gastroenterol. 2017 Jun; 112 (6):903-909 Epub 2017 Mar 14
    View PubMed
  178. Jacob D, Vijayvargiya P, Camilleri M. Abdominal electroacupuncture demonstrates an increase in complete spontaneous bowel movements. Evid Based Med 2017 Jun; 22 (3):101 Epub 2017 May 12
    View PubMed
  179. Camilleri M, Boeckxstaens G. Dietary and pharmacological treatment of abdominal pain in IBS. Gut. 2017 May; 66 (5):966-974 Epub 2017 Feb 23
    View PubMed
  180. Oduyebo I, Camilleri M. Bile acid disease: the emerging epidemic. Curr Opin Gastroenterol. 2017 May; 33 (3):189-195
    View PubMed
  181. Camilleri M, Malhi H, Acosta A. Gastrointestinal Complications of Obesity. Gastroenterology. 2017 May; 152 (7):1656-1670 Epub 2017 Feb 10
    View PubMed
  182. Khemani D, Camilleri M, Roldan A, Nelson AD, Park SY, Acosta A, Zinsmeister AR. Opioid analgesic use among patients presenting with acute abdominal pain and factors associated with surgical diagnoses. Neurogastroenterol Motil. 2017 May; 29 (5) Epub 2016 Dec 25
    View PubMed
  183. Peleman C, Camilleri M, Busciglio I, Burton D, Donato L, Zinsmeister AR. Colonic Transit and Bile Acid Synthesis or Excretion in Patients With Irritable Bowel Syndrome-Diarrhea Without Bile Acid Malabsorption. Clin Gastroenterol Hepatol. 2017 May; 15 (5):720-727.e1 Epub 2016 Nov 14
    View PubMed
  184. Klem F, Wadhwa A, Prokop LJ, Sundt WJ, Farrugia G, Camilleri M, Singh S, Grover M. Prevalence, Risk Factors, and Outcomes of Irritable Bowel Syndrome After Infectious Enteritis: A Systematic Review and Meta-analysis. Gastroenterology. 2017 Apr; 152 (5):1042-1054.e1 Epub 2017 Jan 06
    View PubMed
  185. Camilleri M, Halawi H, Oduyebo I. Biomarkers as a diagnostic tool for irritable bowel syndrome: where are we? Expert Rev Gastroenterol Hepatol. 2017 Apr; 11 (4):303-316 Epub 2017 Feb 13
    View PubMed
  186. Park SY, Khemani D, Nelson AD, Eckert D, Camilleri M. Rectal Gas Volume Measured by Computerized Tomography Identifies Evacuation Disorders in Patients With Constipation. Clin Gastroenterol Hepatol. 2017 Apr; 15 (4):543-552.e4 Epub 2016 Nov 14
    View PubMed
  187. Valentin N, Camilleri M, Carlson P, Harrington SC, Eckert D, O'Neill J, Burton D, Chen J, Shaw AL, Acosta A. Potential mechanisms of effects of serum-derived bovine immunoglobulin/protein isolate therapy in patients with diarrhea-predominant irritable bowel syndrome. Physiol Rep. 2017 Mar; 5 (5)
    View PubMed
  188. Camilleri M, Sellin JH, Barrett KE. Pathophysiology, Evaluation, and Management of Chronic Watery Diarrhea. Gastroenterology. 2017 Feb; 152 (3):515-532.e2 Epub 2016 Oct 20
    View PubMed
  189. Marietta EV, Geno DM, Smyrk TC, Becker A, Alexander JA, Camilleri M, Murray JA, Katzka DA. Presence of intraepithelial food antigen in patients with active eosinophilic oesophagitis. Aliment Pharmacol Ther. 2017 Feb; 45 (3):427-433 Epub 2016 Nov 22
    View PubMed
  190. Parthasarathy G, Kudva YC, Low PA, Camilleri M, Basu A, Bharucha AE. Relationship Between Gastric Emptying and Diurnal Glycemic Control in Type 1 Diabetes Mellitus: A Randomized Trial. J Clin Endocrinol Metab. 2017 Feb 1; 102 (2):398-406
    View PubMed
  191. Camilleri M, Park SY, Scarpato E, Staiano A. Exploring hypotheses and rationale for causes of infantile colic. Neurogastroenterol Motil. 2017 Feb; 29 (2) Epub 2016 Sept 20
    View PubMed
  192. Park SY, Burton D, Busciglio I, Eckert D, Camilleri M. Regional Colonic Transit Pattern Does Not Conclusively Identify Evacuation Disorders in Constipated Patients with Delayed Colonic Transit. J Neurogastroenterol Motil. 2017 Jan 30; 23 (1):92-100
    View PubMed
  193. Abu Dayyeh BK, Acosta A, Camilleri M, Mundi MS, Rajan E, Topazian MD, Gostout CJ. Endoscopic Sleeve Gastroplasty Alters Gastric Physiology and Induces Loss of Body Weight in Obese Individuals. Clin Gastroenterol Hepatol. 2017 Jan; 15 (1):37-43.e1 Epub 2015 Dec 31
    View PubMed
  194. Parthasarathy G, Kudva YC, Low PA, Camilleri M, Basu A, Bharucha AE. Relationship between gastric emptying and diurnal glycemic control in type 1 diabetes mellitus: A randomized trial Journal of Clinical Endocrinology and Metabolism. 2017; 102: (2)398-406.
  195. Camilleri M, Ford AC. Irritable Bowel Syndrome: Pathophysiology and Current Therapeutic Approaches. Handb Exp Pharmacol. 2017; 239:75-113
    View PubMed
  196. Wu RL, Vazquez-Roque MI, Carlson P, Burton D, Grover M, Camilleri M, Turner JR. Gluten-induced symptoms in diarrhea-predominant irritable bowel syndrome are associated with increased myosin light chain kinase activity and claudin-15 expression. Lab Invest. 2017 Jan; 97 (1):14-23 Epub 2016 Nov 21
    View PubMed
  197. Acosta A, Camilleri M. A working paradigm for the treatment of obesity in gastrointestinal practice. Tech Gastrointest Endosc. 2017 Jan; 19 (1):52-60 Epub 2017 Jan 25
    View PubMed
  198. Camilleri M. What’s new in functional and motility disorders in the lower GI tract? Malta Medical Journal. 2017; 29 (2):3-13
  199. Valentin N, Camilleri M, Altayar O, Vijayvargiya P, Acosta A, Nelson AD, Murad MH. Biomarkers for bile acid diarrhoea in functional bowel disorder with diarrhoea: a systematic review and meta-analysis. Gut. 2016 Dec; 65 (12):1951-1959 Epub 2015 Sept 07
    View PubMed
  200. Valentin N, Camilleri M, Altayar O, Vijayvargiya P, Acosta A, Nelson AD, Murad MH. Biomarkers for bile acid diarrhoea in functional bowel disorder with diarrhoea: a systematic review and meta-analysis Gut. 2016 Dec; 65: (12)1951-U170.
  201. Iturrino J, Camilleri M, Acosta A, O'Neill J, Burton D, Edakkanambeth Varayil J, Carlson PJ, Zinsmeister AR, Hurt R. Acute Effects of a Glucagon-Like Peptide 2 Analogue, Teduglutide, on Gastrointestinal Motor Function and Permeability in Adult Patients With Short Bowel Syndrome on Home Parenteral Nutrition. JPEN J Parenter Enteral Nutr. 2016 Nov; 40 (8):1089-1095 Epub 2015 July 28
    View PubMed
  202. Camilleri M, Oduyebo I, Halawi H. Chemical and molecular factors in irritable bowel syndrome: current knowledge, challenges, and unanswered questions. Am J Physiol Gastrointest Liver Physiol. 2016 Nov 1; 311 (5):G777-G784 Epub 2016 Sept 08
    View PubMed
  203. Nelson AD, Camilleri M, Acosta A, Busciglio I, Linker Nord S, Boldingh A, Rhoten D, Ryks M, Burton D. Effects of ghrelin receptor agonist, relamorelin, on gastric motor functions and satiation in healthy volunteers. Neurogastroenterol Motil. 2016 Nov; 28 (11):1705-1713 Epub 2016 June 09
    View PubMed
  204. Bharucha AE, Daley SL, Low PA, Gibbons SJ, Choi KM, Camilleri M, Saw JJ, Farrugia G, Zinsmeister AR. Effects of hemin on heme oxygenase-1, gastric emptying, and symptoms in diabetic gastroparesis. Neurogastroenterol Motil. 2016 Nov; 28 (11):1731-1740 Epub 2016 June 09
    View PubMed
  205. Camilleri M, Katzka DA. Enhancing High Value Care in Gastroenterology Practice. Clin Gastroenterol Hepatol. 2016 Oct; 14 (10):1376-84 Epub 2016 May 20
    View PubMed
  206. Sood R, Camilleri M, Gracie DJ, Gold MJ, To N, Law GR, Ford AC. Enhancing Diagnostic Performance of Symptom-Based Criteria for Irritable Bowel Syndrome by Additional History and Limited Diagnostic Evaluation. Am J Gastroenterol. 2016 Oct; 111 (10):1446-1454 Epub 2016 Aug 02
    View PubMed
  207. Camilleri M, Carlson P, Valentin N, Acosta A, O'Neill J, Eckert D, Dyer R, Na J, Klee EW, Murray JA. Pilot study of small bowel mucosal gene expression in patients with irritable bowel syndrome with diarrhea. Am J Physiol Gastrointest Liver Physiol. 2016 Sep 1; 311 (3):G365-76 Epub 2016 July 21
    View PubMed
  208. Miner PB Jr, Camilleri M, Burton D, Achenbach H, Wan H, Dragone J, Mellgard B. Prucalopride induces high-amplitude propagating contractions in the colon of patients with chronic constipation: a randomized study. Neurogastroenterol Motil. 2016 Sep; 28 (9):1341-8 Epub 2016 June 07
    View PubMed
  209. Camilleri M. Novel Diet, Drugs, and Gastric Interventions for Gastroparesis. Clin Gastroenterol Hepatol. 2016 Aug; 14 (8):1072-80 Epub 2016 Jan 04
    View PubMed
  210. Camilleri M, Piessevaux H, Yiannakou Y, Tack J, Kerstens R, Quigley EMM, Ke M, Da Silva S, Levine A. Efficacy and Safety of Prucalopride in Chronic Constipation: An Integrated Analysis of Six Randomized, Controlled Clinical Trials. Dig Dis Sci. 2016 Aug; 61 (8):2357-2372 Epub 2016 Apr 07
    View PubMed
  211. Camilleri M. Drug-resin drug interactions in patients with delayed gastric emptying: What is optimal time window for drug administration? Neurogastroenterol Motil. 2016 Aug; 28 (8):1268-71 Epub 2016 Mar 14
    View PubMed
  212. Grover M, Camilleri M, Hines J, Burton D, Ryks M, Wadhwa A, Sundt W, Dyer R, Singh RJ. (13) C mannitol as a novel biomarker for measurement of intestinal permeability. Neurogastroenterol Motil. 2016 Jul; 28 (7):1114-9 Epub 2016 Feb 23
    View PubMed
  213. Lembo A, Camilleri M, McCallum R, Sastre R, Breton C, Spence S, White J, Currie M, Gottesdiener K, Stoner E, RM-131-004 Trial Group. Relamorelin Reduces Vomiting Frequency and Severity and Accelerates Gastric Emptying in Adults With Diabetic Gastroparesis. Gastroenterology. 2016 Jul; 151 (1):87-96.e6 Epub 2016 Apr 04
    View PubMed
  214. Chang L, Heitkemper MM, Wiley JW, Camilleri M. 2015 James W. Freston Single Topic Conference: A Renaissance in the Understanding and Management of Irritable Bowel Syndrome. Gastroenterology. 2016 Jul; 151 (1):e1-8 Epub 2016 May 20
    View PubMed
  215. Chang L, Heitkemper MM, Wiley JW, Camilleri M. 2015 James W. Freston Single Topic Conference: A Renaissance in the Understanding and Management of Irritable Bowel Syndrome. Cell Mol Gastroenterol Hepatol. 2016 Jul; 2 (4):394-399.e2 Epub 2016 May 28
    View PubMed
  216. Camilleri M, Linden DR. Measurement of Gastrointestinal and Colonic Motor Functions in Humans and Animals. Cell Mol Gastroenterol Hepatol. 2016 Jul; 2 (4):412-428
    View PubMed
  217. Chang L, Heitkemper MM, Wiley JW, Camilleri M. 2015 James W. Freston Single Topic Conference: A Renaissance in the Understanding and Management of Irritable Bowel Syndrome. Clin Gastroenterol Hepatol. 2016 Jul; 14 (7):e77-86 Epub 2016 May 27
    View PubMed
  218. Khera R, Murad MH, Chandar AK, Dulai PS, Wang Z, Prokop LJ, Loomba R, Camilleri M, Singh S. Association of Pharmacological Treatments for Obesity With Weight Loss and Adverse Events: A Systematic Review and Meta-analysis. JAMA. 2016 Jun 14; 315 (22):2424-34
    View PubMed
  219. Mouchli MA, Camilleri M, Lee T, Parthasarathy G, Vijayvargiya P, Halland M, Acosta A, Bharucha AE. Evaluating the safety and the effects on colonic compliance of neostigmine during motility testing in patients with chronic constipation. Neurogastroenterol Motil. 2016 Jun; 28 (6):871-8 Epub 2016 Feb 03
    View PubMed
  220. Gibbons D, Camilleri M, Nelson AD, Eckert D. Characteristics of chronic megacolon among patients diagnosed with multiple endocrine neoplasia type 2B. United European Gastroenterol J. 2016 Jun; 4 (3):449-54 Epub 2015 Oct 13
    View PubMed
  221. Acosta A, Camilleri M, Shin A, Linker Nord S, O'Neill J, Gray AV, Lueke AJ, Donato LJ, Burton DD, Szarka LA, Zinsmeister AR, Golden PL, Fodor A. Effects of Rifaximin on Transit, Permeability, Fecal Microbiome, and Organic Acid Excretion in Irritable Bowel Syndrome. Clin Transl Gastroenterol. 2016 May 26; 7:e173
    View PubMed
  222. Acosta A, Camilleri M, Busciglio I, Boldingh A, Nelson AD, Burton D. Short-Term Effects of Relamorelin on Descending Colon Motility in Chronic Constipation: A Randomized, Controlled Trial. Dig Dis Sci. 2016 Mar; 61 (3):852-60 Epub 2015 Oct 14
    View PubMed
  223. Nelson AD, Camilleri M. Opioid-induced constipation: advances and clinical guidance. Ther Adv Chronic Dis. 2016 Mar; 7 (2):121-34 Epub 2016 Jan 25
    View PubMed
  224. Camilleri M. Dissecting Molecular Mechanisms in Bile Acid Diarrhea. Am J Gastroenterol 2016 Mar; 111 (3):433-5
    View PubMed
  225. Boeckxstaens G, Camilleri M, Sifrim D, Houghton LA, Elsenbruch S, Lindberg G, Azpiroz F, Parkman HP. Fundamentals of Neurogastroenterology: Physiology/Motility - Sensation. Gastroenterology. 2016 Feb 18 [Epub ahead of print]
    View PubMed
  226. Camilleri M, Bueno L, Andresen V, De Ponti F, Choi MG, Lembo A. Pharmacological, Pharmacokinetic, and Pharmacogenomic Aspects of Functional Gastrointestinal Disorders. Gastroenterology. 2016 Feb 18 [Epub ahead of print]
    View PubMed
  227. Acosta A, Camilleri M, Linker-Nord S, Busciglio I, Iturrino J, Szarka LA, Zinsmeister AR. A Pilot Study of the Effect of Daikenchuto on Rectal Sensation in Patients with Irritable Bowel Syndrome. J Neurogastroenterol Motil. 2016 Jan 31; 22 (1):69-77
    View PubMed
  228. Camilleri M, Acosta A. Gastrointestinal traits: individualizing therapy for obesity with drugs and devices. Gastrointest Endosc. 2016 Jan; 83 (1):48-56 Epub 2015 Aug 10
    View PubMed
  229. Chang L, Heitkemper MM, Wiley JW, Camilleri M. 2015 James W. Freston Single Topic Conference: a renaissance in the understanding and management of irritable bowel syndrome Gastroenterology. 2016; 151: (1)e1-8.
  230. Faubion WA, Camilleri M, Murray JA, Kelly P, Amadi B, Kosek MN, Enders F, Larson J, Grover M, Boe G, Dyer R, Singh R. Improving the detection of environmental enteric dysfunction: a lactulose, rhamnose assay of intestinal permeability in children aged under 5 years exposed to poor sanitation and hygiene. BMJ Glob Health. 2016; 1 (1):e000066 Epub 2016 July 04
    View PubMed
  231. Camilleri M. Functional Dyspepsia and Gastroparesis. Dig Dis. 2016; 34 (5):491-9 Epub 2016 June 22
    View PubMed
  232. Webster LR, Camilleri M, Finn A. Opioid-induced constipation: rationale for the role of norbuprenorphine in buprenorphine-treated individuals. Subst Abuse Rehabil. 2016; 7:81-6 Epub 2016 June 14
    View PubMed
  233. Argoff CE, Brennan MJ, Camilleri M, Davies A, Fudin J, Galluzzi KE, Gudin J, Lembo A, Stanos SP, Webster LR. Consensus Recommendations on Initiating Prescription Therapies for Opioid-Induced Constipation. Pain Med. 2015 Dec; 16 (12):2324-37 Epub 2015 Nov 19
    View PubMed
  234. Parthasarathy G, Ravi K, Camilleri M, Andrews C, Szarka LA, Low PA, Zinsmeister AR, Bharucha AE. Effect of neostigmine on gastroduodenal motility in patients with suspected gastrointestinal motility disorders. Neurogastroenterol Motil. 2015 Dec; 27 (12):1736-46 Epub 2015 Sept 20
    View PubMed
  235. Wadhwa A, Camilleri M, Grover M. New and Investigational Agents for Irritable Bowel Syndrome. Curr Gastroenterol Rep. 2015 Dec; 17 (12):46
    View PubMed
  236. Acosta A, Camilleri M, Kolar G, Iturrino J, Szarka LA, Boldingh A, Burton D, Ryks M, Rhoten D, Zinsmeister AR, Spence SC, Gottesdiener K, Bouras EP, Vazquez-Roque MI. Relamorelin Relieves Constipation and Accelerates Colonic Transit in a Phase 2, Placebo-Controlled, Randomized Trial. Clin Gastroenterol Hepatol. 2015 Dec; 13: (13)2312-9.e1.
    View PubMed
  237. Ek WE, Reznichenko A, Ripke S, Niesler B, Zucchelli M, Rivera NV, Schmidt PT, Pedersen NL, Magnusson P, Talley NJ, Holliday EG, Houghton L, Gazouli M, Karamanolis G, Rappold G, Burwinkel B, Surowy H, Rafter J, Assadi G, Li L, Papadaki E, Gambaccini D, Marchi S, Colucci R, Blandizzi C, Barbaro R, Karling P, Walter S, Ohlsson B, Tornblom H, Bresso F, Andreasson A, Dlugosz A, Simren M, Agreus L, Lindberg G, Boeckxstaens G, Bellini M, Stanghellini V, Barbara G, Daly MJ, Camilleri M, Wouters MM, D'Amato M. Exploring the genetics of irritable bowel syndrome: a GWA study in the general population and replication in multinational case-control cohorts. Gut. 2015 Nov; 64: (11)1774-82.
    View PubMed
  238. Acosta A, Camilleri M, Burton D, O'Neill J, Eckert D, Carlson P, Zinsmeister AR. Exenatide in obesity with accelerated gastric emptying: a randomized, pharmacodynamics study. Physiol Rep. 2015 Nov; 3 (11)
    View PubMed
  239. Nelson AD, Mouchli MA, Valentin N, Deyle D, Pichurin P, Acosta A, Camilleri M. Ehlers Danlos syndrome and gastrointestinal manifestations: a 20-year experience at Mayo Clinic. Neurogastroenterol Motil. 2015 Nov; 27: (11)1657-66.
    View PubMed
  240. Hunt RH, Camilleri M, Crowe SE, El-Omar EM, Fox JG, Kuipers EJ, Malfertheiner P, McColl KE, Pritchard DM, Rugge M, Sonnenberg A, Sugano K, Tack J. The stomach in health and disease. Gut. 2015 Oct; 64 (10):1650-68 Epub 2015 Sept 04
    View PubMed
  241. Camilleri M. Review article: biomarkers and personalised therapy in functional lower gastrointestinal disorders. Aliment Pharmacol Ther. 2015 Oct; 42 (7):818-28 Epub 2015 Aug 11
    View PubMed
  242. Wang YT, Mohammed SD, Farmer AD, Wang D, Zarate N, Hobson AR, Hellstrom PM, Semler JR, Kuo B, Rao SS, Hasler WL, Camilleri M, Scott SM. Regional gastrointestinal transit and pH studied in 215 healthy volunteers using the wireless motility capsule: influence of age, gender, study country and testing protocol. Aliment Pharmacol Ther. 2015 Sep; 42 (6):761-72 Epub 2015 July 29
    View PubMed
  243. Sathananthan M, Shah M, Edens KL, Grothe KB, Piccinini F, Farrugia LP, Micheletto F, Man CD, Cobelli C, Rizza RA, Camilleri M, Vella A. Six and 12 Weeks of Caloric Restriction Increases beta Cell Function and Lowers Fasting and Postprandial Glucose Concentrations in People with Type 2 Diabetes. J Nutr. 2015 Sep; 145 (9):2046-51 Epub 2015 Aug 05
    View PubMed
  244. Camilleri M, Gores GJ. Therapeutic targeting of bile acids. Am J Physiol Gastrointest Liver Physiol. 2015 Aug 15; 309 (4):G209-15 Epub 2015 July 02
    View PubMed
  245. O'Dwyer RH, Acosta A, Camilleri M, Burton D, Busciglio I, Bharucha AE. Clinical Features and Colonic Motor Disturbances in Chronic Megacolon in Adults. Dig Dis Sci. 2015 Aug; 60 (8):2398-407 Epub 2015 Apr 14
    View PubMed
  246. Talley NJ, Locke GR, Saito YA, Almazar AE, Bouras EP, Howden CW, Lacy BE, DiBaise JK, Prather CM, Abraham BP, El-Serag HB, Moayyedi P, Herrick LM, Szarka LA, Camilleri M, Hamilton FA, Schleck CD, Tilkes KE, Zinsmeister AR. Effect of Amitriptyline and Escitalopram on Functional Dyspepsia: A Multicenter, Randomized Controlled Study. Gastroenterology. 2015 Aug; 149 (2):340-9.e2 Epub 2015 Apr 25
    View PubMed
  247. Rudling M, Camilleri M, Graffner H, Holst JJ, Rikner L. Specific inhibition of bile acid transport alters plasma lipids and GLP-1. BMC Cardiovasc Disord. 2015 Jul 22; 15:75 Epub 2015 July 22
    View PubMed
  248. Katzka DA, Ravi K, Geno DM, Smyrk TC, Iyer PG, Alexander JA, Mabary JE, Camilleri M, Vaezi MF. Endoscopic Mucosal Impedance Measurements Correlate With Eosinophilia and Dilation of Intercellular Spaces in Patients With Eosinophilic Esophagitis. Clin Gastroenterol Hepatol. 2015 Jul; 13: (7)1242-1248.e1.
    View PubMed
  249. Camilleri M, Carlson P, Acosta A, Busciglio I. Colonic mucosal gene expression and genotype in irritable bowel syndrome patients with normal or elevated fecal bile acid excretion. Am J Physiol Gastrointest Liver Physiol. 2015 Jul 1; 309 (1):G10-20 Epub 2015 Apr 30
    View PubMed
  250. Nelson AD, Camilleri M. Chronic opioid induced constipation in patients with nonmalignant pain: challenges and opportunities. Therap Adv Gastroenterol. 2015 Jul; 8 (4):206-20
    View PubMed
  251. Camilleri M. Intestinal secretory mechanisms in irritable bowel syndrome-diarrhea. Clin Gastroenterol Hepatol. 2015 Jun; 13 (6):1051-7; quiz e61-2 Epub 2014 July 17
    View PubMed
  252. Valentin N, Acosta A, Camilleri M. Early investigational therapeutics for gastrointestinal motility disorders: from animal studies to Phase II trials. Expert Opin Investig Drugs. 2015 Jun; 24 (6):769-79
    View PubMed
  253. Camilleri M. Bile Acid diarrhea: prevalence, pathogenesis, and therapy. Gut Liver. 2015 May 23; 9 (3):332-9
    View PubMed
  254. Camilleri M. Peripheral mechanisms in appetite regulation. Gastroenterology. 2015 May; 148 (6):1219-33 Epub 2014 Sept 21
    View PubMed
  255. Shin A, Acosta A, Camilleri M, Boldingh A, Burton D, Ryks M, Rhoten D, Zinsmeister AR. A randomized trial of 5-hydroxytryptamine4-receptor agonist, YKP10811, on colonic transit and bowel function in functional constipation. Clin Gastroenterol Hepatol. 2015 Apr; 13: (4)701-8.e1.
    View PubMed
  256. Katzka DA, Geno DM, Blair HE, Lamsam JL, Alexander JA, Camilleri M. Small intestinal permeability in patients with eosinophilic oesophagitis during active phase and remission. Gut. 2015 Apr; 64 (4):538-43 Epub 2014 June 23
    View PubMed
  257. Acosta A, Camilleri M, Shin A, Vazquez-Roque MI, Iturrino J, Lanza IR, Nair KS, Burton D, O'Neill J, Eckert D, Carlson P, Vella A, Zinsmeister AR. Association of UCP-3 rs1626521 with obesity and stomach functions in humans. Obesity (Silver Spring). 2015 Apr; 23 (4):898-906 Epub 2015 Mar 07
    View PubMed
  258. Bharucha AE, Kudva Y, Basu A, Camilleri M, Low PA, Vella A, Zinsmeister AR. Relationship between glycemic control and gastric emptying in poorly controlled type 2 diabetes. Clin Gastroenterol Hepatol. 2015 Mar; 13 (3):466-476.e1 Epub 2014 July 17
    View PubMed
  259. Camilleri M. Guanylate cyclase C agonists: emerging gastrointestinal therapies and actions. Gastroenterology. 2015 Mar; 148 (3):483-7 Epub 2015 Jan 07
    View PubMed
  260. Camilleri M, Acosta A, Busciglio I, Boldingh A, Dyer RB, Zinsmeister AR, Lueke A, Gray A, Donato LJ. Effect of colesevelam on faecal bile acids and bowel functions in diarrhoea-predominant irritable bowel syndrome. Aliment Pharmacol Ther. 2015 Mar; 41 (5):438-48 Epub 2015 Jan 16
    View PubMed
  261. Camilleri M, Acosta A. Emerging treatments in Neurogastroenterology: relamorelin: a novel gastrocolokinetic synthetic ghrelin agonist. Neurogastroenterol Motil. 2015 Mar; 27 (3):324-32 Epub 2014 Dec 29
    View PubMed
  262. Acosta A, Camilleri M, Shin A, Vazquez-Roque MI, Iturrino J, Burton D, O'Neill J, Eckert D, Zinsmeister AR. Quantitative gastrointestinal and psychological traits associated with obesity and response to weight-loss therapy. Gastroenterology. 2015 Mar; 148 (3):537-546.e4 Epub 2014 Dec 06
    View PubMed
  263. Acosta A, Camilleri M. Prokinetics in gastroparesis. Gastroenterol Clin North Am. 2015 Mar; 44: (1)97-111.
    View PubMed
  264. Camilleri M, Lembo AJ, Lavins BJ, MacDougall JE, Carson RT, Williams VS, Nelson LM, Shiff SJ, Currie MG, Kurtz CB, Johnston JM. Comparison of adequate relief with symptom, global, and responder endpoints in linaclotide phase 3 trials in IBS-C. United European Gastroenterol J. 2015 Feb; 3 (1):53-62
    View PubMed
  265. Gaertner J, Siemens W, Camilleri M, Davies A, Drossman DA, Webster LR, Becker G. Definitions and outcome measures of clinical trials regarding opioid-induced constipation: a systematic review. J Clin Gastroenterol. 2015 Jan; 49 (1):9-16
    View PubMed
  266. Tack J, Camilleri M, Dubois D, Vandeplassche L, Joseph A, Kerstens R. Association between health-related quality of life and symptoms in patients with chronic constipation: An integrated analysis of three phase 3 trials of prucalopride. Neurogastroenterol Motil. 2015; 27(3):397-405.
    View PubMed
  267. Czogalla B, Schmitteckert S, Houghton LA, Sayuk GS, Camilleri M, Olivo-Diaz A, Spiller R, Wouters MM, Boeckxstaens G, Lorenzo Bermejo J, Niesler B. A meta-analysis of immunogenetic Case-Control Association Studies in irritable bowel syndrome. Neurogastroenterol Motil. 2015; 27(5):717-27.
    View PubMed
  268. Kasim A, Shkedy Z, Lin D, Van Sanden S, Abrahantes JC, Gohlmann HWH, Bijnens L, Yekutieli D, Camilleri M, Aerssens J, Talloen W. Translation of disease associated gene signatures across tissues. International Journal of Data Mining and Bioinformatics. 2015; 11(3):301-13.
    View PubMed
  269. Katzka DA, Geno DM, Ravi A, Smyrk TC, Lao-Sirieix P, Miremadi A, Debiram I, O'Donovan M, Kita H, Kephart GM, Kryzer LA, Camilleri M, Alexander JA, Fitzgerald RC. Accuracy, safety, and tolerability of tissue collection by Cytosponge vs endoscopy for evaluation of eosinophilic esophagitis. Clin Gastroenterol Hepatol. 2015 Jan; 13 (1):77-83.e2 Epub 2014 July 03
    View PubMed
  270. Camilleri M, Shin A, Busciglio I, Carlson P, Acosta A, Bharucha AE, Burton D, Lamsam J, Lueke A, Donato LJ, Zinsmeister AR. Validating biomarkers of treatable mechanisms in irritable bowel syndrome. Neurogastroenterol Motil. 2014 Dec; 26 (12):1677-85 Epub 2014 Sept 22
    View PubMed
  271. Bharucha AE, Camilleri M, Burton DD, Thieke SL, Feuerhak KJ, Basu A, Zinsmeister AR. Increased nutrient sensitivity and plasma concentrations of enteral hormones during duodenal nutrient infusion in functional dyspepsia. Am J Gastroenterol. 2014 Dec; 109 (12):1910-20; quiz 1909, 1921 Epub 2014 Nov 18
    View PubMed
  272. Katzka DA, Tadi R, Smyrk TC, Katarya E, Sharma A, Geno DM, Camilleri M, Iyer PG, Alexander JA, Buttar NS. Effects of topical steroids on tight junction proteins and spongiosis in esophageal epithelia of patients with eosinophilic esophagitis. Clin Gastroenterol Hepatol. 2014 Nov; 12(11):1824-9.e1. Epub 2014 Mar 27.
    View PubMed
  273. Camilleri M, Busciglio I, Acosta A, Shin A, Carlson P, Burton D, Ryks M, Rhoten D, Lamsam J, Lueke A, Donato LJ, Zinsmeister AR. Effect of increased bile acid synthesis or fecal excretion in irritable bowel syndrome-diarrhea. Am J Gastroenterol. 2014 Oct; 109 (10):1621-30 Epub 2014 July 29
    View PubMed
  274. Camilleri M, Drossman DA, Becker G, Webster LR, Davies AN, Mawe GM. Emerging treatments in neurogastroenterology: a multidisciplinary working group consensus statement on opioid-induced constipation. Neurogastroenterol Motil. 2014 Oct; 26 (10):1386-95 Epub 2014 Aug 28
    View PubMed
  275. Vijayvargiya P, Camilleri M. Proximal megacolon in an adult. Clin Gastroenterol Hepatol. 2014 Sep; 12(9):e83-4. Epub 2013 Jun 28.
    View PubMed
  276. Camilleri M, Shin A, Busciglio I, Carlson P, Acosta A, Bharucha AE, Burton D, Lamsam J, Lueke A, Donato LJ, Zinsmeister AR. Genetic variation in GPBAR1 predisposes to quantitative changes in colonic transit and bile acid excretion. Am J Physiol Gastrointest Liver Physiol. 2014 Sep 1; 307 (5):G508-16 Epub 2014 July 10
    View PubMed
  277. Camilleri M. Novel therapeutic agents in neurogastroenterology: advances in the past year. Neurogastroenterol Motil. 2014 Aug; 26 (8):1070-8 Epub 2014 June 23
    View PubMed
  278. Camilleri M. Physiological underpinnings of irritable bowel syndrome: neurohormonal mechanisms. J Physiol. 2014 Jul 15; 592 (14):2967-80 Epub 2014 Mar 24
    View PubMed
  279. Acosta A, Camilleri M. Elobixibat and its potential role in chronic idiopathic constipation. Therap Adv Gastroenterol. 2014 Jul; 7 (4):167-75
    View PubMed
  280. Camilleri M, Carlson P, Acosta A, Busciglio I, Nair AA, Gibbons SJ, Farrugia G, Klee EW. RNA sequencing shows transcriptomic changes in rectosigmoid mucosa in patients with irritable bowel syndrome-diarrhea: a pilot case-control study. Am J Physiol Gastrointest Liver Physiol. 2014 Jun 15; 306 (12):G1089-98 Epub 2014 Apr 24
    View PubMed
  281. Beyder A, Mazzone A, Strege PR, Tester DJ, Saito YA, Bernard CE, Enders FT, Ek WE, Schmidt PT, Dlugosz A, Lindberg G, Karling P, Ohlsson B, Gazouli M, Nardone G, Cuomo R, Usai-Satta P, Galeazzi F, Neri M, Portincasa P, Bellini M, Barbara G, Camilleri M, Locke GR, Talley NJ, D'Amato M, Ackerman MJ, Farrugia G. Loss-of-function of the voltage-gated sodium channel NaV1.5 (channelopathies) in patients with irritable bowel syndrome. Gastroenterology. 2014 Jun; 146 (7):1659-1668 Epub 2014 Mar 05
    View PubMed
  282. Bharucha AE, Fletcher JG, Camilleri M, Edge J, Carlson P, Zinsmeister AR. Effects of clonidine in women with fecal incontinence. Clin Gastroenterol Hepatol. 2014 May; 12 (5):843-851.e2; quiz e44 Epub 2013 July 23
    View PubMed
  283. Acosta A, Camilleri M. Gastrointestinal morbidity in obesity. Ann N Y Acad Sci. 2014 Apr; 1311:42-56 Epub 2014 Mar 06
    View PubMed
  284. Acosta A, Abu Dayyeh BK, Port JD, Camilleri M. Recent advances in clinical practice challenges and opportunities in the management of obesity. Gut. 2014 Apr; 63 (4):687-95 Epub 2014 Jan 08
    View PubMed
  285. Acosta A, Camilleri M, Shin A, Carlson P, Burton D, O'Neill J, Eckert D, Zinsmeister AR. Association of melanocortin 4 receptor gene variation with satiation and gastric emptying in overweight and obese adults. Genes Nutr. 2014 Mar; 9 (2):384 Epub 2014 Jan 24
    View PubMed
  286. Shin A, Camilleri M, Kolar G, Erwin P, West CP, Murad MH. Systematic review with meta-analysis: highly selective 5-HT4 agonists (prucalopride, velusetrag or naronapride) in chronic constipation. Aliment Pharmacol Ther. 2014 Feb; 39 (3):239-53 Epub 2013 Dec 05
    View PubMed
  287. Vijayvargiya P, Iturrino J, Camilleri M, Shin A, Vazquez-Roque M, Katzka DA, Snuggerud JR, Seime RJ. Novel Association of Rectal Evacuation Disorder and Rumination Syndrome: Diagnosis, Co-morbidities and Treatment. United European Gastroenterol J. 2014 Feb 1; 2 (1):38-46
    View PubMed
  288. Shah M, Law JH, Micheletto F, Sathananthan M, Dalla Man C, Cobelli C, Rizza RA, Camilleri M, Zinsmeister AR, Vella A. Contribution of endogenous glucagon-like peptide 1 to glucose metabolism after Roux-en-Y gastric bypass. Diabetes. 2014 Feb; 63 (2):483-93 Epub 2013 Oct 02
    View PubMed
  289. Iturrino J, Camilleri M, Busciglio I, Burton D, Zinsmeister AR. Pilot trial: pregabalin on colonic sensorimotor functions in irritable bowel syndrome. Dig Liver Dis. 2014 Feb; 46 (2):113-8 Epub 2013 Oct 04
    View PubMed
  290. Grover M, Camilleri M, Smith K, Linden DR, Farrugia G. On the fiftieth anniversary. Postinfectious irritable bowel syndrome: mechanisms related to pathogens. Neurogastroenterol Motil. 2014 Feb; 26: (2)156-67.
    View PubMed
  291. Camilleri M, Klee EW, Shin A, Carlson P, Li Y, Grover M, Zinsmeister AR. Irritable bowel syndrome-diarrhea: characterization of genotype by exome sequencing, and phenotypes of bile acid synthesis and colonic transit. Am J Physiol Gastrointest Liver Physiol. 2014 Jan 1; 306 (1):G13-26 Epub 2013 Nov 07
    View PubMed
  292. Kolar GJ, Camilleri M, Burton D, Nadeau A, Zinsmeister AR. Prevalence of colonic motor or evacuation disorders in patients presenting with chronic nausea and vomiting evaluated by a single gastroenterologist in a tertiary referral practice. Neurogastroenterol Motil. 2014 Jan; 26 (1):131-8 Epub 2013 Oct 10
    View PubMed
  293. Camilleri M. Advances in understanding of bile acid diarrhea. Expert Rev Gastroenterol Hepatol. 2014 Jan; 8 (1):49-61 Epub 2013 Nov 25
    View PubMed
  294. Sathananthan M, Ikramuddin S, Swain JM, Shah M, Piccinini F, Dalla Man C, Cobelli C, Rizza RA, Camilleri M, Vella A. The effect of vagal nerve blockade using electrical impulses on glucose metabolism in nondiabetic subjects. Diabetes Metab Syndr Obes. 2014; 7:305-12 Epub 2014 July 11
    View PubMed
  295. Camilleri M. American college of gastroenterology monograph on the management of irritable bowel syndrome. Expert Opin Pharmacother. 2014; 16(5):629-32.
  296. Maurer AH, Camilleri M, Donohoe K, Knight LC, Madsen JL, Mariani G, Parkman HP, Van Dolsen J. The SNMMI and EANM practice guideline for small-bowel and colon transit 1.0. J Nucl Med. 2013 Nov; 54(11):2004-13. Epub 2013 Oct 03.
    View PubMed
  297. Shin A, Camilleri M, Busciglio I, Burton D, Smith SA, Vella A, Ryks M, Rhoten D, Zinsmeister AR. The ghrelin agonist RM-131 accelerates gastric emptying of solids and reduces symptoms in patients with type 1 diabetes mellitus. Clin Gastroenterol Hepatol. 2013 Nov; 11 (11):1453-1459.e4 Epub 2013 Apr 30
    View PubMed
  298. Camilleri M. Pharmacological agents currently in clinical trials for disorders in neurogastroenterology. J Clin Invest. 2013 Oct 01; 123(10):4111-20.
    View PubMed
  299. Shin A, Camilleri M, Vijayvargiya P, Busciglio I, Burton D, Ryks M, Rhoten D, Lueke A, Saenger A, Girtman A, Zinsmeister AR. Bowel functions, fecal unconjugated primary and secondary bile acids, and colonic transit in patients with irritable bowel syndrome. Clin Gastroenterol Hepatol. 2013 Oct; 11 (10):1270-1275.e1 Epub 2013 Apr 30
    View PubMed
  300. Shin AS, Camilleri M. Diagnostic assessment of diabetic gastroparesis. Diabetes. 2013 Aug; 62 (8):2667-73
    View PubMed
  301. Camilleri M. Genetics of human gastrointestinal sensation. Neurogastroenterol Motil. 2013 Jun; 25 (6):458-66 Epub 2013 Apr 17
    View PubMed
  302. Camilleri M. Current and future pharmacological treatments for diarrhea-predominant irritable bowel syndrome. Expert Opin Pharmacother. 2013 Jun; 14(9):1151-60. Epub 2013 Apr 27.
    View PubMed
  303. Shin A, Camilleri M, Nadeau A, Nullens S, Rhee JC, Jeong ID, Burton DD. Interpretation of overall colonic transit in defecation disorders in males and females. Neurogastroenterol Motil. 2013 Jun; 25 (6):502-8 Epub 2013 Feb 14
    View PubMed
  304. Vijayvargiya P, Camilleri M, Shin A, Breen M, Burton D. Simplifying the measurement of gastric accommodation using SPECT. Neurogastroenterol Motil. 2013 Jun; 25 (6):542-6 Epub 2013 Feb 17
    View PubMed
  305. Vazquez-Roque MI, Camilleri M, Smyrk T, Murray JA, Marietta E, O'Neill J, Carlson P, Lamsam J, Janzow D, Eckert D, Burton D, Zinsmeister AR. A controlled trial of gluten-free diet in patients with irritable bowel syndrome-diarrhea: effects on bowel frequency and intestinal function. Gastroenterology. 2013 May; 144 (5):903-911.e3 Epub 2013 Jan 25
    View PubMed
  306. Bharucha AE, Low P, Camilleri M, Veil E, Burton D, Kudva Y, Shah P, Gehrking T, Zinsmeister AR. A randomised controlled study of the effect of cholinesterase inhibition on colon function in patients with diabetes mellitus and constipation. Gut. 2013 May; 62 (5):708-15 Epub 2012 June 07
    View PubMed
  307. Schemann M, Camilleri M. Functions and imaging of mast cell and neural axis of the gut. Gastroenterology. 2013 Apr; 144(4):698-704.e4. Epub 2013 Jan 24.
    View PubMed
  308. Iturrino J, Camilleri M, Wong BS, Linker Nord SJ, Burton D, Zinsmeister AR. Randomised clinical trial: the effects of daikenchuto, TU-100, on gastrointestinal and colonic transit, anorectal and bowel function in female patients with functional constipation. Aliment Pharmacol Ther. 2013 Apr; 37(8):776-85. Epub 2013 Mar 04.
    View PubMed
  309. Camilleri M, Stanghellini V. Current management strategies and emerging treatments for functional dyspepsia. Nat Rev Gastroenterol Hepatol. 2013 Mar; 10 (3):187-94 Epub 2013 Feb 05
    View PubMed
  310. Camilleri M, Kolar GJ, Vazquez-Roque MI, Carlson P, Burton DD, Zinsmeister AR. Cannabinoid receptor 1 gene and irritable bowel syndrome: phenotype and quantitative traits. Am J Physiol Gastrointest Liver Physiol. 2013 Mar 1; 304 (5):G553-60 Epub 2013 Jan 10
    View PubMed
  311. Grover M, Camilleri M. Effects on gastrointestinal functions and symptoms of serotonergic psychoactive agents used in functional gastrointestinal diseases. J Gastroenterol. 2013 Feb; 48 (2):177-81 Epub 2012 Dec 20
    View PubMed
  312. Topazian M, Camilleri M, Enders FT, Clain JE, Gleeson FC, Levy MJ, Rajan E, Nehra V, Dierkhising RA, Collazo-Clavell ML, Talley NJ, Clark MM. Gastric antral injections of botulinum toxin delay gastric emptying but do not reduce body weight. Clin Gastroenterol Hepatol. 2013 Feb; 11 (2):145-50.e1 Epub 2012 Oct 09
    View PubMed
  313. Wong BS, Camilleri M. Elobixibat for the treatment of constipation. Expert Opin Investig Drugs. 2013 Feb; 22(2):277-84. Epub 2012 Dec 08.
    View PubMed
  314. Zinsmeister AR, Burton D, Camilleri M. Pharmacodynamic and clinical endpoints for functional colonic disorders: statistical considerations. Dig Dis Sci. 2013 Feb; 58 (2):509-18 Epub 2012 Aug 24
    View PubMed
  315. Tack J, Quigley E, Camilleri M, Vandeplassche L, Kerstens R. Efficacy and safety of oral prucalopride in women with chronic constipation in whom laxatives have failed: an integrated analysis. United European Gastroenterol J. 2013 Feb; 1 (1):48-59
    View PubMed
  316. Shin A, Camilleri M, Busciglio I, Burton D, Stoner E, Noonan P, Gottesdiener K, Smith SA, Vella A, Zinsmeister AR. Randomized controlled phase Ib study of ghrelin agonist, RM-131, in type 2 diabetic women with delayed gastric emptying: pharmacokinetics and pharmacodynamics. Diabetes Care. 2013 Jan; 36 (1):41-8 Epub 2012 Sept 06
    View PubMed
  317. Raffals L, Camilleri M. Visceral hypersensitivity and IBD. Inflammatory Bowel Disease Monitor. 2013; 13(3):85-91.
  318. Grover M, Camilleri M. Treatment with Methylnaltrexone and IVIG for Paraneoplastic Gastrointestinal Dysmotility. Gastroenterol Hepatol (N Y). 2013 Jan; 9 (1):51-3
    View PubMed
  319. Bharucha AE, Camilleri M, Veil E, Burton D, Zinsmeister AR. Comprehensive assessment of gastric emptying with a stable isotope breath test. Neurogastroenterol Motil. 2013 Jan; 25 (1):e60-9 Epub 2012 Dec 06
    View PubMed
  320. Camilleri M, Parkman HP, Shafi MA, Abell TL, Gerson L, American College of Gastroenterology. Clinical guideline: management of gastroparesis. Am J Gastroenterol. 2013 Jan; 108 (1):18-37; quiz 38 Epub 2012 Nov 13
    View PubMed
  321. Camilleri M, Iturrino J, Bharucha AE, Burton D, Shin A, Jeong ID, Zinsmeister AR. Performance characteristics of scintigraphic measurement of gastric emptying of solids in healthy participants. Neurogastroenterol Motil. 2012 Dec; 24 (12):1076-e562 Epub 2012 July 02
    View PubMed
  322. Zinsmeister AR, Bharucha AE, Camilleri M. Comparison of calculations to estimate gastric emptying half-time of solids in humans. Neurogastroenterol Motil. 2012 Dec; 24 (12):1142-5 Epub 2012 July 20
    View PubMed
  323. Vazquez-Roque MI, Camilleri M, Smyrk T, Murray JA, O'Neill J, Carlson P, Lamsam J, Eckert D, Janzow D, Burton D, Ryks M, Rhoten D, Zinsmeister AR. Association of HLA-DQ gene with bowel transit, barrier function, and inflammation in irritable bowel syndrome with diarrhea. Am J Physiol Gastrointest Liver Physiol. 2012 Dec 1; 303 (11):G1262-9 Epub 2012 Oct 04
    View PubMed
  324. Camilleri M. Irritable bowel syndrome: how useful is the term and the 'diagnosis'? Therap Adv Gastroenterol. 2012 Nov; 5 (6):381-6
    View PubMed
  325. Camilleri M. Peripheral mechanisms in irritable bowel syndrome. N Engl J Med. 2012 Oct 25; 367(17):1626-35.
    View PubMed
  326. Camilleri M, Lasch K, Zhou W. Irritable bowel syndrome: methods, mechanisms, and pathophysiology. The confluence of increased permeability, inflammation, and pain in irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol. 2012 Oct; 303(7):G775-85. Epub 2012 Jul 26.
    View PubMed
  327. Wong BS, Camilleri M, Carlson P, McKinzie S, Busciglio I, Bondar O, Dyer RB, Lamsam J, Zinsmeister AR. Increased bile acid biosynthesis is associated with irritable bowel syndrome with diarrhea. Clin Gastroenterol Hepatol. 2012 Sep; 10 (9):1009-15.e3 Epub 2012 May 18
    View PubMed
  328. Katzka DA, Loftus EV Jr, Camilleri M. Evolving molecular targets in the treatment of nonmalignant gastrointestinal diseases. Clin Pharmacol Ther. 2012 Sep; 92(3):306-20. Epub 2012 Jul 25.
    View PubMed
  329. Nullens S, Nelsen T, Camilleri M, Burton D, Eckert D, Iturrino J, Vazquez-Roque M, Zinsmeister AR. Regional colon transit in patients with dys-synergic defaecation or slow transit in patients with constipation. Gut. 2012 Aug; 61 (8):1132-9 Epub 2011 Dec 16
    View PubMed
  330. Iturrino J, Camilleri M, Busciglio I, Burton D, Zinsmeister AR. Sensations of gas and pain and their relationship with compliance during distension in human colon. Neurogastroenterol Motil. 2012 Jul; 24 (7):646-51, e275 Epub 2012 Mar 06
    View PubMed
  331. Camilleri M, Grover M, Farrugia G. What are the important subsets of gastroparesis? Neurogastroenterol Motil. 2012 Jul; 24 (7):597-603 Epub 2012 May 24
    View PubMed
  332. Camilleri M, Vazquez-Roque M, Iturrino J, Boldingh A, Burton D, McKinzie S, Wong BS, Rao AS, Kenny E, Mansson M, Zinsmeister AR. Effect of a glucagon-like peptide 1 analog, ROSE-010, on GI motor functions in female patients with constipation-predominant irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol. 2012 Jul; 303: (1)G120-8.
    View PubMed
  333. Camilleri M. Guanylate cyclase C signaling: an intestinal secretory pathway where bugs, genes and new drugs intersect. Genome Med. 2012 Jun 26; 4 (6):50 Epub 2012 June 26
    View PubMed
  334. Kimpinski K, Iodice V, Burton DD, Camilleri M, Mullan BP, Lipp A, Sandroni P, Gehrking TL, Sletten DM, Ahlskog JE, Fealey RD, Singer W, Low PA. The role of autonomic testing in the differentiation of Parkinson's disease from multiple system atrophy. J Neurol Sci. 2012 Jun 15; 317(1-2):92-6. Epub 2012 Mar 14.
    View PubMed
  335. Camilleri M, Madsen K, Spiller R, Greenwood-Van Meerveld B, Verne GN. Intestinal barrier function in health and gastrointestinal disease. Neurogastroenterol Motil. 2012 Jun; 24 (6):503-12
    View PubMed
  336. Money ME, Camilleri M. Review: Management of postprandial diarrhea syndrome. Am J Med. 2012 Jun; 125(6):538-44.
    View PubMed
  337. Camilleri M, Katzka DA. Irritable bowel syndrome: methods, mechanisms, and pathophysiology. Genetic epidemiology and pharmacogenetics in irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol. 2012 May 15; 302 (10):G1075-84 Epub 2012 Mar 08
    View PubMed
  338. Wong BS, Camilleri M, Carlson PJ, Odunsi-Shiyanbade S, McKinzie S, Busciglio I, Burton D, Zinsmeister AR. Pharmacogenetics of the effects of colesevelam on colonic transit in irritable bowel syndrome with diarrhea. Dig Dis Sci. 2012 May; 57 (5):1222-6 Epub 2012 Jan 21
    View PubMed
  339. Jeong ID, Camilleri M, Shin A, Iturrino J, Boldingh A, Busciglio I, Burton D, Ryks M, Rhoten D, Zinsmeister AR. A randomised, placebo-controlled trial comparing the effects of tapentadol and oxycodone on gastrointestinal and colonic transit in healthy humans. Aliment Pharmacol Ther. 2012 May; 35 (9):1088-96 Epub 2012 Feb 21
    View PubMed
  340. Revicki DA, Camilleri M, Kuo B, Szarka LA, McCormack J, Parkman HP. Evaluating symptom outcomes in gastroparesis clinical trials: validity and responsiveness of the Gastroparesis Cardinal Symptom Index-Daily Diary (GCSI-DD). Neurogastroenterol Motil. 2012 May; 24(5):456-63, e215-6. Epub 2012 Jan 27.
    View PubMed
  341. Tack J, Camilleri M, Chang L, Chey WD, Galligan JJ, Lacy BE, Muller-Lissner S, Quigley EM, Schuurkes J, De Maeyer JH, Stanghellini V. Systematic review: cardiovascular safety profile of 5-HT(4) agonists developed for gastrointestinal disorders. Aliment Pharmacol Ther. 2012 Apr; 35 (7):745-67 Epub 2012 Feb 22
    View PubMed
  342. Camilleri M, Di Lorenzo C. Brain-gut axis: from basic understanding to treatment of IBS and related disorders. J Pediatr Gastroenterol Nutr. 2012 Apr; 54 (4):446-53
    View PubMed
  343. Wong BS, Camilleri M, Eckert D, Carlson P, Ryks M, Burton D, Zinsmeister AR. Randomized pharmacodynamic and pharmacogenetic trial of dronabinol effects on colon transit in irritable bowel syndrome-diarrhea. Neurogastroenterol Motil. 2012 Apr; 24 (4):358-e169 Epub 2012 Jan 30
    View PubMed
  344. Camilleri M, Tremaine WJ. Governance of clinical research. Am J Gastroenterol. 2012 Mar; 107(3):336-8.
    View PubMed
  345. Szarka LA, Camilleri M. Methods for the assessment of small-bowel and colonic transit. Semin Nucl Med. 2012 Mar; 42 (2):113-23
    View PubMed
  346. Camilleri M. The role of pharmacogenetics in nonmalignant gastrointestinal diseases. Nat Rev Gastroenterol Hepatol. 2012 Feb 7; 9 (3):173-84 Epub 2012 Feb 07
    View PubMed
  347. Sathananthan A, Dalla Man C, Zinsmeister AR, Camilleri M, Rodeheffer RJ, Toffolo G, Cobelli C, Rizza RA, Vella A. A concerted decline in insulin secretion and action occurs across the spectrum of fasting and postchallenge glucose concentrations. Clin Endocrinol (Oxf). 2012 Feb; 76 (2):212-9
    View PubMed
  348. Smushkin G, Sathananthan A, Man CD, Zinsmeister AR, Camilleri M, Cobelli C, Rizza RA, Vella A. Defects in GLP-1 response to an oral challenge do not play a significant role in the pathogenesis of prediabetes. J Clin Endocrinol Metab. 2012 Feb; 97 (2):589-98 Epub 2011 Nov 16
    View PubMed
  349. Camilleri M, Nullens S, Nelsen T. Enteroendocrine and neuronal mechanisms in pathophysiology of acute infectious diarrhea. Dig Dis Sci. 2012 Jan; 57 (1):19-27 Epub 2011 Oct 15
    View PubMed
  350. Camilleri M. Pharmacology of the new treatments for lower gastrointestinal motility disorders and irritable bowel syndrome. Clin Pharmacol Ther. 2012 Jan; 91(1):44-59. Epub 2011 Nov 09.
    View PubMed
  351. Vazquez-Roque M, Camilleri M. Clarifications about linaclotide. Expert Rev Gastroenterol Hepatol. 2012 Jan; 6(1):15.
  352. Wong BS, Camilleri M, McKinzie S, Burton D, Graffner H, Zinsmeister AR. Effects of A3309, an ileal bile acid transporter inhibitor, on colonic transit and symptoms in females with functional constipation. Am J Gastroenterol. 2011 Dec; 106(12):2154-64. Epub 2011 Aug 30.
    View PubMed
  353. Zucchelli M, Camilleri M, Andreasson AN, Bresso F, Dlugosz A, Halfvarson J, Torkvist L, Schmidt PT, Karling P, Ohlsson B, Duerr RH, Simren M, Lindberg G, Agreus L, Carlson P, Zinsmeister AR, D'Amato M. Association of TNFSF15 polymorphism with irritable bowel syndrome. Gut. 2011 Dec; 60 (12):1671-1677 Epub 2011 June 02
    View PubMed
  354. Camilleri M, Vazquez-Roque MI, Carlson P, Burton D, Wong BS, Zinsmeister AR. Association of bile acid receptor TGR5 variation and transit in health and lower functional gastrointestinal disorders. Neurogastroenterol Motil. 2011 Nov; 23 (11):995-9, e458 Epub 2011 Aug 24
    View PubMed
  355. Wong BS, Camilleri M, Busciglio I, Carlson P, Szarka LA, Burton D, Zinsmeister AR. Pharmacogenetic trial of a cannabinoid agonist shows reduced fasting colonic motility in patients with nonconstipated irritable bowel syndrome. Gastroenterology. 2011 Nov; 141 (5):1638-47.e1-7 Epub 2011 July 29
    View PubMed
  356. Rao AS, Camilleri M, Eckert DJ, Busciglio I, Burton DD, Ryks M, Wong BS, Lamsam J, Singh R, Zinsmeister AR. Urine sugars for in vivo gut permeability: validation and comparisons in irritable bowel syndrome-diarrhea and controls. Am J Physiol Gastrointest Liver Physiol. 2011 Nov; 301 (5):G919-28 Epub 2011 Aug 11
    View PubMed
  357. Camilleri M, Carlson P, McKinzie S, Zucchelli M, D'Amato M, Busciglio I, Burton D, Zinsmeister AR. Genetic susceptibility to inflammation and colonic transit in lower functional gastrointestinal disorders: preliminary analysis. Neurogastroenterol Motil. 2011 Oct; 23 (10):935-e398 Epub 2011 July 14
    View PubMed
  358. Camilleri M. New treatment options for chronic constipation: mechanisms, efficacy and safety. Can J Gastroenterol. 2011 Oct; 25 Suppl B:29B-35B
    View PubMed
  359. Chey WD, Camilleri M, Chang L, Rikner L, Graffner H. A randomized placebo-controlled phase IIb trial of a3309, a bile acid transporter inhibitor, for chronic idiopathic constipation. Am J Gastroenterol. 2011 Oct; 106(10):1803-12. Epub 2011 May 24.
    View PubMed
  360. Iturrino J, Camilleri M, Busciglio I, Burton D, Zinsmeister AR. Effect of the alpha2delta ligand, pregabalin, on colonic sensory and motor functions in healthy adults. Am J Physiol Gastrointest Liver Physiol. 2011 Aug; 301 (2):G377-84 Epub 2011 May 19
    View PubMed
  361. Vazquez-Roque MI, Camilleri M, Vella A, Carlson P, Laugen J, Zinsmeister AR. Association of genetic variation in cannabinoid mechanisms and gastric motor functions and satiation in overweight and obesity. Neurogastroenterol Motil. 2011 Jul; 23 (7):637-e257 Epub 2011 Apr 07
    View PubMed
  362. Iturrino J, Camilleri M, Orrock JM. Mega-intestine after subtotal colectomy for constipation. Clin Gastroenterol Hepatol. 2011 Jul; 9(7):A38. Epub 2011 Mar 04.
    View PubMed
  363. Vazquez-Roque M, Camilleri M. VELUSETRAG 5-HT(4) receptor agonist treatment of chronic constipation. Drugs Future. 2011 Jun; 36(6):447-54.
  364. Vazquez-Roque MI, Camilleri M, Vella A, Carlson P, Laugen J, Zinsmeister AR. Association of TCF7L2 allelic variations with gastric function, satiation, and GLP-1 levels. Clin Transl Sci. 2011 Jun; 4 (3):183-7
    View PubMed
  365. Vazquez-Roque MI, Camilleri M, Carlson P, McKinzie S, Murray JA, Brantner TL, Burton DD, Zinsmeister AR. HLA-DQ genotype is associated with accelerated small bowel transit in patients with diarrhea-predominant irritable bowel syndrome. Eur J Gastroenterol Hepatol. 2011 Jun; 23 (6):481-7
    View PubMed
  366. Camilleri M, Breen M, Ryks M, Burton D. Proximal and overall gastric emptying of solids in patients with reduced gastric volume accommodation compared to matched controls. Dig Dis Sci. 2011 Jun; 56 (6):1729-34 Epub 2011 Feb 17
    View PubMed
  367. Wong BS, Camilleri M, Carlson PJ, Guicciardi ME, Burton D, McKinzie S, Rao AS, Zinsmeister AR, Gores GJ. A Klothobeta variant mediates protein stability and associates with colon transit in irritable bowel syndrome with diarrhea. Gastroenterology. 2011 Jun; 140 (7):1934-42 Epub 2011 Mar 09
    View PubMed
  368. Vazquez Roque M, Camilleri M. Linaclotide, a synthetic guanylate cyclase C agonist, for the treatment of functional gastrointestinal disorders associated with constipation. Expert Rev Gastroenterol Hepatol. 2011 Jun; 5 (3):301-10
    View PubMed
  369. Camilleri M. Inclusion criteria for pharmacodynamic and clinical trials in chronic idiopathic constipation: pitfalls in using Rome III for functional constipation. Therap Adv Gastroenterol. 2011 May; 4 (3):159-63
    View PubMed
  370. Camilleri M. Opioid-induced constipation: challenges and therapeutic opportunities. Am J Gastroenterol. 2011 May; 106 (5):835-42; quiz 843 Epub 2011 Feb 22
    View PubMed
  371. Camilleri M. Managing symptoms of irritable bowel syndrome in patients with inflammatory bowel disease. Gut. 2011 Apr; 60 (4):425-8 Epub 2011 Feb 02
    View PubMed
  372. Breen M, Camilleri M, Burton D, Zinsmeister AR. Performance characteristics of the measurement of gastric volume using single photon emission computed tomography. Neurogastroenterol Motil. 2011 Apr; 23 (4):308-15 Epub 2011 Jan 06
    View PubMed
  373. Wong BS, Camilleri M. Lubiprostone for the treatment of opioid-induced bowel dysfunction. Expert Opin Pharmacother. 2011 Apr; 12(6):983-90. Epub 2011 Mar 09.
    View PubMed
  374. Camilleri M. LX-1031, a tryptophan 5-hydroxylase inhibitor, and its potential in chronic diarrhea associated with increased serotonin. Neurogastroenterol Motil. 2011 Mar; 23 (3):193-200 Epub 2010 Dec 15
    View PubMed
  375. Camilleri M, Rothman M, Ho KF, Etropolski M. Validation of a bowel function diary for assessing opioid-induced constipation. Am J Gastroenterol. 2011 Mar; 106 (3):497-506 Epub 2010 Nov 09
    View PubMed
  376. Wong BS, Camilleri M, Carlson PJ, Guicciardi ME, Burton D, McKinzie S, Rao AS, Zinsmeister AR, Gores GJ. A klotho beta variant mediates protein stability and associates with colon transit in irritable bowel syndrome with diarrhea. Gastroenterology. 2011; 140(7):1934-42.
  377. Camilleri M, Bharucha AE, Farrugia G. Epidemiology, mechanisms, and management of diabetic gastroparesis. Clin Gastroenterol Hepatol. 2011 Jan; 9: (1)5-12; quiz e7.
    View PubMed
  378. Rao SS, Camilleri M, Hasler WL, Maurer AH, Parkman HP, Saad R, Scott MS, Simren M, Soffer E, Szarka L. Evaluation of gastrointestinal transit in clinical practice: position paper of the American and European Neurogastroenterology and Motility Societies. Neurogastroenterol Motil. 2011 Jan; 23(1):8-23.
    View PubMed
  379. Lacy BE, Talley NJ, Camilleri M. Functional dyspepsia: time to change clinical trial design? Am J Gastroenterol. 2010 Dec; 105 (12):2525-9
    View PubMed
  380. Camilleri M. LX-1031, a tryptophan 5-hydroxylase inhibitor that reduces 5-HT levels for the potential treatment of irritable bowel syndrome. IDrugs. 2010 Dec; 13(12):921-8.
    View PubMed
  381. Rao AS, Wong BS, Camilleri M, Odunsi-Shiyanbade ST, McKinzie S, Ryks M, Burton D, Carlson P, Lamsam J, Singh R, Zinsmeister AR. Chenodeoxycholate in females with irritable bowel syndrome-constipation: a pharmacodynamic and pharmacogenetic analysis. Gastroenterology. 2010 Nov; 139 (5):1549-58, 1558.e1 Epub 2010 Aug 04
    View PubMed
  382. Camilleri M, Van Outryve MJ, Beyens G, Kerstens R, Robinson P, Vandeplassche L. Clinical trial: the efficacy of open-label prucalopride treatment in patients with chronic constipation - follow-up of patients from the pivotal studies. Aliment Pharmacol Ther. 2010 Nov; 32(9):1113-23. Epub 2010 Sep 16.
    View PubMed
  383. Manabe N, Rao AS, Wong BS, Camilleri M. Emerging pharmacologic therapies for irritable bowel syndrome. Curr Gastroenterol Rep. 2010 Oct; 12 (5):408-16
    View PubMed
  384. Wong BS, Rao AS, Camilleri M, Manabe N, McKinzie S, Busciglio I, Burton DD, Ryks M, Zinsmeister AR. The effects of methylnaltrexone alone and in combination with acutely administered codeine on gastrointestinal and colonic transit in health. Aliment Pharmacol Ther. 2010 Oct; 32 (7):884-93
    View PubMed
  385. Camilleri M, Bharucha AE. Behavioural and new pharmacological treatments for constipation: getting the balance right. Gut. 2010 Sep; 59 (9):1288-96
    View PubMed
  386. Camilleri M, Tack JF. Current medical treatments of dyspepsia and irritable bowel syndrome. Gastroenterol Clin North Am. 2010 Sep; 39(3):481-93.
    View PubMed
  387. Sathananthan A, Man CD, Micheletto F, Zinsmeister AR, Camilleri M, Giesler PD, Laugen JM, Toffolo G, Rizza RA, Cobelli C, Vella A. Common genetic variation in GLP1R and insulin secretion in response to exogenous GLP-1 in nondiabetic subjects: a pilot study. Diabetes Care. 2010 Sep; 33 (9):2074-6
    View PubMed
  388. Odunsi ST, Vazquez-Roque MI, Camilleri M, Papathanasopoulos A, Clark MM, Wodrich L, Lempke M, McKinzie S, Ryks M, Burton D, Zinsmeister AR. Effect of alginate on satiation, appetite, gastric function, and selected gut satiety hormones in overweight and obesity. Obesity (Silver Spring). 2010 Aug; 18 (8):1579-84 Epub 2009 Dec 03
    View PubMed
  389. Spiegel BM, Roberts L, Mody R, Harding G, Kothari-Talwar S, Kahrilas PJ, Camilleri ML, Dabbous O, Revicki DA. The development and validation of a Nocturnal Gastro-oesophageal Reflux Disease Symptom Severity and Impact Questionnaire for adults. Aliment Pharmacol Ther. 2010 Aug; 32(4):591-602. Epub 2010 Jun 02.
    View PubMed
  390. Camilleri M, Thorne NK, Ringel Y, Hasler WL, Kuo B, Esfandyari T, Gupta A, Scott SM, McCallum RW, Parkman HP, Soffer E, Wilding GE, Semler JR, Rao SS. Wireless pH-motility capsule for colonic transit: prospective comparison with radiopaque markers in chronic constipation. Neurogastroenterol Motil. 2010 Aug; 22 (8):874-82, e233 Epub 2010 May 11
    View PubMed
  391. Rashtak S, Marietta E, Cheng S, Camilleri M, Pittelkow M, David C, Grande J, Murray J. Spontaneous lupus-like syndrome in HLA-DQ2 transgenic mice with a mixed genetic background. Lupus. 2010 Jun; 19 (7):815-29 Epub 2010 Feb 08
    View PubMed
  392. Camilleri M. Scintigraphic biomarkers for colonic dysmotility. Clin Pharmacol Ther. 2010 Jun; 87 (6):748-53 Epub 2010 Apr 21
    View PubMed
  393. Manabe N, Wong BS, Camilleri M. New-generation 5-HT4 receptor agonists: potential for treatment of gastrointestinal motility disorders. Expert Opin Investig Drugs. 2010 Jun; 19(6):765-75.
    View PubMed
  394. Papathanasopoulos A, Camilleri M, Carlson PJ, Vella A, Nord SJ, Burton DD, Odunsi ST, Zinsmeister AR. A preliminary candidate genotype-intermediate phenotype study of satiation and gastric motor function in obesity. Obesity (Silver Spring). 2010 Jun; 18 (6):1201-11 Epub 2009 Oct 29
    View PubMed
  395. Manabe N, Camilleri M, Rao A, Wong BS, Burton D, Busciglio I, Zinsmeister AR, Haruma K. Effect of daikenchuto (TU-100) on gastrointestinal and colonic transit in humans. Am J Physiol Gastrointest Liver Physiol. 2010 Jun; 298(6):G970-5. Epub 2010 Apr 08.
    View PubMed
  396. Deiteren A, Camilleri M, Bharucha AE, Burton D, McKinzie S, Rao AS, Zinsmeister AR. Performance characteristics of scintigraphic colon transit measurement in health and irritable bowel syndrome and relationship to bowel functions. Neurogastroenterol Motil. 2010 Apr; 22 (4):415-23, e95 Epub 2009 Dec 18
    View PubMed
  397. Odunsi ST, Camilleri M, Bharucha AE, Papathanasopoulos A, Busciglio I, Burton D, Zinsmeister AR. Reproducibility and performance characteristics of colonic compliance, tone, and sensory tests in healthy humans. Dig Dis Sci. 2010 Mar; 55 (3):709-15 Epub 2009 Mar 17
    View PubMed
  398. Manabe N, Wong BS, Camilleri M, Burton D, McKinzie S, Zinsmeister AR. Lower functional gastrointestinal disorders: evidence of abnormal colonic transit in a 287 patient cohort. Neurogastroenterol Motil. 2010 Mar; 22 (3):293-e82 Epub 2009 Dec 21
    View PubMed
  399. Bharucha AE, Kulkarni A, Choi KM, Camilleri M, Lempke M, Brunn GJ, Gibbons SJ, Zinsmeister AR, Farrugia G. First-in-human study demonstrating pharmacological activation of heme oxygenase-1 in humans. Clin Pharmacol Ther. 2010 Feb; 87 (2):187-90 Epub 2009 Dec 02
    View PubMed
  400. Camilleri M, Deiteren A. Prucalopride for constipation. Expert Opin Pharmacother. 2010 Feb; 11(3):451-61.
    View PubMed
  401. Parkman HP, Camilleri M, Farrugia G, McCallum RW, Bharucha AE, Mayer EA, Tack JF, Spiller R, Horowitz M, Vinik AI, Galligan JJ, Pasricha PJ, Kuo B, Szarka LA, Marciani L, Jones K, Parrish CR, Sandroni P, Abell T, Ordog T, Hasler W, Koch KL, Sanders K, Norton NJ, Hamilton F. Gastroparesis and functional dyspepsia: excerpts from the AGA/ANMS meeting. Neurogastroenterol Motil. 2010 Feb; 22(2):113-33. Epub 2009 Dec 09.
    View PubMed
  402. Deiteren A, Camilleri M, Burton D, McKinzie S, Rao A, Zinsmeister AR. Effect of meal ingestion on ileocolonic and colonic transit in health and irritable bowel syndrome. Dig Dis Sci. 2010 Feb; 55 (2):384-91
    View PubMed
  403. Spiller R, Camilleri M, Longstreth GF. Do the symptom-based, Rome criteria of irritable bowel syndrome lead to better diagnosis and treatment outcomes? Clin Gastroenterol Hepatol. 2010 Feb; 8(2):125-9; discussion 129-36.
    View PubMed
  404. Odunsi-Shiyanbade ST, Camilleri M, McKinzie S, Burton D, Carlson P, Busciglio IA, Lamsam J, Singh R, Zinsmeister AR. Effects of chenodeoxycholate and a bile acid sequestrant, colesevelam, on intestinal transit and bowel function. Clin Gastroenterol Hepatol. 2010 Feb; 8 (2):159-65 Epub 2009 Oct 30
    View PubMed
  405. Manini ML, Camilleri M, Goldberg M, Sweetser S, McKinzie S, Burton D, Wong S, Kitt MM, Li YP, Zinsmeister AR. Effects of Velusetrag (TD-5108) on gastrointestinal transit and bowel function in health and pharmacokinetics in health and constipation. Neurogastroenterol Motil. 2010 Jan; 22 (1):42-9, e7-8 Epub 2009 Aug 18
    View PubMed
  406. Ravi K, Bharucha AE, Camilleri M, Rhoten D, Bakken T, Zinsmeister AR. Phenotypic variation of colonic motor functions in chronic constipation. Gastroenterology. 2010 Jan; 138 (1):89-97 Epub 2009 Aug 04
    View PubMed
  407. Camilleri M, Nadeau A, Lamsam J, Nord SL, Ryks M, Burton D, Sweetser S, Zinsmeister AR, Singh R. Understanding measurements of intestinal permeability in healthy humans with urine lactulose and mannitol excretion. Neurogastroenterol Motil. 2010 Jan; 22 (1):e15-26 Epub 2009 July 13
    View PubMed
  408. Camilleri M. Review article: new receptor targets for medical therapy in irritable bowel syndrome. Aliment Pharmacol Ther. 2010 Jan; 31 (1):35-46
    View PubMed
  409. Camilleri M, Carlson P, Zinsmeister AR, McKinzie S, Busciglio I, Burton D, Zucchelli M, D'Amato M. Neuropeptide S receptor induces neuropeptide expression and associates with intermediate phenotypes of functional gastrointestinal disorders. Gastroenterology. 2010 Jan; 138 (1):98-107.e4 Epub 2009 Sept 02
    View PubMed
  410. Camilleri M, Parke DW 2nd. Perspective: Conflict of interest and professional organizations: considerations and recommendations. Acad Med. 2010 Jan; 85(1):85-91.
    View PubMed
  411. Papathanasopoulos A, Camilleri M. Dietary fiber supplements: effects in obesity and metabolic syndrome and relationship to gastrointestinal functions. Gastroenterology. 2010 Jan; 138 (1):65-72.e1-2 Epub 2009 Nov 18
    View PubMed
  412. Wong BS, Manabe N, Camilleri M. Role of prucalopride, a serotonin (5-HT(4)) receptor agonist, for the treatment of chronic constipation. Clin Exp Gastroenterol. 2010; 3:49-56 Epub 2010 May 24
    View PubMed
  413. Cremonini F, Camilleri M, Clark MM, Beebe TJ, Locke GR, Zinsmeister AR, Herrick LM, Talley NJ. "Associations among binge eating behavior patterns and gastrointestinal symptoms: A population-based study": Corrigendum. Int J Obes. 2010 Jan; 34(1):214.
  414. Szarka LA, Camilleri M. Stomach dysfunction in diabetes mellitus: emerging technology and pharmacology. J Diabetes Sci Technol. 2010 Jan 1; 4 (1):180-9 Epub 2010 Jan 01
    View PubMed
  415. Rao AS, Camilleri M. Review article: metoclopramide and tardive dyskinesia. Aliment Pharmacol Ther. 2010 Jan; 31(1):11-9.
    View PubMed
  416. Camilleri M, Andresen V. Current and novel therapeutic options for irritable bowel syndrome management. Dig Liver Dis. 2009 Dec; 41 (12):854-62 Epub 2009 Aug 08
    View PubMed
  417. Spiegel B, Camilleri M, Bolus R, Andresen V, Chey WD, Fehnel S, Mangel A, Talley NJ, Whitehead WE. Psychometric evaluation of patient-reported outcomes in irritable bowel syndrome randomized controlled trials: a Rome Foundation report. Gastroenterology. 2009 Dec; 137(6):1944-53.e1-3. Epub 2009 Aug 23.
    View PubMed
  418. Camilleri M, Beyens G, Kerstens R, Robinson P, Vandeplassche L. Safety assessment of prucalopride in elderly patients with constipation: a double-blind, placebo-controlled study. Neurogastroenterol Motil. 2009 Dec; 21: (12)1256-e117.
    View PubMed
  419. Camilleri M. Genetics and irritable bowel syndrome: from genomics to intermediate phenotype and pharmacogenetics. Dig Dis Sci. 2009 Nov; 54 (11):2318-24 Epub 2009 Aug 05
    View PubMed
  420. Manabe N, Cremonini F, Camilleri M, Sandborn WJ, Burton DD. Effects of bisacodyl on ascending colon emptying and overall colonic transit in healthy volunteers. Aliment Pharmacol Ther. 2009 Nov 1; 30 (9):930-6 Epub 2009 Aug 12
    View PubMed
  421. Camilleri M. Do the Symptom-Based, Rome Criteria of Irritable Bowel Syndrome Lead to Better Diagnosis and Treatment Outcomes? The Con Argument. Clin Gastroenterol Hepatol. 2009 Oct 20; 8 (2):129
    View PubMed
  422. Keller J, Andresen V, Wolter J, Layer P, Camilleri M. Influence of clinical parameters on the results of 13C-octanoic acid breath tests: examination of different mathematical models in a large patient cohort. Neurogastroenterol Motil. 2009 Oct; 21(10):1039-e83. Epub 2009 Jun 22.
    View PubMed
  423. Revicki DA, Camilleri M, Kuo B, Norton NJ, Murray L, Palsgrove A, Parkman HP. Development and content validity of a gastroparesis cardinal symptom index daily diary. Aliment Pharmacol Ther. 2009 Sep 15; 30(6):670-80. Epub 2009 Jun 25.
    View PubMed
  424. Gathaiya N, Locke GR 3rd, Camilleri M, Schleck CD, Zinsmeister AR, Talley NJ. Novel associations with dyspepsia: a community-based study of familial aggregation, sleep dysfunction and somatization. Neurogastroenterol Motil. 2009 Sep; 21 (9):922-e69 Epub 2009 June 02
    View PubMed
  425. Camilleri M. Peripheral mechanisms in the control of appetite and related experimental therapies in obesity. Regul Pept. 2009 Aug 7; 156 (1-3):24-7 Epub 2009 May 03
    View PubMed
  426. Szarka LA, Camilleri M. Gastric emptying. Clin Gastroenterol Hepatol. 2009 Aug; 7(8):823-7. Epub 2009 Apr 24.
    View PubMed
  427. Izzo AA, Camilleri M. Cannabinoids in intestinal inflammation and cancer. Pharmacol Res. 2009 Aug; 60(2):117-25. Epub 2009 Mar 18.
    View PubMed
  428. Odunsi ST, Camilleri M, Szarka LA, Zinsmeister AR. Optimizing analysis of stable isotope breath tests to estimate gastric emptying of solids. Neurogastroenterol Motil. 2009 Jul; 21 (7):706-e38 Epub 2009 Feb 27
    View PubMed
  429. Bernard CE, Gibbons SJ, Gomez-Pinilla PJ, Lurken MS, Schmalz PF, Roeder JL, Linden D, Cima RR, Dozois EJ, Larson DW, Camilleri M, Zinsmeister AR, Pozo MJ, Hicks GA, Farrugia G. Effect of age on the enteric nervous system of the human colon. Neurogastroenterol Motil. 2009 Jul; 21 (7):746-e46 Epub 2009 Feb 08
    View PubMed
  430. Camilleri M, Nadeau A, Tremaine WJ, Lamsam J, Burton D, Odunsi S, Sweetser S, Singh R. Measurement of serum 7alpha-hydroxy-4-cholesten-3-one (or 7alphaC4), a surrogate test for bile acid malabsorption in health, ileal disease and irritable bowel syndrome using liquid chromatography-tandem mass spectrometry. Neurogastroenterol Motil. 2009 Jul; 21 (7):734-e43 Epub 2009 Mar 13
    View PubMed
  431. Camilleri M, Papathanasopoulos A, Odunsi ST. Actions and therapeutic pathways of ghrelin for gastrointestinal disorders. Nat Rev Gastroenterol Hepatol. 2009 Jun; 6 (6):343-52
    View PubMed
  432. Sweetser S, Camilleri M, Linker Nord SJ, Burton DD, Castenada L, Croop R, Tong G, Dockens R, Zinsmeister AR. Do corticotropin releasing factor-1 receptors influence colonic transit and bowel function in women with irritable bowel syndrome? Am J Physiol Gastrointest Liver Physiol. 2009 Jun; 296 (6):G1299-306 Epub 2009 Apr 02
    View PubMed
  433. Odunsi ST, Camilleri M. Selected interventions in nuclear medicine: gastrointestinal motor functions. Semin Nucl Med. 2009 May; 39 (3):186-94
    View PubMed
  434. Camilleri M. Evolving concepts of the pathogenesis of irritable bowel syndrome: to treat the brain or the gut? J Pediatr Gastroenterol Nutr. 2009 Apr; 48 Suppl 2:S46-8
    View PubMed
  435. Camilleri M, Busciglio I, Carlson P, McKinzie S, Burton D, Baxter K, Ryks M, Zinsmeister AR. Pharmacogenetics of low dose clonidine in irritable bowel syndrome. Neurogastroenterol Motil. 2009 Apr; 21 (4):399-410
    View PubMed
  436. Manini ML, Burton DD, Meixner DD, Eckert DJ, Callstrom M, Schmit G, El-Youssef M, Camilleri M. Feasibility and application of 3-dimensional ultrasound for measurement of gastric volumes in healthy adults and adolescents. J Pediatr Gastroenterol Nutr. 2009 Mar; 48 (3):287-93
    View PubMed
  437. Szarka LA, Camilleri M. Methods for measurement of gastric motility. Am J Physiol Gastrointest Liver Physiol. 2009 Mar; 296(3):G461-75. Epub 2009 Jan 15.
    View PubMed
  438. Camilleri M, Carlson P, Zinsmeister AR, McKinzie S, Busciglio I, Burton D, Zaki EA, Boles RG. Mitochondrial DNA and gastrointestinal motor and sensory functions in health and functional gastrointestinal disorders. Am J Physiol Gastrointest Liver Physiol. 2009 Mar; 296(3):G510-6. Epub 2009 Jan 15.
    View PubMed
  439. Cremonini F, Camilleri M, Clark MM, Beebe TJ, Locke GR, Zinsmeister AR, Herrick LM, Talley NJ. Associations among binge eating behavior patterns and gastrointestinal symptoms: a population-based study. Int J Obes (Lond). 2009 Mar; 33 (3):342-53 Epub 2009 Jan 13
    View PubMed
  440. Camilleri M. The stomach in diabetes: from villain to ally. Clin Gastroenterol Hepatol. 2009 Mar; 7 (3):285-7 Epub 2008 Nov 06
    View PubMed
  441. Camilleri M, Toouli J, Herrera MF, Kow L, Pantoja JP, Billington CJ, Tweden KS, Wilson RR, Moody FG. Selection of electrical algorithms to treat obesity with intermittent vagal block using an implantable medical device. Surg Obes Relat Dis. 2009 Mar-Apr; 5(2):224-9; discussion 229-30. Epub 2008 Sep 12.
    View PubMed
  442. Floyd BN, Camilleri M, Busciglio I, Sweetser S, Burton D, Wong GY, Kell S, Khanna S, Hwang S, Zinsmeister AR. Effect of a kappa-opioid agonist, i.v. JNJ-38488502, on sensation of colonic distensions in healthy male volunteers. Neurogastroenterol Motil. 2009 Mar; 21(3):281-90. Epub 2008 Sep 23.
    View PubMed
  443. Bharucha AE, Camilleri M, Forstrom LA, Zinsmeister AR. Relationship between clinical features and gastric emptying disturbances in diabetes mellitus. Clin Endocrinol (Oxf). 2009 Mar; 70 (3):415-20 Epub 2008 Aug 22
    View PubMed
  444. Camilleri M. Serotonin in the gastrointestinal tract. Curr Opin Endocrinol Diabetes Obes. 2009 Feb; 16 (1):53-9
    View PubMed
  445. Cremonini F, Camilleri M, Zinsmeister AR, Herrick LM, Beebe T, Talley NJ. Sleep disturbances are linked to both upper and lower gastrointestinal symptoms in the general population. Neurogastroenterol Motil. 2009 Feb; 21(2):128-35. Epub 2008 Sep 18.
    View PubMed
  446. Sweetser S, Busciglio IA, Camilleri M, Bharucha AE, Szarka LA, Papathanasopoulos A, Burton DD, Eckert DJ, Zinsmeister AR. Effect of a chloride channel activator, lubiprostone, on colonic sensory and motor functions in healthy subjects. Am J Physiol Gastrointest Liver Physiol. 2009 Feb; 296 (2):G295-301 Epub 2008 Nov 25
    View PubMed
  447. Dalla Man C, Bock G, Giesler PD, Serra DB, Ligueros Saylan M, Foley JE, Camilleri M, Toffolo G, Cobelli C, Rizza RA, Vella A. Dipeptidyl peptidase-4 inhibition by vildagliptin and the effect on insulin secretion and action in response to meal ingestion in type 2 diabetes. Diabetes Care. 2009 Jan; 32(1):14-8. Epub 2008 Oct 17.
    View PubMed
  448. Fidler J, Bharucha AE, Camilleri M, Camp J, Burton D, Grimm R, Riederer SJ, Robb RA, Zinsmeister AR. Application of magnetic resonance imaging to measure fasting and postprandial volumes in humans. Neurogastroenterol Motil. 2009 Jan; 21 (1):42-51 Epub 2008 Oct 06
    View PubMed
  449. Rao AS, Camilleri M. Review article: metoclopramide and tardive dyskinesia. Aliment Pharmacol Ther. 2009 Jan 1; 31(1):11-9.
  450. Camilleri M. Review article: new receptor targets for medical therapy in irritable bowel syndrome. Aliment Pharmacol Ther. 2009 Jan 1; 31(1):35-46.
  451. Gibbons SJ, De Giorgio R, Faussone Pellegrini MS, Garrity-Park MM, Miller SM, Schmalz PF, Young-Fadok TM, Larson DW, Dozois EJ, Camilleri M, Stanghellini V, Szurszewski JH, Farrugia G. Apoptotic cell death of human interstitial cells of Cajal. Neurogastroenterol Motil. 2009 Jan; 21 (1):85-93 Epub 2008 Sept 16
    View PubMed
  452. Camilleri M, Bharucha AE, di Lorenzo C, Hasler WL, Prather CM, Rao SS, Wald A. American Neurogastroenterology and Motility Society consensus statement on intraluminal measurement of gastrointestinal and colonic motility in clinical practice. Neurogastroenterol Motil. 2008 Dec; 20(12):1269-82.
    View PubMed
  453. Camilleri M, Chang L. Challenges to the therapeutic pipeline for irritable bowel syndrome: end points and regulatory hurdles. Gastroenterology. 2008 Dec; 135 (6):1877-91 Epub 2008 Oct 09
    View PubMed
  454. Camilleri M. Drug development and IBS drugs: experience from the past, current challenges, and proposal for the future. Curr Opin Pharmacol. 2008 Dec; 8(6):671-6. Epub 2008 Jul 09.
    View PubMed
  455. Vella A, Bock G, Giesler PD, Burton DB, Serra DB, Saylan ML, Deacon CF, Foley JE, Rizza RA, Camilleri M. The effect of dipeptidyl peptidase-4 inhibition on gastric volume, satiation and enteroendocrine secretion in type 2 diabetes: a double-blind, placebo-controlled crossover study. Clin Endocrinol (Oxf). 2008 Nov; 69 (5):737-44 Epub 2008 Mar 10
    View PubMed
  456. Grudell AB, Sweetser S, Camilleri M, Eckert DJ, Vazquez-Roque MI, Carlson PJ, Burton DD, Braddock AE, Clark MM, Graszer KM, Kalsy SA, Zinsmeister AR. A controlled pharmacogenetic trial of sibutramine on weight loss and body composition in obese or overweight adults. Gastroenterology. 2008 Oct; 135 (4):1142-54 Epub 2008 July 16
    View PubMed
  457. Camilleri M. Novel pharmacology: asimadoline, a kappa-opioid agonist, and visceral sensation. Neurogastroenterol Motil. 2008 Sep; 20 (9):971-9
    View PubMed
  458. Bharucha AE, Charkoudian N, Andrews CN, Camilleri M, Sletten D, Zinsmeister AR, Low PA. Effects of glucagon-like peptide-1, yohimbine, and nitrergic modulation on sympathetic and parasympathetic activity in humans. Am J Physiol Regul Integr Comp Physiol. 2008 Sep; 295 (3):R874-80 Epub 2008 July 02
    View PubMed
  459. Camilleri M. Probiotics and irritable bowel syndrome: rationale, mechanisms, and efficacy. J Clin Gastroenterol. 2008 Sep; 42 Suppl 3 Pt 1:S123-5.
    View PubMed
  460. Bharucha AE, Skaar T, Andrews CN, Camilleri M, Philips S, Seide B, Burton D, Baxter K, Zinsmeister AR. Relationship of cytochrome P450 pharmacogenetics to the effects of yohimbine on gastrointestinal transit and catecholamines in healthy subjects. Neurogastroenterol Motil. 2008 Aug; 20 (8):891-9 Epub 2008 Apr 16
    View PubMed
  461. Delgado-Aros S, Camilleri M, Garcia MA, Burton D, Busciglio I. High body mass alters colonic sensory-motor function and transit in humans. Am J Physiol Gastrointest Liver Physiol. 2008 Aug; 295(2):G382-8. Epub 2008 Jul 10.
    View PubMed
  462. Camilleri M. New therapeutic approaches in irritable bowel syndrome. Eur Rev Med Pharmacol Sci. 2008 Aug; 12 Suppl 1:139-40.
    View PubMed
  463. Izzo AA, Camilleri M. Emerging role of cannabinoids in gastrointestinal and liver diseases: basic and clinical aspects. Gut. 2008 Aug; 57(8):1140-55. Epub 2008 Apr 08.
    View PubMed
  464. Camilleri M, Busciglio I, Carlson P, McKinzie S, Burton D, Baxter K, Ryks M, Zinsmeister AR. Candidate genes and sensory functions in health and irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol. 2008 Aug; 295 (2):G219-25 Epub 2008 May 29
    View PubMed
  465. Bharucha AE, Low PA, Camilleri M, Burton D, Gehrking TL, Zinsmeister AR. Pilot study of pyridostigmine in constipated patients with autonomic neuropathy. Clin Auton Res. 2008 Aug; 18 (4):194-202 Epub 2008 July 11
    View PubMed
  466. Bouras EP, Talley NJ, Camilleri M, Burton DD, Heckman MG, Crook JE, Richelson E. Effects of amitriptyline on gastric sensorimotor function and postprandial symptoms in healthy individuals: a randomized, double-blind, placebo-controlled trial. Am J Gastroenterol. 2008 Aug; 103 (8):2043-50
    View PubMed
  467. Andresen V, Camilleri M. Linaclotide acetate guanylate cyclase C receptor agonist treatment of irritable bowel syndrome treatment of constipation. Drugs Future. 2008 Jul; 33(7):570-6.
  468. Camilleri M, McKinzie S, Busciglio I, Low PA, Sweetser S, Burton D, Baxter K, Ryks M, Zinsmeister AR. Prospective study of motor, sensory, psychologic, and autonomic functions in patients with irritable bowel syndrome. Clin Gastroenterol Hepatol. 2008 Jul; 6 (7):772-81 Epub 2008 May 05
    View PubMed
  469. Szarka LA, Camilleri M, Vella A, Burton D, Baxter K, Simonson J, Zinsmeister AR. A stable isotope breath test with a standard meal for abnormal gastric emptying of solids in the clinic and in research. Clin Gastroenterol Hepatol. 2008 Jun; 6 (6):635-643.e1 Epub 2008 Apr 14
    View PubMed
  470. Talley NJ, Choung RS, Camilleri M, Dierkhising RA, Zinsmeister AR. Asimadoline, a kappa-opioid agonist, and satiation in functional dyspepsia. Aliment Pharmacol Ther. 2008 Jun 1; 27 (11):1122-31 Epub 2008 Mar 07
    View PubMed
  471. Camilleri M, Toouli J, Herrera MF, Kulseng B, Kow L, Pantoja JP, Marvik R, Johnsen G, Billington CJ, Moody FG, Knudson MB, Tweden KS, Vollmer M, Wilson RR, Anvari M. Intra-abdominal vagal blocking (VBLOC therapy): clinical results with a new implantable medical device. Surgery. 2008 Jun; 143(6):723-31. Epub 2008 May 09.
    View PubMed
  472. Camilleri M, Kerstens R, Rykx A, Vandeplassche L. A placebo-controlled trial of prucalopride for severe chronic constipation. N Engl J Med. 2008 May 29; 358: (22)2344-54.
    View PubMed
  473. Vella A, Camilleri M. Pharmacogenetics: potential role in the treatment of diabetes and obesity. Expert Opin Pharmacother. 2008 May; 9 (7):1109-19
    View PubMed
  474. Grudell AB, Camilleri M, Jensen KL, Foxx-Orenstein AE, Burton DD, Ryks MD, Baxter KL, Cox DS, Dukes GE, Kelleher DL, Zinsmeister AR. Dose-response effect of a beta3-adrenergic receptor agonist, solabegron, on gastrointestinal transit, bowel function, and somatostatin levels in health. Am J Physiol Gastrointest Liver Physiol. 2008 May; 294(5):G1114-9. Epub 2008 Mar 27.
    View PubMed
  475. Andresen V, Montori VM, Keller J, West CP, Layer P, Camilleri M. Effects of 5-hydroxytryptamine (serotonin) type 3 antagonists on symptom relief and constipation in nonconstipated irritable bowel syndrome: a systematic review and meta-analysis of randomized controlled trials. Clin Gastroenterol Hepatol. 2008 May; 6 (5):545-55 Epub 2008 Jan 31
    View PubMed
  476. Sweetser S, Camilleri M. Clinical challenges and images in GI. Hindgut dysgenesis with megacolon. Gastroenterology. 2008 May; 134(5):1293, 1635.
    View PubMed
  477. Topazian M, Camilleri M, De La Mora-Levy J, Enders FB, Foxx-Orenstein AE, Levy MJ, Nehra V, Talley NJ. Endoscopic ultrasound-guided gastric botulinum toxin injections in obese subjects: a pilot study. Obes Surg. 2008 Apr; 18 (4):401-7 Epub 2008 Feb 20
    View PubMed
  478. Floyd BN, Camilleri M, Andresen V, Esfandyari T, Busciglio I, Zinsmeister AR. Comparison of mathematical methods for calculating colonic compliance in humans: power exponential, computer-based and manual linear interpolation models. Neurogastroenterol Motil. 2008 Apr; 20 (4):330-5 Epub 2007 Oct 25
    View PubMed
  479. Camilleri M, Cowen T, Koch TR. Enteric neurodegeneration in ageing. Neurogastroenterol Motil. 2008 Apr; 20(4):418-29.
    View PubMed
  480. Camilleri M, Cowen T, Koch TR. Enteric neurodegeneration in ageing. Neurogastroenterol Motil. 2008 Mar; 20(3):185-96.
    View PubMed
  481. Abell TL, Camilleri M, Donohoe K, Hasler WL, Lin HC, Maurer AH, McCallum RW, Nowak T, Nusynowitz ML, Parkman HP, Shreve P, Szarka LA, Snape WJ Jr, Ziessman HA, American Neurogastroenterology and Motility Society and the Society of Nuclear Medicine. Consensus recommendations for gastric emptying scintigraphy: a joint report of the American Neurogastroenterology and Motility Society and the Society of Nuclear Medicine. Am J Gastroenterol. 2008 Mar; 103(3):753-63. Epub 2007 Nov 19.
    View PubMed
  482. Grudell AB, Camilleri M, Carlson P, Gorman H, Ryks M, Burton D, Baxter K, Zinsmeister AR. An exploratory study of the association of adrenergic and serotonergic genotype and gastrointestinal motor functions. Neurogastroenterol Motil. 2008 Mar; 20: (3)213-9.
    View PubMed
  483. Abell TL, Camilleri M, Donohoe K, Hasler WL, Lin HC, Maurer AH, McCallum RW, Nowak T, Nusynowitz ML, Parkman HP, Shreve P, Szarka LA, Snape WJ Jr, Ziessman HA, American Neurogastroenterology and Motility Society and the Society of Nuclear Medicine. Consensus recommendations for gastric emptying scintigraphy: a joint report of the American Neurogastroenterology and Motility Society and the Society of Nuclear Medicine. J Nucl Med Technol. 2008 Mar; 36(1):44-54. Epub 2008 Feb 20.
    View PubMed
  484. Aerssens J, Camilleri M, Talloen W, Thielemans L, Gohlmann HW, Van Den Wyngaert I, Thielemans T, De Hoogt R, Andrews CN, Bharucha AE, Carlson PJ, Busciglio I, Burton DD, Smyrk T, Urrutia R, Coulie B. Alterations in mucosal immunity identified in the colon of patients with irritable bowel syndrome. Clin Gastroenterol Hepatol. 2008 Feb; 6(2):194-205.
    View PubMed
  485. Mariani A, Camilleri M, Petersen IA, Ward EM, Farrugia G, Kelly DG, Podratz KC. Audit of suspected chronic intestinal pseudo-obstruction in patients with gynecologic cancer. Eur J Gynaecol Oncol. 2008; 29 (6):578-82
    View PubMed
  486. Camilleri M, Carlson P, McKinzie S, Grudell A, Busciglio I, Burton D, Baxter K, Ryks M, Zinsmeister AR. Genetic variation in endocannabinoid metabolism, gastrointestinal motility, and sensation. Am J Physiol Gastrointest Liver Physiol. 2008 Jan; 294(1):G13-9. Epub 2007 Oct 25.
    View PubMed
  487. Camilleri M, Andresen V, Keller J, Layer P, Montori V. Pharmacological and non-pharmacological interventions for symptomatic gastroparesis. Cochrane Database Syst Rev. 2008; (2):CD007116.
  488. Camilleri M, Saito YA. Pharmacogenomics in gastrointestinal disorders. Methods Mol Biol. 2008; 448:395-412
    View PubMed
  489. Choi KM, Zhu J, Stoltz GJ, Vernino S, Camilleri M, Szurszewski JH, Gibbons SJ, Farrugia G. Determination of gastric emptying in nonobese diabetic mice. Am J Physiol Gastrointest Liver Physiol. 2007 Nov; 293: (5)G1039-45.
    View PubMed
  490. Szarka LA, Camilleri M, Burton D, Fox JC, McKinzie S, Stanislav T, Simonson J, Sullivan N, Zinsmeister AR. Efficacy of on-demand asimadoline, a peripheral kappa-opioid agonist, in females with irritable bowel syndrome. Clin Gastroenterol Hepatol. 2007 Nov; 5 (11):1268-75 Epub 2007 Sept 27
    View PubMed
  491. Foxx-Orenstein AE, Camilleri M, Szarka LA, McKinzie S, Burton D, Thomforde G, Baxter K, Zinsmeister AR. Does co-administration of a non-selective opiate antagonist enhance acceleration of transit by a 5-HT4 agonist in constipation-predominant irritable bowel syndrome? A randomized controlled trial. Neurogastroenterol Motil. 2007 Oct; 19: (10)821-30.
    View PubMed
  492. Beebe TJ, Talley NJ, Camilleri M, Jenkins SM, Anderson KJ, Locke GR 3rd. The HIPAA authorization form and effects on survey response rates, nonresponse bias, and data quality: a randomized community study. Med Care. 2007 Oct; 45 (10):959-65
    View PubMed
  493. Andrews CN, Bharucha AE, Camilleri M, Low PA, Seide BM, Burton DD, Nickander KK, Baxter KL, Zinsmeister AR. Effects of glucagon-like peptide-1 and sympathetic stimulation on gastric accommodation in humans. Neurogastroenterol Motil. 2007 Sep; 19 (9):716-23
    View PubMed
  494. Houghton LA, Cremonini F, Camilleri M, Busciglio I, Fell C, Cox V, Alpers DH, Dewit OE, Dukes GE, Gray E, Lea R, Zinsmeister AR, Whorwell PJ. Effect of the NK(3) receptor antagonist, talnetant, on rectal sensory function and compliance in healthy humans. Neurogastroenterol Motil. 2007 Sep; 19(9):732-43.
    View PubMed
  495. Tremaine WJ, Camilleri M. Ethical issues concerning therapeutic studies in inflammatory bowel disease. Inflamm Bowel Dis. 2007 Sep; 13 (9):1141-5
    View PubMed
  496. Andresen V, Camilleri M, Busciglio IA, Grudell A, Burton D, McKinzie S, Foxx-Orenstein A, Kurtz CB, Sharma V, Johnston JM, Currie MG, Zinsmeister AR. Effect of 5 days linaclotide on transit and bowel function in females with constipation-predominant irritable bowel syndrome. Gastroenterology. 2007 Sep; 133 (3):761-8 Epub 2007 July 03
    View PubMed
  497. Camilleri M. Functional dyspepsia: mechanisms of symptom generation and appropriate management of patients. Gastroenterol Clin North Am. 2007 Sep; 36(3):649-64, xi-x.
    View PubMed
  498. Camilleri M. Pharmacogenomics and serotonergic agents: research observations and potential clinical practice implications. Neurogastroenterol Motil. 2007 Aug; 19 Suppl 2:40-5.
    View PubMed
  499. Camilleri M, Gorman H. Intestinal permeability and irritable bowel syndrome. Neurogastroenterol Motil. 2007 Jul; 19 (7):545-52
    View PubMed
  500. Vazquez Roque MI, Camilleri M, Clark MM, Tepoel DA, Jensen MD, Graszer KM, Kalsy SA, Burton DD, Baxter KL, Zinsmeister AR. Alteration of gastric functions and candidate genes associated with weight reduction in response to sibutramine. Clin Gastroenterol Hepatol. 2007 Jul; 5(7):829-37. Epub 2007 Jun 04.
    View PubMed
  501. Esfandyari T, Camilleri M, Busciglio I, Burton D, Baxter K, Zinsmeister AR. Effects of a cannabinoid receptor agonist on colonic motor and sensory functions in humans: a randomized, placebo-controlled study. Am J Physiol Gastrointest Liver Physiol. 2007 Jul; 293(1):G137-45. Epub 2007 Mar 29.
    View PubMed
  502. Andrews CN, Bharucha AE, Camilleri M, Low PA, Seide B, Burton D, Baxter K, Zinsmeister AR. Nitrergic contribution to gastric relaxation induced by glucagon-like peptide-1 (GLP-1) in healthy adults. Am J Physiol Gastrointest Liver Physiol. 2007 May; 292: (5)G1359-65.
    View PubMed
  503. Camilleri M, Grudell AB. Appetite and obesity: a gastroenterologist's perspective. Neurogastroenterol Motil. 2007 May; 19(5):333-41.
    View PubMed
  504. Camilleri M, Mangel AW, Fehnel SE, Drossman DA, Mayer EA, Talley NJ. Primary endpoints for irritable bowel syndrome trials: a review of performance of endpoints. Clin Gastroenterol Hepatol. 2007 May; 5 (5):534-40 Epub 2007 Apr 11
    View PubMed
  505. Vella A, Bock G, Giesler PD, Burton DB, Serra DB, Saylan ML, Dunning BE, Foley JE, Rizza RA, Camilleri M. Effects of dipeptidyl peptidase-4 inhibition on gastrointestinal function, meal appearance, and glucose metabolism in type 2 diabetes. Diabetes. 2007 May; 56: (5)1475-80.
    View PubMed
  506. Camilleri M, Cortese DA. Managing conflict of interest in clinical practice. Mayo Clin Proc. 2007 May; 82(5):607-14.
    View PubMed
  507. Choung RS, Talley NJ, Peterson J, Camilleri M, Burton D, Harmsen WS, Zinsmeister AR. A double-blind, randomized, placebo-controlled trial of itopride (100 and 200 mg three times daily) on gastric motor and sensory function in healthy volunteers. Neurogastroenterol Motil. 2007 Mar; 19(3):180-7.
    View PubMed
  508. Camilleri M, Dubnansky EC, Rustgi AK. Conflicts of interest and disclosures in publications. Clin Gastroenterol Hepatol. 2007 Mar; 5(3):268-73.
    View PubMed
  509. Camilleri M. Clinical practice. Diabetic gastroparesis. N Engl J Med. 2007 Feb 22; 356: (8)820-9.
    View PubMed
  510. Limsui D, Pardi DS, Camilleri M, Loftus EV Jr, Kammer PP, Tremaine WJ, Sandborn WJ. Symptomatic overlap between irritable bowel syndrome and microscopic colitis. Inflamm Bowel Dis. 2007 Feb; 13 (2):175-81
    View PubMed
  511. Park MI, Camilleri M, O'Connor H, Oenning L, Burton D, Stephens D, Zinsmeister AR. Effect of different macronutrients in excess on gastric sensory and motor functions and appetite in normal-weight, overweight, and obese humans. Am J Clin Nutr. 2007 Feb; 85 (2):411-8
    View PubMed
  512. Camilleri M. Is there an experimental basis for the development of ischaemic colitis as a result of 5-HT3 antagonist treatment? Neurogastroenterol Motil. 2007 Feb; 19(2):77-84.
    View PubMed
  513. Grudell AB, Camilleri M. The role of peptide YY in integrative gut physiology and potential role in obesity. Curr Opin Endocrinol Diabetes Obes. 2007 Feb; 14(1):52-7.
    View PubMed
  514. Camilleri M, Vazquez-Roque MI, Burton D, Ford T, McKinzie S, Zinsmeister AR, Druzgala P. Pharmacodynamic effects of a novel prokinetic 5-HT receptor agonist, ATI-7505, in humans. Neurogastroenterol Motil. 2007 Jan; 19 (1):30-8
    View PubMed
  515. Azpiroz F, Bouin M, Camilleri M, Mayer EA, Poitras P, Serra J, Spiller RC. Mechanisms of hypersensitivity in IBS and functional disorders. Neurogastroenterol Motil. 2007 Jan; 19(Suppl 1):62-88.
    View PubMed
  516. Camilleri M, Andrews CN, Bharucha AE, Carlson PJ, Ferber I, Stephens D, Smyrk TC, Urrutia R, Aerssens J, Thielemans L, Gohlmann H, van den Wyngaert I, Coulie B. Alterations in expression of p11 and SERT in mucosal biopsy specimens of patients with irritable bowel syndrome. Gastroenterology. 2007 Jan; 132 (1):17-25 Epub 2006 Nov 17
    View PubMed
  517. Camilleri M. Is there a role for probiotics in irritable bowel syndrome? Dig Liver Dis. 2006 Dec; 38 Suppl 2:S266-9.
    View PubMed
  518. Vazquez Roque MI, Camilleri M, Stephens DA, Jensen MD, Burton DD, Baxter KL, Zinsmeister AR. Gastric sensorimotor functions and hormone profile in normal weight, overweight, and obese people. Gastroenterology. 2006 Dec; 131(6):1717-24. Epub 2006 Oct 15.
    View PubMed
  519. Xue L, Camilleri M, Locke GR 3rd, Schuurkes JA, Meulemans A, Coulie BJ, Szurszewski JH, Farrugia G. Serotonergic modulation of murine fundic tone. Am J Physiol Gastrointest Liver Physiol. 2006 Dec; 291(6):G1180-6. Epub 2006 Jul 27.
    View PubMed
  520. Dalla Man C, Camilleri M, Cobelli C. A system model of oral glucose absorption: validation on gold standard data. IEEE Trans Biomed Eng. 2006 Dec; 53(12 Pt 1):2472-8.
    View PubMed
  521. Camilleri M. Gastroenterology and hepatology clinical research update: 2005-2006. Clin Gastroenterol Hepatol. 2006 Dec; 4(12):1428-33. Epub 2006 Sep 01.
    View PubMed
  522. Cremonini F, Camilleri M, Vazquez Roque M, McKinzie S, Burton D, Baxter K, Zinsmeister AR. Obesity does not increase effects of synthetic ghrelin on human gastric motor functions. Gastroenterology. 2006 Nov; 131(5):1431-9. Epub 2006 Sep 20.
    View PubMed
  523. Chial HJ, Camilleri M. A twenty-one-year-old college student with postprandial regurgitation and weight loss. Clin Gastroenterol Hepatol. 2006 Nov; 4(11):1314-7. Epub 2006 Oct 23.
    View PubMed
  524. Grudell AB, Camilleri M, Burton DD, Stephens DA. Effect of a proton pump inhibitor on postprandial gastric volume, emptying and symptoms in healthy human subjects: a pilot study. Aliment Pharmacol Ther. 2006 Oct 1; 24(7):1037-43.
    View PubMed
  525. Saito YA, Camilleri M. Clinical application of pharmacogenetics in gastrointestinal diseases. Expert Opin Pharmacother. 2006 Oct; 7(14):1857-69.
    View PubMed
  526. Gonenne J, Esfandyari T, Camilleri M, Burton DD, Stephens DA, Baxter KL, Zinsmeister AR, Bharucha AE. Effect of female sex hormone supplementation and withdrawal on gastrointestinal and colonic transit in postmenopausal women. Neurogastroenterol Motil. 2006 Oct; 18(10):911-8.
    View PubMed
  527. Esfandyari T, Camilleri M, Ferber I, Burton D, Baxter K, Zinsmeister AR. Effect of a cannabinoid agonist on gastrointestinal transit and postprandial satiation in healthy human subjects: a randomized, placebo-controlled study. Neurogastroenterol Motil. 2006 Sep; 18(9):831-8.
    View PubMed
  528. Camilleri M. New imaging in neurogastroenterology: an overview. Neurogastroenterol Motil. 2006 Sep; 18(9):805-12.
    View PubMed
  529. Talley NJ, Camilleri M, Burton D, Thomforde G, Koch K, Rucker MJ, Peterson J, Zinsmeister AR, Earnest DL. Double-blind, randomized, placebo-controlled study to evaluate the effects of tegaserod on gastric motor, sensory and myoelectric function in healthy volunteers. Aliment Pharmacol Ther. 2006 Sep 1; 24 (5):859-67
    View PubMed
  530. Park MI, Camilleri M. Is there a role of food allergy in irritable bowel syndrome and functional dyspepsia? A systematic review. Neurogastroenterol Motil. 2006 Aug; 18 (8):595-607
    View PubMed
  531. Camilleri M. Integrated upper gastrointestinal response to food intake. Gastroenterology. 2006 Aug; 131(2):640-58.
    View PubMed
  532. Camilleri M. Management of patients with chronic abdominal pain in clinical practice. Neurogastroenterol Motil. 2006 Jul; 18(7):499-506.
    View PubMed
  533. Andresen V, Camilleri M, Kim HJ, Stephens DA, Carlson PJ, Talley NJ, Saito YA, Urrutia R, Zinsmeister AR. Is there an association between GNbeta3-C825T genotype and lower functional gastrointestinal disorders? Gastroenterology. 2006 Jun; 130(7):1985-94.
    View PubMed
  534. Park MI, Camilleri M. Gastroparesis: clinical update. Am J Gastroenterol. 2006 May; 101(5):1129-39.
    View PubMed
  535. Andresen V, Camilleri M. Challenges in drug development for functional gastrointestinal disorders. Part I: functional dyspepsia. Neurogastroenterol Motil. 2006 May; 18(5):346-53.
    View PubMed
  536. Andresen V, Camilleri M. Challenges in drug development for functional gastrointestinal disorders. Part II: visceral pain. Neurogastroenterol Motil. 2006 May; 18(5):354-60.
    View PubMed
  537. Camilleri M, Bharucha AE, Ueno R, Burton D, Thomforde GM, Baxter K, McKinzie S, Zinsmeister AR. Effect of a selective chloride channel activator, lubiprostone, on gastrointestinal transit, gastric sensory, and motor functions in healthy volunteers. Am J Physiol Gastrointest Liver Physiol. 2006 May; 290(5):G942-7.
    View PubMed
  538. Camilleri M, Bueno L, de Ponti F, Fioramonti J, Lydiard RB, Tack J. Pharmacological and pharmacokinetic aspects of functional gastrointestinal disorders. Gastroenterology. 2006 Apr; 130(5):1421-34.
    View PubMed
  539. Tack J, Talley NJ, Camilleri M, Holtmann G, Hu P, Malagelada JR, Stanghellini V. Functional gastroduodenal disorders. Gastroenterology. 2006 Apr; 130(5):1466-79.
    View PubMed
  540. Skoog SM, Bharucha AE, Camilleri M, Burton DD, Zinsmeister AR. Effects of an osmotically active agent on colonic transit. Neurogastroenterol Motil. 2006 Apr; 18: (4)300-6.
    View PubMed
  541. Camilleri CE, Carlson PJ, Camilleri M, Castillo EJ, Locke GR 3rd, Geno DM, Stephens DA, Zinsmeister AR, Urrutia R. A study of candidate genotypes associated with dyspepsia in a U.S. community. Am J Gastroenterol. 2006 Mar; 101 (3):581-92 Epub 2006 Feb 08
    View PubMed
  542. Camilleri M. Probiotics and irritable bowel syndrome: rationale, putative mechanisms, and evidence of clinical efficacy. J Clin Gastroenterol. 2006 Mar; 40 (3):264-9
    View PubMed
  543. Floch MH, Madsen KK, Jenkins DJ, Guandalini S, Katz JA, Onderdonk A, Walker WA, Fedorak RN, Camilleri M. Recommendations for probiotic use. J Clin Gastroenterol. 2006 Mar; 40(3):275-8.
    View PubMed
  544. Xue L, Locke GR, Camilleri M, Schuurkes JA, Meulemans A, Coulie BJ, Szurszewski JH, Farrugia G. Effect of modulation of serotonergic, cholinergic, and nitrergic pathways on murine fundic size and compliance measured by ultrasonomicrometry. Am J Physiol Gastrointest Liver Physiol. 2006 Jan; 290 (1):G74-82 Epub 2005 Sept 15
    View PubMed
  545. Park MI, Ferber I, Camilleri M, Allenby K, Trillo R, Burton D, Zinsmeister AR. Effect of atilmotin on gastrointestinal transit in healthy subjects: a randomized, placebo-controlled study. Neurogastroenterol Motil. 2006 Jan; 18(1):28-36.
    View PubMed
  546. Schiller LR, Camilleri M. Lubiprostone: profile report. Drugs and Therapy Perspectives. 2006; 22(9):5-6.
  547. Andresen V, Camilleri M. Irritable bowel syndrome: recent and novel therapeutic approaches. Drugs. 2006; 66 (8):1073-88
    View PubMed
  548. Camilleri M. GIH clinical research update: 2004-2005. Clin Gastroenterol Hepatol. 2005 Dec; 3(12):1161-6.
  549. Cremonini F, Houghton LA, Camilleri M, Ferber I, Fell C, Cox V, Castillo EJ, Alpers DH, Dewit OE, Gray E, Lea R, Zinsmeister AR, Whorwell PJ. Barostat testing of rectal sensation and compliance in humans: comparison of results across two centres and overall reproducibility. Neurogastroenterology & Motility. 2005 Dec; 17(6):810-20.
    View PubMed
  550. Camilleri M. GIH clinical research update: 2004-2005. Clin Gastroenterol Hepatol. 2005 Dec; 3 (12):1161-6
    View PubMed
  551. Camilleri M, Gamble GL, Kopecky SL, Wood MB, Hockema ML. Principles and process in the development of the Mayo Clinic's individual and institutional conflict of interest policy. Mayo Clin Proc. 2005 Oct; 80(10):1340-6.
    View PubMed
  552. Delgado-Aros S, Camilleri M, Castillo EJ, Cremonini F, Stephens D, Ferber I, Baxter K, Burton D, Zinsmeister AR. Effect of gastric volume or emptying on meal-related symptoms after liquid nutrients in obesity: a pharmacologic study. Clin Gastroenterol Hepatol. 2005 Oct; 3 (10):997-1006
    View PubMed
  553. Kim HJ, Vazquez Roque MI, Camilleri M, Stephens D, Burton DD, Baxter K, Thomforde G, Zinsmeister AR. A randomized controlled trial of a probiotic combination VSL# 3 and placebo in irritable bowel syndrome with bloating. Neurogastroenterol Motil. 2005 Oct; 17(5):687-96.
    View PubMed
  554. Cremonini F, Camilleri M, Gonenne J, Stephens D, Oenning L, Baxter K, Foxx-Orenstein A, Burton D. Effect of somatostatin analog on postprandial satiation in obesity. Obes Res. 2005 Sep; 13(9):1572-9.
    View PubMed
  555. Burton DD, Kim HJ, Camilleri M, Stephens DA, Mullan BP, O'Connor MK, Talley NJ. Relationship of gastric emptying and volume changes after a solid meal in humans. Am J Physiol Gastrointest Liver Physiol. 2005 Aug; 289: (2)G261-6.
    View PubMed
  556. Gonenne J, Camilleri M, Ferber I, Burton D, Baxter K, Keyashian K, Foss J, Wallin B, Du W, Zinsmeister AR. Effect of alvimopan and codeine on gastrointestinal transit: a randomized controlled study. Clin Gastroenterol Hepatol. 2005 Aug; 3 (8):784-91
    View PubMed
  557. Camilleri M. Pharmacogenomics and functional gastrointestinal disorders. Pharmacogenomics. 2005 Jul; 6(5):491-501.
    View PubMed
  558. Nickander KK, Carlson PJ, Urrutia RA, Camilleri M, Low PA. A screen of candidate genes and influence of beta2-adrenergic receptor genotypes in postural tachycardia syndrome. Auton Neurosci. 2005 Jun 15; 120 (1-2):97-103
    View PubMed
  559. Park MI, Camilleri M. Genetics and genotypes in irritable bowel syndrome: implications for diagnosis and treatment. Gastroenterol Clin North Am. 2005 Jun; 34(2):305-17.
    View PubMed
  560. Camilleri M, Dubois D, Coulie B, Jones M, Kahrilas PJ, Rentz AM, Sonnenberg A, Stanghellini V, Stewart WF, Tack J, Talley NJ, Whitehead W, Revicki DA. Prevalence and socioeconomic impact of upper gastrointestinal disorders in the United States: results of the US Upper Gastrointestinal Study. Clin Gastroenterol Hepatol. 2005 Jun; 3 (6):543-52
    View PubMed
  561. Delgado-Aros S, Camilleri M. Visceral hypersensitivity. J Clin Gastroenterol. 2005 May-Jun; 39 (5 Suppl 3):S194-203; discussion S210
    View PubMed
  562. Chitkara DK, Camilleri M, Zinsmeister AR, Burton D, El-Youssef M, Freese D, Walker L, Stephens D. Gastric sensory and motor dysfunction in adolescents with functional dyspepsia. J Pediatr. 2005 Apr; 146(4):500-5.
    View PubMed
  563. Camilleri M. Alvimopan, a selective peripherally acting mu-opioid antagonist. Neurogastroenterol Motil. 2005 Apr; 17(2):157-65.
    View PubMed
  564. Park MI, Camilleri M. Gastric motor and sensory functions in obesity. Obes Res. 2005 Mar; 13(3):491-500.
    View PubMed
  565. Cremonini F, Camilleri M, McKinzie S, Carlson P, Camilleri CE, Burton D, Thomforde G, Urrutia R, Zinsmeister AR. Effect of CCK-1 antagonist, dexloxiglumide, in female patients with irritable bowel syndrome: a pharmacodynamic and pharmacogenomic study. Am J Gastroenterol. 2005 Mar; 100(3):652-63.
    View PubMed
  566. Gonenne J, Castillo EJ, Camilleri M, Burton D, Thomforde GM, Baxter KL, Zinsmeister AR. Does the nutrient drink test accurately predict postprandial gastric volume in health and community dyspepsia? Neurogastroenterol Motil. 2005 Feb; 17: (1)44-50.
    View PubMed
  567. Talley NJ, Camilleri M, Chitkara DK, Bouras E, Locke GR 3rd, Burton D, Rucker MJ, Thapa P, Zinsmeister AR. Effects of desipramine and escitalopram on postprandial symptoms induced by the nutrient drink test in healthy volunteers: a randomized, double-blind, placebo-controlled study. Digestion. 2005; 72 (2-3):97-103 Epub 2005 Sept 16
    View PubMed
  568. Camilleri M. Etiology and pathophysiology of irritable bowel syndrome and chronic constipation. Advanced Studies in Medicine. 2005; 5(10 B):S955-64.
  569. Bouras EP, Burton DD, Camilleri M, Stephens DA, Thomforde GM. Effect of cyclooxygenase-2 inhibitors on gastric emptying and small intestinal transit in humans. Neurogastroenterol Motil. 2004 Dec; 16(6):729-35.
    View PubMed
  570. Delgado-Aros S, Camilleri M, Cremonini F, Ferber I, Stephens D, Burton DD. Contributions of gastric volumes and gastric emptying to meal size and postmeal symptoms in functional dyspepsia. Gastroenterology. 2004 Dec; 127 (6):1685-94
    View PubMed
  571. Castillo EJ, Camilleri M, Locke GR, Burton DD, Locke GR, Stephens DA, Geno DM, Zinsmeister AR. A community-based, controlled study of the epidemiology and pathophysiology of dyspepsia. Clin Gastroenterol Hepatol. 2004 Nov; 2 (11):985-96
    View PubMed
  572. Hicks GA, Dehaven-Hudkins DL, Camilleri M. Opiates in the control of gastrointestinal tract function: current knowledge and new avenues for research. Neurogastroenterol Motil. 2004 Oct; 16(Suppl 2):67-70.
    View PubMed
  573. De Giorgio R, Camilleri M. Human enteric neuropathies: morphology and molecular pathology. Neurogastroenterol Motil. 2004 Oct; 16(5):515-31.
    View PubMed
  574. De Schepper H, Camilleri M, Cremonini F, Foxx-Orenstein A, Burton D. Comparison of gastric volumes in response to isocaloric liquid and mixed meals in humans. Neurogastroenterol Motil. 2004 Oct; 16 (5):567-73
    View PubMed
  575. Camilleri M, McKinzie S, Fox J, Foxx-Orenstein A, Burton D, Thomforde G, Baxter K, Zinsmeister AR. Effect of renzapride on transit in constipation-predominant irritable bowel syndrome. Clin Gastroenterol Hepatol. 2004 Oct; 2 (10):895-904
    View PubMed
  576. Camilleri M. Objectives of the meeting: think opiates. Neurogastroenterol Motil. 2004 Oct; 16 Suppl 2:1-2
    View PubMed
  577. Delgado-Aros S, Locke GR, Camilleri M, Talley NJ, Fett S, Zinsmeister AR, Melton LJ. Obesity is associated with increased risk of gastrointestinal symptoms: A population-based study. Am J Gastroenterol. 2004 Sep; 99(9):1801-6.
    View PubMed
  578. De Schepper HU, Cremonini F, Park MI, Camilleri M. Opioids and the gut: pharmacology and current clinical experience. Neurogastroenterol Motil. 2004 Aug; 16(4):383-94.
    View PubMed
  579. Chitkara DK, Bredenoord AJ, Cremonini F, Delgado-Aros S, Smoot RL, El-Youssef M, Freese D, Camilleri M. The role of pelvic floor dysfunction and slow colonic transit in adolescents with refractory constipation. Am J Gastroenterol. 2004 Aug; 99(8):1579-84.
    View PubMed
  580. Castillo EJ, Delgado-Aros S, Camilleri M, Burton D, Stephens D, O'Connor-Semmes R, Walker A, Shachoy-Clark A, Zinsmeister AR. Effect of oral CCK-1 agonist GI181771X on fasting and postprandial gastric functions in healthy volunteers. Am J Physiol Gastrointest Liver Physiol. 2004 Aug; 287(2):G363-9.
  581. Vella A, Camilleri M, Rizza RA. The gastrointestinal tract and glucose tolerance. Curr Opin Clin Nutr Metab Care. 2004 Jul; 7 (4):479-84
    View PubMed
  582. Kim HJ, Kim HJ, Camilleri M, Carlson PJ, Cremonini F, Ferber I, Stephens D, McKinzie S, Zinsmeister AR, Urrutia R. Association of distinct alpha(2) adrenoceptor and serotonin transporter polymorphisms with constipation and somatic symptoms in functional gastrointestinal disorders. Gut. 2004 Jun; 53 (6):829-37
    View PubMed
  583. De Schepper HU, Cremonini F, Chitkara D, Camilleri M. Assessment of gastric accommodation: overview and evaluation of current methods. Neurogastroenterol Motil. 2004 Jun; 16(3):275-85.
    View PubMed
  584. Camilleri M. Advances in pharmacological treatments of IBS. J Pediatr Gastroenterol Nutr. 2004 Jun; 39 Suppl 3:S766-7
    View PubMed
  585. Camilleri M, Talley NJ. Pathophysiology as a basis for understanding symptom complexes and therapeutic targets. Neurogastroenterol Motil. 2004 Apr; 16(2):135-42.
    View PubMed
  586. Camilleri M. Treating irritable bowel syndrome: overview, perspective and future therapies. Br J Pharmacol. 2004 Apr; 141 (8):1237-48 Epub 2004 Mar 22
    View PubMed
  587. Camilleri M. Nonmalignant gastrointestinal syndromes in the elderly: part II -- midgut and hindgut diseases. Clinical Geriatrics. 2004 Mar; 12(3):24, 25-7, 31-2.
  588. Camilleri M. Chronic diarrhea: a review on pathophysiology and management for the clinical gastroenterologist. Clin Gastroenterol Hepatol. 2004 Mar; 2 (3):198-206
    View PubMed
  589. Delgado-Aros S, Cremonini F, Castillo JE, Chial HJ, Burton DD, Ferber I, Camilleri M. Independent influences of body mass and gastric volumes on satiation in humans. Gastroenterology. 2004 Feb; 126 (2):432-40
    View PubMed
  590. Camilleri M. Nonmalignant gastrointestinal syndromes in the elderly: part I -- alterations in physiology and foregut diseases. Clinical Geriatrics. 2004 Feb; 12(2):38-40, 41-3.
  591. Delgado-Aros S, Camilleri M. [Clinical management of acute colonic pseudo-obstruction in patients: a systematic review of the literature]. Gastroenterol Hepatol. 2003 Dec; 26 (10):646-55
    View PubMed
  592. Chitkara DK, Delgado-Aros S, Bredenoord AJ, Cremonini F, El-Youssef M, Freese D, Camilleri M. Functional dyspepsia, upper gastrointestinal symptoms, and transit in children. J Pediatr. 2003 Nov; 143: (5)609-13.
    View PubMed
  593. Foxx-Orenstein A, Camilleri M, Stephens D, Burton D. Effect of a somatostatin analogue on gastric motor and sensory functions in healthy humans. Gut. 2003 Nov; 52 (11):1555-61
    View PubMed
  594. Camilleri M. GI clinical research 2002-2003: the year in review. Clin Gastroenterol Hepatol. 2003 Nov; 1 (6):415-20
    View PubMed
  595. Lembo A, Camilleri M. Current concepts: Chronic constipation. N Engl J Med. 2003 Oct 2; 349(14):1360-8.
    View PubMed
  596. Delgado-Aros S, Chial HJ, Cremonini F, Ferber I, McKinzie S, Burton DD, Camilleri M. Effects of asimadoline, a kappa-opioid agonist, on satiation and postprandial symptoms in health. Aliment Pharmacol Ther. 2003 Sep 1; 18 (5):507-14
    View PubMed
  597. Cremonini F, Di Caro S, Delgado-Aros S, Sepulveda A, Gasbarrini G, Gasbarrini A, Camilleri M. Meta-analysis: the relationship between Helicobacter pylori infection and gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 2003 Aug 1; 18 (3):279-89
    View PubMed
  598. Delgado-Aros S, Vella A, Camilleri M, Low PA, Burton DD, Thomforde GM, Stephens D. Effects of glucagon-like peptide-1 and feeding on gastric volumes in diabetes mellitus with cardio-vagal dysfunction. Neurogastroenterol Motil. 2003 Aug; 15 (4):435-43
    View PubMed
  599. Zangeneh F, Basu R, Shah P, Arora P, Camilleri M, Rizza RA. Enteral infusion of glucose at rates approximating EGP enhances glucose disposal but does not cause hypoglycemia. Am J Physiol Endocrinol Metab. 2003 Aug; 285(2):E280-6.
    View PubMed
  600. Delgado-Aros S, Cremonini F, Bredenoord AJ, Camilleri M. Systematic review and meta-analysis: does gall-bladder ejection fraction on cholecystokinin cholescintigraphy predict outcome after cholecystectomy in suspected functional biliary pain? Aliment Pharmacol Ther. 2003 Jul 15; 18 (2):167-74
    View PubMed
  601. Bredenoord AJ, Chial HJ, Camilleri M, Mullan BP, Murray JA. Gastric accommodation and emptying in evaluation of patients with upper gastrointestinal symptoms. Clin Gastroenterol Hepatol. 2003 Jul; 1 (4):264-72
    View PubMed
  602. Delgado-Aros S, Camilleri M. Pseudo-obstruction in the critically ill. Best Pract Res Clin Gastroenterol. 2003 Jun; 17 (3):427-44
    View PubMed
  603. Kane SV, Sandborn WJ, Rufo PA, Zholudev A, Boone J, Lyerly D, Camilleri M, Hanauer SB. Fecal lactoferrin is a sensitive and specific marker in identifying intestinal inflammation. Am J Gastroenterol. 2003 Jun; 98(6):1309-14.
    View PubMed
  604. Chial HJ, Camilleri M, Ferber I, Delgado-Aros S, Burton D, McKinzie S, Zinsmeister AR. Effects of venlafaxine, buspirone, and placebo on colonic sensorimotor functions in healthy humans. Clin Gastroenterol Hepatol. 2003 May; 1(3):211-8.
    View PubMed
  605. Kim HJ, Kim HJ, Camilleri M, McKinzie S, Lempke MB, Burton DD, Thomforde GM, Zinsmeister AR. A randomized controlled trial of a probiotic, VSL#3, on gut transit and symptoms in diarrhoea-predominant irritable bowel syndrome. Aliment Pharmacol Ther. 2003 Apr 1; 17 (7):895-904
    View PubMed
  606. Delgado-Aros S, Chial HJ, Camilleri M, Szarka LA, Weber FT, Jacob J, Ferber I, McKinzie S, Burton DD, Zinsmeister AR. Effects of a kappa-opioid agonist, asimadoline, on satiation and GI motor and sensory functions in humans. Am J Physiol Gastrointest Liver Physiol. 2003 Apr; 284(4):G558-66.
    View PubMed
  607. Camilleri M, Kim DY, McKinzie S, Kim HJ, Thomforde GM, Burton DD, Low PA, Zinsmeister AR. A randomized, controlled exploratory study of clonidine in diarrhea-predominant irritable bowel syndrome. Clin Gastroenterol Hepatol. 2003 Mar; 1(2):111-21.
    View PubMed
  608. Camilleri M. Diagnosis and treatment of enteric neuromuscular diseases. Clin Auton Res. 2003 Feb; 13(1):10-5.
    View PubMed
  609. Cremonini F, Delgado-Aros S, Camilleri M. Efficacy of alosetron in irritable bowel syndrome: a meta-analysis of randomized controlled trials. Neurogastroenterol Motil. 2003 Feb; 15 (1):79-86
    View PubMed
  610. Chial HJ, Camilleri M, Burton D, Thomforde G, Olden KW, Stephens D. Selective effects of serotonergic psychoactive agents on gastrointestinal functions in health. Am J Physiol Gastrointest Liver Physiol. 2003 Jan; 284: (1)G130-7.
    View PubMed
  611. Chial HJ, Camilleri M, Williams DE, Litzinger K, Perrault J. Rumination syndrome in children and adolescents: diagnosis, treatment, and prognosis. Pediatrics. 2003 Jan; 111 (1):158-62
    View PubMed
  612. Bouras EP, Delgado-Aros S, Camilleri M, Castillo EJ, Burton DD, Thomforde GM, Chial HJ. SPECT imaging of the stomach: comparison with barostat, and effects of sex, age, body mass index, and fundoplication. Single photon emission computed tomography. Gut. 2002 Dec; 51 (6):781-6
    View PubMed
  613. Drossman DA, Camilleri M, Mayer EA, Whitehead WE. AGA technical review on irritable bowel syndrome. Gastroenterology. 2002 Dec; 123(6):2108-31.
    View PubMed
  614. Camilleri M. Drugs targeting functional bowel disorders: lessons from drug trials. Curr Opin Pharmacol. 2002 Dec; 2 (6):684-90
    View PubMed
  615. Cremonini F, Mullan BP, Camilleri M, Burton DD, Rank MR. Performance characteristics of scintigraphic transit measurements for studies of experimental therapies. Aliment Pharmacol Ther. 2002 Oct; 16 (10):1781-90
    View PubMed
  616. Vella A, Shah P, Basu R, Basu A, Camilleri M, Schwenk WF, Rizza RA. Effect of enteral vs. parenteral glucose delivery on initial splanchnic glucose uptake in nondiabetic humans. Am J Physiol Endocrinol Metab. 2002 Aug; 283(2):E259-66.
    View PubMed
  617. Camilleri M, Atanasova E, Carlson PJ, Ahmad U, Kim HJ, Viramontes BE, Kim HJ, McKinzie S, Urrutia R. Serotonin-transporter polymorphism pharmacogenetics in diarrhea-predominant irritable bowel syndrome. Gastroenterology. 2002 Aug; 123 (2):425-32
    View PubMed
  618. Camilleri M, Heading RC, Thompson WG. Clinical perspectives, mechanisms, diagnosis and management of irritable bowel syndrome. Aliment Pharmacol Ther. 2002 Aug; 16 (8):1407-30
    View PubMed
  619. Camilleri M. Testing the sensitivity hypothesis in practice: tools and methods, assumptions and pitfalls. Gut. 2002 Jul; 51 Suppl 1:i34-40
    View PubMed
  620. Camilleri M. Serotonergic modulation of visceral sensation: lower gut. Gut. 2002 Jul; 51 Suppl 1:i81-6
    View PubMed
  621. Chial HJ, Camilleri C, Delgado-Aros S, Burton D, Thomforde G, Ferber I, Camilleri M. A nutrient drink test to assess maximum tolerated volume and postprandial symptoms: effects of gender, body mass index and age in health. Neurogastroenterol Motil. 2002 Jun; 14 (3):249-53
    View PubMed
  622. Chial HJ, Camilleri M. Gender differences in irritable bowel syndrome. J Gend Specif Med. 2002 May-Jun; 5(3):37-45.
    View PubMed
  623. Vella A, Lee JS, Lee JS, Camilleri M, Szarka LA, Burton DD, Zinsmeister AR, Rizza RA, Klein PD. Effects of pramlintide, an amylin analogue, on gastric emptying in type 1 and 2 diabetes mellitus. Neurogastroenterol Motil. 2002 Apr; 14 (2):123-31
    View PubMed
  624. Delgado-Aros S, Kim DY, Burton DD, Thomforde GM, Stephens D, Brinkmann BH, Vella A, Camilleri M. Effect of GLP-1 on gastric volume, emptying, maximum volume ingested, and postprandial symptoms in humans. Am J Physiol Gastrointest Liver Physiol. 2002 Mar; 282 (3):G424-31
    View PubMed
  625. Kuo B, Camilleri M, Burton D, Viramontes B, McKinzie S, Thomforde G, O'Connor MK, Brinkmann BH. Effects of 5-HT(3) antagonism on postprandial gastric volume and symptoms in humans. Aliment Pharmacol Ther. 2002 Feb; 16 (2):225-33
    View PubMed
  626. Chial HJ, McAlpine DE, Camilleri M. Anorexia nervosa: Manifestations and management for the gastroenterologist. Am J Gastroenterol. 2002 Feb; 97(2):255-69.
    View PubMed
  627. Camilleri M. Advances in diabetic gastroparesis. Reviews in Gastroenterological Disorders. 2002; 2(2):47-56.
    View PubMed
  628. Pardi DS, Loftus EV Jr, Camilleri M. Treatment of inflammatory bowel disease in the elderly: an update. Drugs Aging. 2002; 19 (5):355-63
    View PubMed
  629. Viramontes BE, Malcolm A, Camilleri M, Szarka LA, McKinzie S, Burton DD, Zinsmeister AR. Effects of an alpha(2)-adrenergic agonist on gastrointestinal transit, colonic motility, and sensation in humans. Am J Physiol Gastrointest Liver Physiol. 2001 Dec; 281 (6):G1468-76
    View PubMed
  630. Liau SS, Camilleri M, Kim DY, Stephens D, Burton DD, O'Connor MK. Pharmacological modulation of human gastric volumes demonstrated noninvasively using SPECT imaging. Neurogastroenterol Motil. 2001 Dec; 13 (6):533-42
    View PubMed
  631. Viramontes BE, Kim DY, Camilleri M, Lee JS, Stephens D, Burton DD, Thomforde GM, Klein PD, Zinsmeister AR. Validation of a stable isotope gastric emptying test for normal, accelerated or delayed gastric emptying. Neurogastroenterol Motil. 2001 Dec; 13 (6):567-74
    View PubMed
  632. Kim DY, Camilleri M, Murray JA, Stephens DA, Levine JA, Burton DD. Is there a role for gastric accommodation and satiety in asymptomatic obese people? Obes Res. 2001 Nov; 9(11):655-61.
    View PubMed
  633. Kim DY, Delgado-Aros S, Camilleri M, Samsom M, Murray JA, O'Connor MK, Brinkmann BH, Stephens DA, Lighvani SS, Burton DD. Noninvasive measurement of gastric accommodation in patients with idiopathic nonulcer dyspepsia. Am J Gastroenterol. 2001 Nov; 96(11):3099-105.
    View PubMed
  634. Camilleri M, Kim DY. What is the relevance of a systematic review of pharmacological management in irritable bowel syndrome to older people? Pharmacologic treatment of the irritable bowel syndrome: a systematic review of randomized, controlled trials. J Am Geriatr Soc. 2001 Sep; 49 (9):1249-52
    View PubMed
  635. Viramontes BE, Camilleri M, McKinzie S, Pardi DS, Burton D, Thomforde GM. Gender-related differences in slowing colonic transit by a 5-HT3 antagonist in subjects with diarrhea-predominant irritable bowel syndrome. Am J Gastroenterol. 2001 Sep; 96(9):2671-6.
    View PubMed
  636. Camilleri M. Enteric nervous system disorders: genetic and molecular insights for the neurogastroenterologist. Neurogastroenterol Motil. 2001 Aug; 13 (4):277-95
    View PubMed
  637. Camilleri M, Chey WY, Mayer EA, Northcutt AR, Heath A, Dukes GE, McSorley D, Mangel AM. A randomized controlled clinical trial of the serotonin type 3 receptor antagonist alosetron in women with diarrhea-predominant irritable bowel syndrome. Arch Intern Med. 2001 Jul 23; 161(14):1733-40.
    View PubMed
  638. Burns TM, Lawn ND, Low PA, Camilleri M, Wijdicks EF. Adynamic ileus in severe Guillain-Barre syndrome. Muscle Nerve. 2001 Jul; 24(7):963-5.
    View PubMed
  639. Bharucha AE, Camilleri M. Functional abdominal pain in the elderly. Gastroenterol Clin North Am. 2001 Jun; 30 (2):517-29
    View PubMed
  640. Vella A, Shah P, Basu R, Basu A, Camilleri M, Schwenk WF, Rizza RA. Type I diabetes mellitus does not alter initial splanchnic glucose extraction or hepatic UDP-glucose flux during enteral glucose administration. Diabetologia. 2001 Jun; 44(6):729-37.
    View PubMed
  641. Camilleri M. Pathophysiology in irritable bowel syndrome. Drug News Perspect. 2001 Jun; 14 (5):268-78
    View PubMed
  642. Coulie B, Camilleri M, Bharucha AE, Sandborn WJ, Burton D. Colonic motility in chronic ulcerative proctosigmoiditis and the effects of nicotine on colonic motility in patients and healthy subjects. Aliment Pharmacol Ther. 2001 May; 15 (5):653-63
    View PubMed
  643. Nehra V, Camilleri M, Burton D, Oenning L, Kelly DG. An open trial of octreotide long-acting release in the management of short bowel syndrome. Am J Gastroenterol. 2001 May; 96(5):1494-8.
    View PubMed
  644. Camilleri M. Review article: tegaserod. Aliment Pharmacol Ther. 2001 Mar; 15 (3):277-89
    View PubMed
  645. Aros SD, Camilleri M. Small-bowel motility. Curr Opin Gastroenterol. 2001 Mar; 17 (2):140-146
    View PubMed
  646. Vella A, Shah P, Basu R, Basu A, Camilleri M, Schwenk FW, Holst JJ, Rizza RA. Effect of glucagon-like peptide-1(7-36)-amide on initial splanchnic glucose uptake and insulin action in humans with type 1 diabetes. Diabetes. 2001 Mar; 50 (3):565-72
    View PubMed
  647. Camilleri M. Management of the irritable bowel syndrome. Gastroenterology. 2001 Feb; 120 (3):652-68
    View PubMed
  648. Bouras EP, Camilleri M, Burton DD, Thomforde G, McKinzie S, Zinsmeister AR. Prucalopride accelerates gastrointestinal and colonic transit in patients with constipation without a rectal evacuation disorder. Gastroenterology. 2001 Feb; 120 (2):354-60
    View PubMed
  649. Lee HR, Lennon VA, Camilleri M, Prather CM. Paraneoplastic gastrointestinal motor dysfunction: clinical and laboratory characteristics. Am J Gastroenterol. 2001 Feb; 96(2):373-9.
    View PubMed
  650. Camilleri M, Coulie B, Tack JF. Visceral hypersensitivity: facts, speculations, and challenges. Gut. 2001 Jan; 48 (1):125-31
    View PubMed
  651. Camilleri M. Novel medications for the irritable bowel syndrome: motility and sensation. J Pediatr Gastroenterol Nutr. 2001; 32 Suppl 1:S35-7
    View PubMed
  652. Camilleri M, Lee JS, Viramontes B, Bharucha AE, Tangalos EG. Progress in Geriatrics: Insights into the pathophysiology and mechanisms of constipation, IBS, and diverticulosis in the elderly. Am J Geriatr Soc. 2001.
  653. Camilleri M. Dyspepsia, irritable bowel syndrome, and constipation: review and what's new. Rev Gastroenterol Disord. 2001; 1(1):2-17.
    View PubMed
  654. Kim DY, Myung SJ, Camilleri M. Novel testing of human gastric motor and sensory functions: rationale, methods, and potential applications in clinical practice. Am J Gastroenterol. 2000 Dec; 95(12):3365-73.
    View PubMed
  655. Camilleri M. Neurogastroenterology: evolving concepts and techniques to study motility and hypersensitivity. Digestive & Liver Disease. 2000 Dec; 32(Suppl 3):S227-32.
  656. Camilleri M. Neurogastroenterology: evolving concepts and techniques to study motility and hypersensitivity. Dig Liver Dis. 2000 Dec; 32 Suppl 3:S227-32
    View PubMed
  657. Camilleri M. Functional bowel disease: roles of sensation and motility. Schweiz Med Wochenschr. 2000 Nov 18; 130(46):1772-81.
    View PubMed
  658. Bharucha AE, Camilleri M, Haydock S, Ferber I, Burton D, Cooper S, Tompson D, Fitzpatrick K, Higgins R, Zinsmeister AR. Effects of a serotonin 5-HT(4) receptor antagonist SB-207266 on gastrointestinal motor and sensory function in humans. Gut. 2000 Nov; 47 (5):667-74
    View PubMed
  659. Maleki D, Locke GR 3rd, Locke GR 3rd, Camilleri M, Zinsmeister AR, Yawn BP, Leibson C, Melton LJ 3rd, Leibson C, Melton LJ 3rd. Gastrointestinal tract symptoms among persons with diabetes mellitus in the community. Arch Intern Med. 2000 Oct 9; 160 (18):2808-16
    View PubMed
  660. Kim DY, Camilleri M. Serotonin: a mediator of the brain-gut connection. Am J Gastroenterol. 2000 Oct; 95(10):2698-709.
    View PubMed
  661. Lee JS, Camilleri M, Zinsmeister AR, Burton DD, Choi MG, Nair KS, Verlinden M. Toward office-based measurement of gastric emptying in symptomatic diabetics using [13C]octanoic acid breath test. Am J Gastroenterol. 2000 Oct; 95 (10):2751-61
    View PubMed
  662. Coulie B, Camilleri M. New therapies for functional bowel diseases. Curr Gastroenterol Rep. 2000 Oct; 2 (5):355-63
    View PubMed
  663. Camilleri M, Lee JS, Viramontes B, Bharucha AE, Tangalos EG. Insights into the pathophysiology and mechanisms of constipation, irritable bowel syndrome, and diverticulosis in older people. J Am Geriatr Soc. 2000 Sep; 48 (9):1142-50
    View PubMed
  664. Thumshirn M, Coulie B, Camilleri M, Zinsmeister AR, Burton DD, Van Dyke C. Effects of alosetron on gastrointestinal transit time and rectal sensation in patients with irritable bowel syndrome. Aliment Pharmacol Ther. 2000 Jul; 14 (7):869-78
    View PubMed
  665. Coulie B, Szarka LA, Camilleri M, Burton DD, McKinzie S, Stambler N, Cedarbaum JM. Recombinant human neurotrophic factors accelerate colonic transit and relieve constipation in humans. Gastroenterology. 2000 Jul; 119 (1):41-50
    View PubMed
  666. Nehra V, Bruce BK, Rath-Harvey DM, Pemberton JH, Camilleri M. Psychological disorders in patients with evacuation disorders and constipation in a tertiary practice. Am J Gastroenterol. 2000 Jul; 95(7):1755-8.
    View PubMed
  667. Lee JS, Lee JS, Camilleri M, Zinsmeister AR, Burton DD, Kost LJ, Klein PD. A valid, accurate, office based non-radioactive test for gastric emptying of solids. Gut. 2000 Jun; 46 (6):768-73
    View PubMed
  668. Malcolm A, Camilleri M, Kost L, Burton DD, Fett SL, Zinsmeister AR. Towards identifying optimal doses for alpha-2 adrenergic modulation of colonic and rectal motor and sensory function. Aliment Pharmacol Ther. 2000 Jun; 14 (6):783-93
    View PubMed
  669. Samsom M, Szarka LA, Camilleri M, Vella A, Zinsmeister AR, Rizza RA. Pramlintide, an amylin analog, selectively delays gastric emptying: potential role of vagal inhibition. Am J Physiol Gastrointest Liver Physiol. 2000 Jun; 278 (6):G946-51
    View PubMed
  670. Camilleri M, Williams DE. Economic burden of irritable bowel syndrome. Proposed strategies to control expenditures. Pharmacoeconomics. 2000 Apr; 17 (4):331-8
    View PubMed
  671. Camilleri M, Northcutt AR, Kong S, Dukes GE, McSorley D, Mangel AW. Efficacy and safety of alosetron in women with irritable bowel syndrome: a randomised, placebo-controlled trial. Lancet. 2000 Mar 25; 355(9209):1035-40.
    View PubMed
  672. Prather CM, Camilleri M, Zinsmeister AR, McKinzie S, Thomforde G. Tegaserod accelerates orocecal transit in patients with constipation-predominant irritable bowel syndrome. Gastroenterology. 2000 Mar; 118 (3):463-8
    View PubMed
  673. Malcolm A, Camilleri M. Coloanal motor coordination in association with high-amplitude colonic contractions after pharmacological stimulation. Am J Gastroenterol. 2000 Mar; 95(3):715-9.
    View PubMed
  674. Camilleri M. Ten secrets for development of drugs for functional gastrointestinal diseases. Comments from the Editors Gastroenterology. 2000; 118:653.
  675. Kellow JE, Delvaux MM, Azpiroz F, Camilleri M, Quigley EMM, Thompson DG. Principles of applied neurogastroenterology: motility/sensation - sensation Rome II: The Functional Gastrointestinal Disorders, 2nd ed. Drossman DA, Corazziari E, Talley NJ, Thompson WG, Whitehead WE, eds. Lawrence, KS: Allen Press, Inc., 2000, pp. 91-156. 2000; 0: 0.
  676. Lee JS, Camilleri M. Image of the month. Gastroenterology. 2000; 119:614.
  677. Camilleri M. Pharmacology and clinical experience with alosetron. Expert Opin Investig Drugs. 2000 Jan; 9 (1):147-59
    View PubMed
  678. Kuiken SD, Samsom M, Camilleri M, Mullan BP, Burton DD, Kost LJ, Hardyman TJ, Brinkmann BH, O'Connor MK. Development of a test to measure gastric accommodation in humans. Am J Physiol. 1999 Dec; 277 (6):G1217-21
    View PubMed
  679. Camilleri M. Therapeutic approach to the patient with irritable bowel syndrome. Am J Med. 1999 Nov 8; 107 (5A):27S-32S
    View PubMed
  680. Camilleri M, Calobrisi SD. Skin eruptions in the diaper area. Curr Probl Dermatol. 1999 Nov-Dec; 11(6):213-244.
  681. Camilleri M. Clinical subgroups of chronic constipation: exploring the potential of polyethylene glycol. Ital J Gastroenterol Hepatol. 1999 Nov; 31 Suppl 3:S253-4
    View PubMed
  682. Kellow JE, Delvaux M, Azpiroz F, Camilleri M, Quigley EMM, Thompson DG. Principles of applied neurogastroenterology: physiology/motility-sensation. Gut. 1999 Sep; 45(Suppl 2):17-24.
    View PubMed
  683. Bouras EP, O'Brien TJ, Camilleri M, O'Connor MK, Mullan BP. Cerebral topography of rectal stimulation using single photon emission computed tomography. Am J Physiol. 1999 Sep; 277 (3):G687-94
    View PubMed
  684. Camilleri M, Mayer EA, Drossman DA, Heath A, Dukes GE, McSorley D, Kong S, Mangel AW, Northcutt AR. Improvement in pain and bowel function in female irritable bowel patients with alosetron, a 5-HT3 receptor antagonist. Aliment Pharmacol Ther. 1999 Sep; 13 (9):1149-59
    View PubMed
  685. Camilleri M. Review article: clinical evidence to support current therapies of irritable bowel syndrome. Aliment Pharmacol Ther. 1999 May; 13 Suppl 2:48-53
    View PubMed
  686. Bouras EP, Camilleri M, Burton DD, McKinzie S. Selective stimulation of colonic transit by the benzofuran 5HT4 agonist, prucalopride, in healthy humans. Gut. 1999 May; 44 (5):682-6
    View PubMed
  687. Mueller LA, Camilleri M, Emslie-Smith AM. Mitochondrial neurogastrointestinal encephalomyopathy: manometric and diagnostic features. Gastroenterology. 1999 Apr; 116(4):959-63.
    View PubMed
  688. Camilleri M. Motor function in irritable bowel syndrome. Can J Gastroenterol. 1999 Mar; 13 Suppl A:8A-11A
    View PubMed
  689. Thumshirn M, Camilleri M, Choi MG, Zinsmeister AR. Modulation of gastric sensory and motor functions by nitrergic and alpha2-adrenergic agents in humans. Gastroenterology. 1999 Mar; 116 (3):573-85
    View PubMed
  690. Mollen RM, Salvioli B, Camilleri M, Burton D, Kost LJ, Phillips SF, Pemberton JH. The effects of biofeedback on rectal sensation and distal colonic motility in patients with disorders of rectal evacuation: evidence of an inhibitory rectocolonic reflex in humans? Am J Gastroenterol. 1999 Mar; 94(3):751-6.
    View PubMed
  691. Scolapio JS, Camilleri M, Weckwerth JA, Romano M. Audit of the treatment of malnutrition due to chronic intestinal pseudo-obstruction with enteral nutrition. Nutr Clin Pract. 1999 Feb; 14(1):29-32.
  692. Forstner-Barthell AW, Murr MM, Nitecki S, Camilleri M, Prather CM, Kelly KA, Sarr MG. Near-total completion gastrectomy for severe postvagotomy gastric stasis: analysis of early and long-term results in 62 patients. J Gastrointest Surg. 1999 Jan-Feb; 3 (1):15-21, discussion 21-3
    View PubMed
  693. Coulie B, Camilleri M. Intestinal pseudo-obstruction. Annu Rev Med. 1999; 50:37-55.
    View PubMed
  694. Thumshirn M, Camilleri M, Saslow SB, Williams DE, Burton DD, Hanson RB. Gastric accommodation in non-ulcer dyspepsia and the roles of Helicobacter pylori infection and vagal function. Gut. 1999 Jan; 44 (1):55-64
    View PubMed
  695. Camilleri M. Review article: Functional bowel disease: a challenging frontier in gastroenterology. Maltese Medical Journal. 1999; 11:4-14.
  696. Camilleri M. Chronic intestinal pseudo-obstruction Approach to the Patient with Chronic Gastrointestinal Disorders. Corazziari E, ed. Millan: Messaggi srl. 1999; 0: pp. 271-93.
  697. Harewood GC, Coulie B, Camilleri M, Rath-Harvey D, Pemberton JH. Descending perineum syndrome: audit of clinical and laboratory features and outcome of pelvic floor retraining. Am J Gastroenterol. 1999 Jan; 94: (1)126-30.
    View PubMed
  698. Wagaman JR, Williams DE, Williams DE, Camilleri M. Behavioral intervention for the treatment of rumination. J Pediatr Gastroenterol Nutr. 1998 Nov; 27 (5):596-8
    View PubMed
  699. Maleki D, Camilleri M, Burton DD, Rath-Harvey DM, Oenning L, Pemberton JH, Low PA. Pilot study of pathophysiology of constipation among community diabetics. Dig Dis Sci. 1998 Nov; 43 (11):2373-8
    View PubMed
  700. Camilleri M, Hasler WL, Parkman HP, Quigley EM, Soffer E. Measurement of gastrointestinal motility in the GI laboratory. Gastroenterology. 1998 Sep; 115 (3):747-62
    View PubMed
  701. Thumshirn M, Camilleri M, Hanson RB, Williams DE, Schei AJ, Kammer PP. Gastric mechanosensory and lower esophageal sphincter function in rumination syndrome. Am J Physiol. 1998 Aug; 275 (2):G314-21
    View PubMed
  702. Thumshirn M, Camilleri M, Hanson RB, Williams DE, Schei AJ, Kammer PP. Gastric mechanosensory and lower esophageal sphincter function in rumination syndrome. Am J Physiol Gastrointest Liver Physiol. 1998 Aug 1; 275 (2):G314-G321
    View PubMed
  703. Weston S, Thumshirn M, Wiste J, Camilleri M. Clinical and upper gastrointestinal motility features in systemic sclerosis and related disorders. Am J Gastroenterol. 1998 Jul; 93(7):1085-9.
    View PubMed
  704. Saslow SB, Scolapio JS, Camilleri M, Forstrom LA, Thomforde GM, Burton DD, Rubin J, Pitot HC, Zinsmeister AR. Medium-term effects of a new 5HT3 antagonist, alosetron, in patients with carcinoid diarrhoea. Gut. 1998 May; 42 (5):628-34
    View PubMed
  705. Choi MG, Camilleri M, Burton DD, Johnson S, Edmonds A. Dose-related effects of N-demethyl-N-isopropyl-8, 9-anhydroerythromycin A 6,9-hemiacetal on gastric emptying of solids in healthy human volunteers. J Pharmacol Exp Ther. 1998 Apr; 285(1):37-40.
    View PubMed
  706. Camilleri M, Ford MJ. Review article: colonic sensorimotor physiology in health, and its alteration in constipation and diarrhoeal disorders. Aliment Pharmacol Ther. 1998 Apr; 12 (4):287-302
    View PubMed
  707. Mullan BP, Camilleri M, Hung JC. Activated charcoal as a potential radioactive marker for gastrointestinal studies. Nucl Med Commun. 1998 Mar; 19 (3):237-40
    View PubMed
  708. Hammer HF, Phillips SF, Camilleri M, Hanson RB. Rectal tone, distensibility, and perception: reproducibility and response to different distensions. Am J Physiol Gastrointest Liver Physiol. 1998 Mar 1; 274 (3):G584-G590
    View PubMed
  709. Hammer HF, Phillips SF, Camilleri M, Hanson RB. Rectal tone, distensibility, and perception: reproducibility and response to different distensions. Am J Physiol. 1998 Mar; 274 (3):G584-90
    View PubMed
  710. Farrugia G, Nitecki S, Harty GJ, Camilleri M, Szurszewski JH. The effect of flufenamic acid on gastrointestinal myoelectrical activity and transit time in dogs. Gut. 1998 Feb; 42 (2):258-65
    View PubMed
  711. Saslow SB, Thumshirn M, Camilleri M, Locke GR 3rd, Thomforde GM, Burton DD, Hanson RB. Influence of H. pylori infection on gastric motor and sensory function in asymptomatic volunteers. Dig Dis Sci. 1998 Feb; 43 (2):258-64
    View PubMed
  712. Frank JW, Camilleri M, Thomforde GM, Dinneen SF, Rizza RA. Effects of glucagon on postprandial carbohydrate metabolism in nondiabetic humans. Metabolism. 1998 Jan; 47 (1):7-12
    View PubMed
  713. Choi MG, Camilleri M, Burton DD, Zinsmeister AR, Forstrom LA, Nair KS. Reproducibility and simplification of 13C-octanoic acid breath test for gastric emptying of solids. Am J Gastroenterol. 1998 Jan; 93: (1)92-8.
    View PubMed
  714. Camilleri M. Gastric emptying in diabetes mellitus: potential strategies to achieve euglycemia. Motility. 1998; issue 43:4-6.
  715. Camilleri M. Gastrointestinal motility disorders. Scientific American Medicine. Dale DC, Federman DD, eds. New York: Scientific American Medicine Publishers. 1998;
  716. Camilleri M, Maleki D, Barnett D. Gastrointestinal complications of diabetes mellitus. The Uncomplicated Guide to Diabetes Complications. Levin ME, Pfeiffer MA, eds. Alexandria, VA: American Diabetes Association,. 1998; pp. 236-49.
  717. Camilleri M. Motor function in functional dyspepsia and irritable bowel syndrome. Functional Dyspepsia and Irritable bowel syndrome: Concepts and Controversies. Goebell H, Holtmann G, Talley N, eds. Lancaster, U.K.: Kluwer Academic Publishers,. 1998; pp 103-12.
  718. Fujimura J, Camilleri M, Low PA, Novak V, Novak P, Opfer-Gehrking TL. Effect of perturbations and a meal on superior mesenteric artery flow in patients with orthostatic hypotension. J Auton Nerv Syst. 1997 Dec 3; 67 (1-2):15-23
    View PubMed
  719. Saslow SB, O'Brien MD, Camilleri M, von der Ohe M, Homburger HA, Klee GG, Pitot HC, Rubin J. Octreotide inhibition of flushing and colonic motor dysfunction in carcinoid syndrome. Am J Gastroenterol. 1997 Dec; 92 (12):2250-6
    View PubMed
  720. Malcolm A, Phillips SF, Camilleri M, Hanson RB. Pharmacological modulation of rectal tone alters perception of distention in humans. Am J Gastroenterol. 1997 Nov; 92(11):2073-9.
    View PubMed
  721. Burton DD, Camilleri M, Mullan BP, Forstrom LA, Hung JC. Colonic transit scintigraphy labeled activated charcoal compared with ion exchange pellets. J Nucl Med. 1997 Nov; 38: (11)1807-10.
    View PubMed
  722. Bharucha AE, Camilleri M, Zinsmeister AR, Hanson RB. Adrenergic modulation of human colonic motor and sensory function. Am J Physiol. 1997 Nov; 273 (5):G997-1006
    View PubMed
  723. Bharucha AE, Novak V, Camilleri M, Zinsmeister AR, Hanson RB, Low PA. Alpha 2-adrenergic modulation of colonic tone during hyperventilation. Am J Physiol. 1997 Nov; 273 (5):G1135-40
    View PubMed
  724. Bharucha AE, Novak V, Camilleri M, Zinsmeister AR, Hanson RB, Low PA. alpha2-Adrenergic modulation of colonic tone during hyperventilation. Am J Physiol Gastrointest Liver Physiol. 1997 Nov 1; 273 (5):G1135-G1140
    View PubMed
  725. Bharucha AE, Camilleri M, Zinsmeister AR, Hanson RB. Adrenergic modulation of human colonic motor and sensory function. Am J Physiol Gastrointest Liver Physiol. 1997 Nov 1; 273 (5):G997-G1006
    View PubMed
  726. Scolapio JS, Camilleri M, Fleming CR, Oenning LV, Burton DD, Sebo TJ, Batts KP, Kelly DG. Effect of growth hormone, glutamine, and diet on adaptation in short-bowel syndrome: a randomized, controlled study. Gastroenterology. 1997 Oct; 113 (4):1074-81
    View PubMed
  727. Maleki D, Camilleri M, Zinsmeister AR, Rizza RA. Effect of acute hyperglycemia on colorectal motor and sensory function in humans. Am J Physiol Gastrointest Liver Physiol. 1997 Oct 1; 273 (4):G859-G864
    View PubMed
  728. Thumshirn M, Bruninga K, Camilleri M. Simplifying the evaluation of postprandial antral motor function in patients with suspected gastroparesis. Am J Gastroenterol. 1997 Sep; 92(9):1496-500.
    View PubMed
  729. Malcolm A, Thumshirn MB, Camilleri M, Williams DE. Rumination syndrome. Mayo Clin Proc. 1997 Jul; 72(7):646-52.
    View PubMed
  730. Scolapio JS, Camilleri M, Fleming CR. Gastrointestinal motility considerations in patients with short-bowel syndrome. Dig Dis. 1997 Jul-Oct; 15 (4-5):253-62
    View PubMed
  731. Drossman DA, Whitehead WE, Camilleri M. Irritable bowel syndrome: a technical review for practice guideline development. Gastroenterology. 1997 Jun; 112(6):2120-37.
    View PubMed
  732. Bruninga K, Camilleri M. Colonic motility and tone after spinal cord and cauda equina injury. Am J Gastroenterol. 1997 May; 92(5):891-4.
    View PubMed
  733. Charles F, Phillips SF, Camilleri M, Thomforde GM. Rapid gastric emptying in patients with functional diarrhea. Mayo Clin Proc. 1997 Apr; 72 (4):323-8
    View PubMed
  734. Choi MG, Camilleri M, Burton DD, Zinsmeister AR, Forstrom LA, Nair KS. [13C]octanoic acid breath test for gastric emptying of solids: accuracy, reproducibility, and comparison with scintigraphy. Gastroenterology. 1997 Apr; 112 (4):1155-62
    View PubMed
  735. Nguyen A, Camilleri M, Kost LJ, Metzger A, Sarr MG, Hanson RB, Fett SL, Zinsmeister AR. SDZ HTF 919 stimulates canine colonic motility and transit in vivo. J Pharmacol Exp Ther. 1997 Mar; 280(3):1270-6.
    View PubMed
  736. Choi MG, Camilleri M, O'Brien MD, Kammer PP, Hanson RB. A pilot study of motility and tone of the left colon in patients with diarrhea due to functional disorders and dysautonomia. Am J Gastroenterol. 1997 Feb; 92(2):297-302.
    View PubMed
  737. Camilleri M, Choi MG. Review article: irritable bowel syndrome. Aliment Pharmacol Ther. 1997 Feb; 11 (1):3-15
    View PubMed
  738. Loftus EV Jr, Farrugia G, Donohue JH, Camilleri M. Duodenal obstruction: diagnosis by gastroduodenal manometry. Mayo Clin Proc. 1997 Feb; 72 (2):130-2
    View PubMed
  739. O'Brien MD, Camilleri M, Thomforde GM, Wiste JA, Hanson RB, Zinsmeister AR. Effect of cholecystokinin octapeptide and atropine on human colonic motility, tone, and transit. Dig Dis Sci. 1997 Jan; 42 (1):26-33
    View PubMed
  740. Camilleri M. Diarrhea and irritable bowel syndrome: Practical approaches. Surgery and Colon & Rectum. Nicholls RJ, Dozois RR, eds. London: Churchill Livingstone,. 1997; 0: pp. 681-689.
  741. Camilleri M. Dysautonomic findings in functional gastrointestinal disorders. Functional Dyspepsia. Mearin F, ed. Barcelona, Spain: Doyma Publishers,. 1997; 0: pp. 133-138.
  742. Whitehead WE, Delvaux M, Azpiroz F, Barlow J, Bradley L, Camilleri M, Crowell MD, Enck P, Fioramonti J, Janssens J, Mayer EA, Morteau O, Phillips SF, Thompson DG, Wingate DL. Standardization of procedures for testing smooth muscle tone and sensory thresholds in the gastrointestinal tract. Dig Dis Sci. 1997; 42:223-41.
    View PubMed
  743. O'Brien MD, Camilleri M, von der Ohe MR, Phillips SF, Pemberton JH, Prather CM, Wiste JA, Hanson RB. Motility and tone of the left colon in constipation: a role in clinical practice? Am J Gastroenterol. 1996 Dec; 91(12):2532-8.
    View PubMed
  744. Camilleri M, Bharucha AE. Gastrointestinal dysfunction in neurologic disease. Semin Neurol. 1996 Sep; 16(3):203-16.
    View PubMed
  745. Bharucha AE, Camilleri M, Ford MJ, O'Connor MK, Hanson RB, Thomforde GM. Hyperventilation alters colonic motor and sensory function: effects and mechanisms in humans. Gastroenterology. 1996 Aug; 111 (2):368-77
    View PubMed
  746. Ford MJ, Camilleri M, Joyner MJ, Hanson RB. Autonomic control of colonic tone and the cold pressore test. Gut. 1996 Jul; 39 (1):125-9
    View PubMed
  747. Camilleri M. Nonulcer dyspepsia: a look into the future. Mayo Clin Proc. 1996 Jun; 71 (6):614-22
    View PubMed
  748. Camilleri M. Gastrointestinal problems in diabetes. Endocrinol Metab Clin North Am. 1996 Jun; 25 (2):361-78
    View PubMed
  749. Camilleri M, Balm RK, Zinsmeister AR. Symptomatic improvement with one-year cisapride treatment in neuropathic chronic intestinal dysmotility. Aliment Pharmacol Ther. 1996 Jun; 10 (3):403-9
    View PubMed
  750. Zein NN, Perrault J, Camilleri M. Recurrent vomiting following Harrington rod instrumentation of the spine. J Pediatr Gastroenterol Nutr. 1996 Apr; 22 (3):318-20
    View PubMed
  751. Surrenti E, Camilleri M, Kammer PP, Prather CM, Schei AJ, Hanson RB. Antral axial forces postprandially and after erythromycin in organic and functional dysmotilities. Dig Dis Sci. 1996 Apr; 41 (4):697-704
    View PubMed
  752. Farrugia G, Camilleri M, Whitehead WE. Therapeutic strategies for motility disorders. Medications, nutrition, biofeedback, and hypnotherapy. Gastroenterol Clin North Am. 1996 Mar; 25 (1):225-46
    View PubMed
  753. Camilleri M, Saslow SB, Bharucha AE. Gastrointestinal sensation. Mechanisms and relation to functional gastrointestinal disorders. Gastroenterol Clin North Am. 1996 Mar; 25 (1):247-58
    View PubMed
  754. Scolapio JS, Camilleri M. Nonulcer dyspepsia. Gastroenterologist. 1996 Mar; 4(1):13-23.
    View PubMed
  755. Saslow SB, Camilleri M, Thomforde GM, Van Dyke CT, Pitot HC, Rubin J. Relation between fat malabsorption and transit abnormalities in human carcinoid diarrhea. Gastroenterology. 1996 Feb; 110 (2):405-10
    View PubMed
  756. Camilleri M. Effects of somatostatin analogues on human gastrointestinal motility. Digestion. 1996; 57 Suppl 1:90-2
    View PubMed
  757. Camilleri M. Effect of altered control of the autonomic nervous system on gastrointestinal function. Proceedings of the International Symposium of NeuroGastroenterology. Corazziari E, ed. Berlin: Walter De Gruyter & Co.,. 1996; 0: pp. 187-198.
  758. Camilleri M. Gastrointestinal neuropathies relieved by prokinetic therapy Gastroenterology Observer. 1996; 15:2-3.
  759. Camilleri M, Saslow SB. Somatostatin analogs in the treatment of gastrointestinal motility disorders Advances in Gastroenterology Hepatology & Clinical Nutrition ,. 1996; 1: 291-8.
  760. Talley NJ, Camilleri M. Epidemiological features of functional dyspepsia and irritable bowel syndrome. Clinican. 1996; 14:7-13.
  761. Murr MM, Sarr MG, Camilleri M. The surgeon's role in the treatment of chronic intestinal pseudoobstruction. Am J Gastroenterol. 1995 Dec; 90: (12)2147-51.
    View PubMed
  762. Ford MJ, Camilleri M, Zinsmeister AR, Hanson RB. Psychosensory modulation of colonic sensation in the human transverse and sigmoid colon. Gastroenterology. 1995 Dec; 109 (6):1772-80
    View PubMed
  763. Rowe FA, Camilleri M, Forstrom LA, Batts KP, Mullan BP, Thomforde GM, Dunn W, Zinsmeister AR. A pilot study of splenic and whole body retention of autologous radiolabeled leukocytes in the assessment of severity in inflammatory colitis. Am J Gastroenterol. 1995 Oct; 90: (10)1771-5.
    View PubMed
  764. Saslow SB, Camilleri M. Diabetic diarrhea. Semin Gastrointest Dis. 1995 Oct; 6(4):187-93.
    View PubMed
  765. Surrenti E, Rath DM, Pemberton JH, Camilleri M. Audit of constipation in a tertiary referral gastroenterology practice. Am J Gastroenterol. 1995 Sep; 90(9):1471-5.
    View PubMed
  766. Frank JW, Saslow SB, Camilleri M, Thomforde GM, Dinneen S, Rizza RA. Mechanism of accelerated gastric emptying of liquids and hyperglycemia in patients with type II diabetes mellitus. Gastroenterology. 1995 Sep; 109 (3):755-65
    View PubMed
  767. Camilleri M. Gastrointestinal manifestations of diabetes mellitus. (Overview). Eur J Gastroenterol Hepatol. 1995 Aug; 7:709-710.
  768. Ford MJ, Camilleri M, Wiste JA, Hanson RB. Differences in colonic tone and phasic response to a meal in the transverse and sigmoid human colon. Gut. 1995 Aug; 37 (2):264-9
    View PubMed
  769. Singaram C, Sweet MA, Gaumnitz EA, Cameron AJ, Camilleri M. Peptidergic and nitringergic denervation in congenital esophageal stenosis. (Note). Gastroenterology. 1995 Jul; 109:275-281.
    View PubMed
  770. Scolapio JS, Camilleri M, von der Ohe MR, Hanson RB. Ascending colon response to feeding: evidence for a 5-hydroxytryptamine-3 mechanism. Scand J Gastroenterol. 1995 Jun; 30 (6):562-7
    View PubMed
  771. von der Ohe MR, Camilleri M, Thomforde GM, Klee GG. Differential regional effects of octreotide on human gastrointestinal motor function. Gut. 1995 May; 36 (5):743-8
    View PubMed
  772. Forstrom LA, Dunn WL, Rowe FA, Camilleri M. 111In-oxine-labelled granulocyte dosimetry in normal subjects. Nucl Med Commun. 1995 May; 16 (5):349-56
    View PubMed
  773. Gaspari JC, Sande JR, Thomas CF Jr, Zighelboim J, Camilleri M. Lupus anticoagulant masquerading as an acute abdomen with multiorgan involvement. Am J Gastroenterol. 1995 May; 90(5):825-6.
    View PubMed
  774. Pemberton JH, Camilleri M, Fleshman JW. Clinical management of the constipated patient. Ann Intern Med. 1995 Apr 15; 122:632.
  775. O'Brien MD, Bruce BK, Camilleri M. The rumination syndrome: clinical features rather than manometric diagnosis. Gastroenterology. 1995 Apr; 108 (4):1024-9
    View PubMed
  776. Charles F, Camilleri M, Phillips SF, Thomforde GM, Forstrom LA. Scintigraphy of the whole gut: clinical evaluation of transit disorders. Mayo Clin Proc. 1995 Feb; 70 (2):113-8
    View PubMed
  777. Thomforde GM, Camilleri M, Phillips SF, Forstrom LA. Evaluation of an inexpensive screening scintigraphic test of gastric emptying. J Nucl Med. 1995 Jan; 36: (1)93-6.
    View PubMed
  778. Camilleri M. The management of chronic intestinal psuedo-obstruction Motility. 1995; 30:7-10.
  779. Camilleri M. Irritable bowel syndrome: the pathophysiologic links to more effective future therapy Participate Practical Gastroenterology (reprint), 1316-18, 1999. 1995; 4: 1-2.
  780. Camilleri M, Ford M, Bharucha A, Hanson R, Zinsmeister A. Psychosensory and autonomic modulation of colonic sensation in healthy humans. Third International Symposium on Brain-Gut Interactions Cambridge, UK, July 19-22,. 1995; 0: 0.
  781. Low PA, Opfer-Gehrking TL, Textor SC, Schondorf R, Suarez GA, Fealey RD, Camilleri M. Comparison of the postural tachycardia syndrome (POTS) with orthostatic hypotension due to autonomic failure. J Auton Nerv Syst. 1994 Dec 15; 50 (2):181-8
    View PubMed
  782. Camilleri M, Prather CM. Axial forces during gastric emptying in health and models of disease. Dig Dis Sci. 1994 Dec; 39 (12 Suppl):14S-17S
    View PubMed
  783. Camilleri M, Thompson WG, Fleshman JW, Pemberton JH. Clinical management of intractable constipation. Ann Intern Med. 1994 Oct 1; 121 (7):520-8
    View PubMed
  784. Camilleri M. Appraisal of medium- and long-term treatment of gastroparesis and chronic intestinal dysmotility. Am J Gastroenterol. 1994 Oct; 89(10):1769-74.
    View PubMed
  785. von der Ohe MR, Camilleri M, Carryer PW. A patient with localized megacolon and intractable constipation: evidence for impairment of colonic muscle tone. Am J Gastroenterol. 1994 Oct; 89(10):1867-70.
    View PubMed
  786. Suarez GA, Fealey RD, Camilleri M, Low PA. Idiopathic autonomic neuropathy: clinical, neurophysiologic, and follow-up studies on 27 patients. Neurology. 1994 Sep; 44 (9):1675-82
    View PubMed
  787. Vonderohe MR, Hanson RB, Camilleri M. Comparison of simultaneous recordings of human colonic contractions by manometry and a barostat. Neurogastroenterol Motil. 1994 Sep; 6:213-222.
  788. Haruma K, Wiste JA, Camilleri M. Effect of octreotide on gastrointestinal pressure profiles in health and in functional and organic gastrointestinal disorders. Gut. 1994 Aug; 35 (8):1064-9
    View PubMed
  789. Camilleri M, Von der Ohe MR. Drugs affecting serotonin receptors. Baillieres Clin Gastroenterol. 1994 Jun; 8 (2):301-19
    View PubMed
  790. von der Ohe MR, Camilleri M, Kvols LK. A 5HT3 antagonist corrects the postprandial colonic hypertonic response in carcinoid diarrhea. Gastroenterology. 1994 May; 106 (5):1184-9
    View PubMed
  791. Camilleri M. Human gastroduodenojejunal manometry. Dig Dis Sci. 1994 May; 39:1149-1150.
  792. Camilleri M. Small bowel motility disorders. Rev Gastroenterol Mex. 1994 Apr-Jun; 59(2):120-6.
    View PubMed
  793. Camilleri M, Balm RK, Zinsmeister AR. Determinants of response to a prokinetic agent in neuropathic chronic intestinal motility disorder. Gastroenterology. 1994 Apr; 106 (4):916-23
    View PubMed
  794. von der Ohe MR, Hanson RB, Camilleri M. Serotonergic mediation of postprandial colonic tonic and phasic responses in humans. Gut. 1994 Apr; 35 (4):536-41
    View PubMed
  795. Frank JW, Sarr MG, Camilleri M. Use of gastroduodenal manometry to differentiate mechanical and functional intestinal obstruction: an analysis of clinical outcome. Am J Gastroenterol. 1994 Mar; 89(3):339-44.
    View PubMed
  796. Camilleri M. Atlas of Gastrointestinal Motility in Health and Disease Gastroenterology (. 1994; Book review): 0.
  797. Von Der Ohe M, Camilleri M, Zimmerman BR. Management of diabetic enteropathy. Endocrinologist. 1993 Nov; 3:400-408.
  798. Valdovinos MA, Camilleri M, Thomforde GM, Frie C. Reduced accuracy of 14C-D-xylose breath test for detecting bacterial overgrowth in gastrointestinal motility disorders. Scand J Gastroenterol. 1993 Nov; 28 (11):963-8
    View PubMed
  799. von der Ohe MR, Camilleri M, Kvols LK, Thomforde GM. Motor dysfunction of the small bowel and colon in patients with the carcinoid syndrome and diarrhea. N Engl J Med. 1993 Oct 07; 329: (15)1073-8.
    View PubMed
  800. Hammer J, Phillips SF, Talley NJ, Camilleri M. Effect of a 5HT3-antagonist (ondansetron) on rectal sensitivity and compliance in health and the irritable bowel syndrome. Aliment Pharmacol Ther. 1993 Oct; 7 (5):543-51
    View PubMed
  801. Valdovinos MA, Camilleri M, Zimmerman BR. Chronic diarrhea in diabetes mellitus: mechanisms and an approach to diagnosis and treatment. Mayo Clin Proc. 1993 Jul; 68 (7):691-702
    View PubMed
  802. Aggarwal AM, Camilleri M, Phillips SF, Schlagheck TG, Brown ML, Thomforde GM, Brown ML. Olestra, a nondigestible, nonabsorbable fat. Effects on gastrointestinal and colonic transit. Dig Dis Sci. 1993 Jun; 38 (6):1009-14
    View PubMed
  803. Oosterbosch L, von der Ohe M, Valdovinos MA, Kost LJ, Phillips SF, Camilleri M. Effects of serotonin on rat ileocolonic transit and fluid transfer in vivo: possible mechanisms of action. Gut. 1993 Jun; 34 (6):794-8
    View PubMed
  804. Badley AD, Camilleri M, O'Connor MK. Noninvasive measurement of human ascending colon volume. Nucl Med Commun. 1993 Jun; 14: (6)485-9.
    View PubMed
  805. Camilleri M. Study of human gastroduodenojejunal motility. Applied physiology in clinical practice. Dig Dis Sci. 1993 May; 38 (5):785-94
    View PubMed
  806. Prather CM, Camilleri M, Thomforde GM, Forstrom LA, Zinsmeister AR. Gastric axial forces in experimentally delayed and accelerated gastric emptying. Am J Physiol. 1993 May; 264 (5 Pt 1):G928-34
    View PubMed
  807. Camilleri M, Balm RK, Low PA. Autonomic dysfunction in patients with chronic intestinal pseudo-obstruction. Clin Auton Res. 1993 Apr; 3 (2):95-100
    View PubMed
  808. Bharucha AE, Camilleri M, Low PA, Zinsmeister AR. Autonomic dysfunction in gastrointestinal motility disorders. Gut. 1993 Mar; 34 (3):397-401
    View PubMed
  809. Valdovinos MA, Thomforde GM, Camilleri M. Effect of putative carcinoid mediators on gastric and small bowel transit in rats and the role of 5-HT receptors. Aliment Pharmacol Ther. 1993 Feb; 7 (1):61-6
    View PubMed
  810. Leighton JA, Valdovinos MA, Pemberton JH, Rath DM, Camilleri M. Anorectal dysfunction and rectal prolapse in progressive systemic sclerosis. Dis Colon Rectum. 1993 Feb; 36 (2):182-5
    View PubMed
  811. Hammer J, Camilleri M, Phillips SF, Aggarwal A, Haddad AM. Does the ileocolonic junction differentiate between solids and liquids? Gut. 1993 Feb; 34 (2):222-6
    View PubMed
  812. Camilleri M. Four patients with intractable constipation. Gastrointestinal Diseases Today. 1993; 2:7-15.
  813. von der Ohe MR, Camilleri M. Measurement of small bowel and colonic transit: indications and methods. Mayo Clin Proc. 1992 Dec; 67 (12):1169-79
    View PubMed
  814. Miedema BW, Kelly KA, Camilleri M, Hanson RB, Zinsmeister AR, O'Connor MK, Brown ML. Human gastric and jejunal transit and motility after Roux gastrojejunostomy. Gastroenterology. 1992 Oct; 103 (4):1133-43
    View PubMed
  815. Fich A, Steadman CJ, Phillips SF, Camilleri M, Brown ML, Haddad AC, Thomforde GM. Ileocolonic transit does not change after right hemicolectomy. Gastroenterology. 1992 Sep; 103 (3):794-9
    View PubMed
  816. Vassallo MJ, Camilleri M, Phillips SF, Steadman CJ, Talley NJ, Hanson RB, Haddad AC. Colonic tone and motility in patients with irritable bowel syndrome. Mayo Clin Proc. 1992 Aug; 67 (8):725-31
    View PubMed
  817. Camilleri M, Prather CM, Evans MA, Andresen-Reid ML. Balance studies and polymeric glucose solution to optimize therapy after massive intestinal resection. Mayo Clin Proc. 1992 Aug; 67 (8):755-60
    View PubMed
  818. Vassallo MJ, Camilleri M, Prather CM, Hanson RB, Thomforde GM. Measurement of axial forces during emptying from the human stomach. Am J Physiol. 1992 Aug; 263 (2 Pt 1):G230-9
    View PubMed
  819. Camilleri M, Zinsmeister AR. Towards a relatively inexpensive, noninvasive, accurate test for colonic motility disorders. Gastroenterology. 1992 Jul; 103 (1):36-42
    View PubMed
  820. Camilleri M, Prather CM. The irritable bowel syndrome: mechanisms and a practical approach to management. Ann Intern Med. 1992 Jun 15; 116 (12 Pt 1):1001-8
    View PubMed
  821. Ruytjens I, Thomforde GM, Camilleri M, Chapman NJ. Effect of chemical sympathectomy on scintigraphic gastric and small bowel transit in the rat. J Auton Nerv Syst. 1992 Jun 15; 39 (2):111-7
    View PubMed
  822. Stark ME, Camilleri M, Fitzpatrick LA, Van Heerden JA. A 47-year-old woman with chronic constipation, hypercalcemia, and pulmonary nodule. Gastroenterology. 1992 Jun; 5:115-125.
  823. Steadman CJ, Phillips SF, Camilleri M, Talley NJ, Haddad A, Hanson R. Control of muscle tone in the human colon. Gut. 1992 Apr; 33 (4):541-6
    View PubMed
  824. Vassallo MJ, Camilleri M, Sullivan SN, Thomforde GM. Effects of erythromycin on gut transit in pseudo-obstruction due to hereditary coproporphyria. J Clin Gastroenterol. 1992 Apr; 14 (3):255-9
    View PubMed
  825. Camilleri M. Targeting therapy for the irritable bowel syndrome. Med Actual. 1992; 28:581-589.
  826. Layer P, Camilleri M. Erbrechan Gastroenterologie Vol 10 Goebell H(ed) Innere Medizine de Gegenwart Munchen, Wien, & Schwarzenberg, , pp 87-92. 1992; Baltimore: Urban.
  827. Layer P, Berges F-W, Camilleri M, Ihe M v d Erckenbrec. Untersuchungen der motilitat und des transits Gastroenterologie Vol 10 Goebell H (ed) Innere Medizin der Gegenwart Munchen, Wien, & Schwarzenberg, , pp 186-203. 1992; Baltimore: Urban.
  828. Vassallo M, Camilleri M, Phillips SF, Brown ML, Chapman NJ, Thomforde GM. Transit through the proximal colon influences stool weight in the irritable bowel syndrome. Gastroenterology. 1992 Jan; 102 (1):102-8
    View PubMed
  829. Prather CM, Camilleri M. Medical management of small bowel motility disorders and chronic intestinal pseudo-obstruction. Pract Gastroenterol. 1992; 16:25-37.
  830. Steadman CJ, Phillips SF, Camilleri M, Haddad AC, Hanson RB. Variation of muscle tone in the human colon. Gastroenterology. 1991 Aug; 101 (2):373-81
    View PubMed
  831. Camilleri M, Carbone LD, Schuffler MD. Familial enteric neuropathy with pseudoobstruction. Dig Dis Sci. 1991 Aug; 36 (8):1168-71
    View PubMed
  832. Stivland T, Camilleri M, Vassallo M, Proano M, Rath D, Brown M, Thomforde G, Pemberton J, Phillips S, Phillips S. Scintigraphic measurement of regional gut transit in idiopathic constipation. Gastroenterology. 1991 Jul; 101 (1):107-15
    View PubMed
  833. Phillips SF, Camilleri M. The ileocecal area and the irritable bowel syndrome. Gastroenterol Clin North Am. 1991 Jun; 20: (2)297-311.
    View PubMed
  834. Camilleri M, Vassallo M. Small intestinal motility and transit in disease. Baillieres Clin Gastroenterol. 1991 Jun; 5(2):431-51.
    View PubMed
  835. Greydanus MP, Vassallo M, Camilleri M, Nelson DK, Hanson RB, Thomforde GM. Neurohormonal factors in functional dyspepsia: insights on pathophysiological mechanisms. Gastroenterology. 1991 May; 100 (5 Pt 1):1311-8
    View PubMed
  836. Camilleri M, Zinsmeister AR, Greydanus MP, Brown ML, Proano M, Brown ML. Towards a less costly but accurate test of gastric emptying and small bowel transit. Dig Dis Sci. 1991 May; 36 (5):609-15
    View PubMed
  837. Abell TL, Camilleri M, DiMagno EP, Hench VS, Zinsmeister AR, Malagelada JR. Long-term efficacy of oral cisapride in symptomatic upper gut dysmotility. Dig Dis Sci. 1991 May; 36 (5):616-20
    View PubMed
  838. Abell TL, Camilleri M, Hench VS, Malagelada JR. Gastric electromechanical function and gastric emptying in diabetic gastroparesis. Eur J Gastroenterol Hepatol. 1991 Feb; 3:163-167.
  839. Camilleri M, Phillips SF. Acute and chronic intestinal pseudo-obstruction. Adv Intern Med. 1991; 36:287-306.
    View PubMed
  840. Vassallo M, Camilleri M, Caron BL, Low PA. Gastrointestinal motor dysfunction in acquired selective cholinergic dysautonomia associated with infectious mononucleosis. Gastroenterology. 1991 Jan; 100 (1):252-8
    View PubMed
  841. Camilleri M. Medical treatment of chronic intestinal pseudo-obstruction. Pract Gastroenterol. 1991; 15:10-22.
  842. Lennon VA, Sas DF, Busk MF, Scheithauer B, Malagelada JR, Camilleri M, Miller LJ. Enteric neuronal autoantibodies in pseudoobstruction with small-cell lung carcinoma. Gastroenterology. 1991 Jan; 100 (1):137-42
    View PubMed
  843. Kelly DG, Camilleri M. Gastrointestinal motility. Support Line. 1991; 13:7-10.
  844. Camilleri M. A guide to the treatment of GI motility disorders. Drug Therapy. 1991; 21:15-28.
    View PubMed
  845. Kim CH, Kennedy FP, Camilleri M, Zinsmeister AR, Ballard DJ. The relationship between clinical factors and gastrointestinal dysmotility in diabetes mellitus. Journal of Gastrointestinal Motility. 1991; 3:268-272.
  846. Sandborn WJ, Camilleri M. Laboratory investigation in inflammatory bowel disease. Pract Gastroenterol. 1991; 15:11-15.
  847. Proano M, Camilleri M, Phillips SF, Thomforde GM, Brown ML, Tucker RL. Unprepared human colon does not discriminate between solids and liquids. Am J Physiol. 1991 Jan; 260 (1 Pt 1):G13-6
    View PubMed
  848. Thomforde GM, Malagelada JR, Camilleri M, Yaksh TL. Demonstration of intrathecal and systemic morphine and ST-91 effects on fed canine upper gut motility. Dig Dis Sci. 1990 Oct; 35 (10):1249-56
    View PubMed
  849. Fich A, Neri M, Camilleri M, Kelly KA, Phillips SF. Stasis syndromes following gastric surgery: clinical and motility features of 60 symptomatic patients. J Clin Gastroenterol. 1990 Oct; 12(5):505-12.
    View PubMed
  850. Greydanus MP, Camilleri M, Colemont LJ, Phillips SF, Brown ML, Thomforde GM, Brown ML. Ileocolonic transfer of solid chyme in small intestinal neuropathies and myopathies. Gastroenterology. 1990 Jul; 99 (1):158-64
    View PubMed
  851. Camilleri M. Disorders of gastrointestinal motility in neurologic diseases. Mayo Clin Proc. 1990 Jun; 65 (6):825-46
    View PubMed
  852. Proano M, Camilleri M, Phillips SF, Brown ML, Thomforde GM. Transit of solids through the human colon: regional quantification in the unprepared bowel. Am J Physiol. 1990 Jun; 258 (6 Pt 1):G856-62
    View PubMed
  853. Camilleri M, Fealey RD. Idiopathic autonomic denervation in eight patients presenting with functional gastrointestinal disease. A causal association? Dig Dis Sci. 1990 May; 35 (5):609-16
    View PubMed
  854. Sodhi N, Camilleri M, Camoriano JK, Low PA, Fealey RD, Perry MC. Autonomic function and motility in intestinal pseudoobstruction caused by paraneoplastic syndrome. Dig Dis Sci. 1989 Dec; 34 (12):1937-42
    View PubMed
  855. Camilleri M, Neri M. Motility disorders and stress. Dig Dis Sci. 1989 Nov; 34 (11):1777-86
    View PubMed
  856. Talley NJ, Camilleri M, Orkin BA, Kramlinger KG. Effect of cyclical unipolar depression on upper gastrointestinal motility and sleep. Gastroenterology. 1989 Sep; 97 (3):775-7
    View PubMed
  857. Fich A, Camilleri M, Phillips SF. Effect of age on human gastric and small bowel motility. J Clin Gastroenterol. 1989 Aug; 11 (4):416-20
    View PubMed
  858. Barbara L, Camilleri M, Corinaldesi R, Crean GP, Heading RC, Johnson AG, Malagelada JR, Stanghellini V, Wienbeck M. Definition and investigation of dyspepsia. Consensus of an international ad hoc working party. Dig Dis Sci. 1989 Aug; 34(8):1272-6.
    View PubMed
  859. Camilleri M, Colemont LJ, Phillips SF, Brown ML, Thomforde GM, Chapman N, Zinsmeister AR. Human gastric emptying and colonic filling of solids characterized by a new method. Am J Physiol. 1989 Aug; 257 (2 Pt 1):G284-90
    View PubMed
  860. Camilleri M, Proano M. Advances in the assessment of disease activity in inflammatory bowel disease. Mayo Clin Proc. 1989 Jul; 64 (7):800-7
    View PubMed
  861. Camilleri M, Phillips SF. Disorders of small intestinal motility. Gastroenterol Clin North Am. 1989 Jun; 18(2):405-24.
    View PubMed
  862. Camilleri M. Jejunal manometry in distal subacute mechanical obstruction: significance of prolonged simultaneous contractions. Gut. 1989 Apr; 30 (4):468-75
    View PubMed
  863. Camilleri M, Malagelada JR, Abell TL, Brown ML, Hench V, Zinsmeister AR. Effect of six weeks of treatment with cisapride in gastroparesis and intestinal pseudoobstruction. Gastroenterology. 1989 Mar; 96 (3):704-12
    View PubMed
  864. Greydanus MP, Camilleri M. Abnormal postcibal antral and small bowel motility due to neuropathy or myopathy in systemic sclerosis. Gastroenterology. 1989 Jan; 96 (1):110-5
    View PubMed
  865. Colemont LJ, Camilleri M. Chronic intestinal pseudo-obstruction: diagnosis and treatment. Mayo Clin Proc. 1989 Jan; 64 (1):60-70
    View PubMed
  866. Camilleri M. Chronic intestinal pseudo-obstruction: new approaches in diagnosis and treatment. Investigation and Treatment of Upper Gastrointestinal Motility Disorders Proceedings of a symposium held in Ottawa, Canada Publishing Foundation, , pp 19-26. 1988; Toronto: The Medicine.
  867. Abell TL, Malagelada JR, Lucas AR, Brown ML, Brown ML, Camilleri M, Go VL, Azpiroz F, Callaway CW, Kao PC, Zinsmeister AR. Gastric electromechanical and neurohormonal function in anorexia nervosa. Gastroenterology. 1987 Nov; 93 (5):958-65
    View PubMed
  868. Shetty N, Camilleri M, Moss DW, Hodgson HJ. Subtle hyperthyroidism presenting as suspected hepatobiliary disease. J Clin Gastroenterol. 1987 Apr; 9(2):186-8.
    View PubMed
  869. Camilleri M. Clinical gastroenterology in Malta. Malta: Printex Publishers; 1987.
  870. Stanghellini V, Camilleri M, Malagelada JR. Chronic idiopathic intestinal pseudo-obstruction: clinical and intestinal manometric findings. Gut. 1987 Jan; 28(1):5-12.
    View PubMed
  871. Vassallo M, Camilleri M. Monoclonal protein amyloidosis presenting with hepatomegaly Clinical Gastroenterology in Malta Camiller M ed Publishers Printex Malta, , pp77-81. 1987; 0: 0.
  872. Camilleri M. AIDS diagnosis and control: report on the current situation in Malta, March 1987. AIDS Diagnosis and Report of a WHO meeting held in Munich March 16-18, Koch MA, Deinhardt F, eds Munich MMV Medizin Verlag, 1988, pp 139-140. 1987; Control: Current Situation.
  873. Camilleri M, Malagelada JR, Kao PC, Zinsmeister AR. Gastric and autonomic responses to stress in functional dyspepsia. Dig Dis Sci. 1986 Nov; 31:1169-1177.
    View PubMed
  874. Camilleri M, Brown ML, Malagelada JR. Impaired transit of chyme in chronic intestinal pseudoobstruction. Correction by cisapride. Gastroenterology. 1986 Sep; 91(3):619-26.
    View PubMed
  875. Camilleri M, Thompson DG, Malagelada JR. Functional dyspepsia. Symptoms and underlying mechanism. J Clin Gastroenterol. 1986 Aug; 8(4):424-9.
    View PubMed
  876. Camilleri M, Brown ML, Malagelada JR. Relationship between impaired gastric emptying and abnormal gastrointestinal motility. Gastroenterology. 1986 Jul; 91(1):94-9.
    View PubMed
  877. Camilleri M, Malagelada JR, Stanghellini V, Zinsmeister AR, Kao PC, Li CH. Dose-related effects of synthetic human beta-endorphin and naloxone on fed gastrointestinal motility. Am J Physiol. 1986 Jul; 251(1 Pt 1):G147-54.
    View PubMed
  878. Mearin F, Camilleri M, Malagelada JR. Pyloric dysfunction in diabetics with recurrent nausea and vomiting. Gastroenterology. 1986 Jun; 90(6):1919-25.
    View PubMed
  879. Saverymuttu SH, Camilleri M, Rees H, Lavender JP, Hodgson HJ, Chadwick VS. Indium 111-granulocyte scanning in the assessment of disease extent and disease activity in inflammatory bowel disease. A comparison with colonoscopy, histology, and fecal indium 111-granulocyte excretion. Gastroenterology. 1986 May; 90(5 Pt 1):1121-8.
    View PubMed
  880. Camilleri M, Mearin F. Evaluation of gastric motility disorders by gastrointestinal manometry and radioscintigraphic gastric emptying studies. Gastrum. 1986 Apr; 34-40.
  881. Mearin F, Camilleri M. Diabetic gastroparesis. Gastrum. 1986 Apr; 40-5.
  882. Camilleri M. Alimentary tract and pancreas. New approaches to the diagnosis of functional upper gut disease. J Gastroenterol Hepatol. 1986; 1:273-279.
  883. Wood JR, Camilleri M, Low PA, Malagelada JR. Brainstem tumor presenting as an upper gut motility disorder. Gastroenterology. 1985 Dec; 89(6):1411-4.
    View PubMed
  884. Camilleri M, Malagelada JR, Brown ML, Becker G, Zinsmeister AR. Relation between antral motility and gastric emptying of solids and liquids in humans. Am J Physiol. 1985 Nov; 249(5 Pt 1):G580-5.
    View PubMed
  885. Camilleri M, Malagelada JR, Stanghellini V, Fealey RD, Sheps SG. Gastrointestinal motility disturbances in patients with orthostatic hypotension. Gastroenterology. 1985 Jun; 88(6):1852-9.
    View PubMed
  886. Camilleri M, Malagelada JR. Abnormal intestinal motility in diabetics with the gastroparesis syndrome. Eur J Clin Invest. 1984 Dec; 14(6):420-7.
    View PubMed
  887. Camilleri M, Malagelada JR, Kao PC, Zinsmeister AR. Effect of somatovisceral reflexes and selective dermatomal stimulation on postcibal antral pressure activity. Am J Physiol. 1984 Dec; 247(6 Pt 1):G703-8.
    View PubMed
  888. Malagelada JR, Camilleri M. Unexplained vomiting: a diagnostic challenge. Ann Intern Med. 1984 Aug; 101(2):211-8.
    View PubMed
  889. Camilleri M, Chadwick VS, Hodgson HJ. Vascular anomalies of the gastrointestinal tract. Hepatogastroenterology. 1984 Jun; 31(3):149-53.
    View PubMed
  890. Camilleri M, Victorino RM, Hodgson HJ. Halothane aggravation of chronic liver disease. Acta Med Port. 1984 Jun; 5(6):194-6.
    View PubMed
  891. Cox TM, O'Donnell MW, Camilleri M. Allelic heterogeneity in adult hereditary fructose intolerance. Detection of structural mutations in the aldolase B molecule. Mol Biol Med. 1983 Nov; 1(4):393-400.
    View PubMed
  892. Camilleri M, Krausz T, Lewis PD, Hodgson HJ, Pallis CA, Chadwick VS. Malignant histiocytosis and encephalomyeloradiculopathy complicating coeliac disease. Gut. 1983 May; 24(5):441-7.
    View PubMed
  893. Camilleri M, Pusey CD, Chadwick VS, Rees AJ. Gastrointestinal manifestations of systemic vasculitis. Q J Med. 1983 Spring; 52(206):141-9.
    View PubMed
  894. Cox TM, O'Donnell MW, Sochor M, Camilleri M, McLean P. Hereditary fructose intolerance: presence of a potent inhibitor of fructose-1-phosphate aldolase in the liver. Biochem Soc Trans. 1983; 11:202-203.
  895. Cox TM, O'Donnell MW, Camilleri M, Burghes A. Isolation and characterization of a mutant liver aldolase in adult hereditary fructose intolerance. J Clin Invest. 1983; 72:201-213.
    View PubMed
  896. Maton PN, Camilleri M, Griffin GE, Allison DJ, Hodgson HJF, Chadwick VS. Role of hepatic artery embolization in the carcinoid syndrome. Br Med J. 1983; 287:932-934.
  897. Camilleri M, Satti MB, Wood CB. Cystic lymphangioma of the colon. Endoscopic and histologic features. Diseases of the Colon & Rectum. 1982 Nov-Dec; 25(8):813-6.
    View PubMed
  898. Camilleri M, Hemingway AP, Chadwick VS, Blumgart LH, Hodgson HJ, Allison DJ. Embolization of an intrapancreatic aneurysm. Br J Radiol. 1982 Sep; 55(657):685-7.
    View PubMed
  899. Cox TM, Camilleri M, O'Donnell MW, Chadwick VS. Pseudodominant transmission of fructose intolerance in an adult and three offspring: Heterozygote detection by intestinal biopsy. N Engl J Med. 1982 Aug 26; 307(9):537-40.
    View PubMed
  900. Camilleri M, Murphy R, Chadwick VS. Pharmacological inhibition of chenodeoxycholic acid-induced secretion of fluid and mucus in the rabbit colon. Dig Dis Sci. 1982; 27:865-869.
    View PubMed
  901. Camilleri M, Schafler K, Chadwick VS, Hodgson HJ, Weinbren K. Periportal sinusoidal dilatation, inflammatory bowel disease, and the contraceptive pill. Gastroenterology. 1981 Apr; 80(4):810-5.
    View PubMed
  902. Camilleri M, Cooper BT, Adrian T, Bloom SR, Chadwick VS. Effects of vasoactive intestinal polypeptide and pancreatic polypeptide in the rabbit intestine. Gut. 1981; 22:14-18.
    View PubMed
  903. Chadwick VS, Camilleri M. Role of bile acids in the pathogenesis of diarrhea in various diseases. Acta Gastroenterol Belg. 1981; 44:43-48.
    View PubMed
  904. Camilleri M, Murphy R, Chadwick VS. Dose-related effects of chenodeoxycholic acid in the rabbit colon. Dig Dis Sci. 1980 Jun; 25(6):433-8.
    View PubMed
  905. Camilleri M, Fenech FF. Thrombophlebitis migrans in ulcerative colitis. Postgrad Med J. 1977; 52:762-763.
  906. Camilleri M. Anatomy of the newborn child. Chest-Piece (Malta). 1972 Dec;